Delaware
|
63-0860407
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(I.R.S.
Employer
Identification
No.)
|
3660
Grandview Parkway, Suite 200
Birmingham,
Alabama
|
35243
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Title of each class
|
Name
of each exchange
on which registered
|
Common
Stock, $0.01 par value
|
New
York Stock Exchange
|
Page
|
||
•
|
each
of the factors discussed in Item 1A,
Risk
Factors
;
|
•
|
uncertainties
and factors discussed elsewhere in this Form 10-K, in our other filings
from time to time with the SEC, or in materials incorporated therein by
reference;
|
•
|
changes
or delays in, or suspension of, reimbursement for our services by
governmental or private payors, including our ability to obtain and retain
favorable arrangements with third-party
payors;
|
•
|
changes
in the regulations of the healthcare industry at either or both of the
federal and state levels;
|
•
|
our
ability to attract and retain nurses, therapists, and other healthcare
professionals in a highly competitive environment with often severe
staffing shortages and the impact on our labor expenses from potential
union activity and staffing
shortages;
|
•
|
competitive
pressures in the healthcare industry and our response to those
pressures;
|
•
|
our
ability to successfully access the credit markets on favorable terms;
and
|
•
|
general
conditions in the economy and capital
markets.
|
Business
|
•
|
People
. We believe our
22,000 employees, in particular our highly skilled clinical staff, share a
steadfast commitment to providing outstanding rehabilitative care to
patients across the country. Because of the value and importance we
attribute to our clinical staff, we work very hard to reduce our turnover
rates. We also undertake significant efforts to ensure our clinical and
support staff maintains the education and training necessary to provide
the highest quality rehabilitative care in a cost-effective
manner.
|
•
|
Quality
. Our hospitals
provide a broad base of clinical experience from which we have developed
clinical best practices and protocols. We believe these clinical best
practices and protocols help ensure the delivery of consistently
high-quality rehabilitative healthcare services across all of our
hospitals.
|
•
|
Efficiency and Cost
Effectiveness
. Our size helps us provide inpatient rehabilitative
healthcare services on a cost-effective basis. Specifically, because of
our large number of inpatient hospitals, we can utilize proven staffing
models and take advantage of certain supply chain efficiencies. We have
also developed a program called “TeamWorks,” which is an
operations-focused initiative using identified “best practices” to reduce
inefficiencies and improve performance across a wide spectrum of
operational areas.
|
•
|
Technology
. As a market
leader in inpatient rehabilitation, we have devoted substantial effort and
expertise to leveraging rehabilitative technology. For example, we have
developed an innovative therapeutic device called the “AutoAmbulator,”
which can help advance the rehabilitative process for patients who
experience difficulty walking. Technology instituted in our facilities
allows us to effectively treat patients with a wide variety of significant
physical disabilities.
|
•
|
strengthening
our balance sheet by reducing our long-term debt and improving our
leverage,
|
•
|
providing
high-quality, cost-effective care,
|
•
|
enhancing
the operations of our inpatient rehabilitation
hospitals,
|
•
|
sustaining
discharge growth and increasing market share,
and
|
•
|
expanding
our inpatient rehabilitation business with disciplined
development.
|
•
|
convert
$300 million of outstanding term loans into a new class of term loans with
an extension of the maturity to September 2015 and a 150 basis point step
up in interest rate;
|
•
|
permit
future extensions of all or a portion of the term loans, revolving credit
facility, and synthetic letter of credit commitments, subject to certain
restrictions;
|
•
|
permit
issuance of senior notes, both secured, on a
pari passu
basis with
indebtedness incurred under our credit agreement, and unsecured;
and
|
•
|
make
other changes, including increasing certain baskets under the restrictive
covenants, that are more consistent with our financial
position.
|
For
the Year Ended December 31,
|
|||||
2009
|
2008
|
2007
|
|||
Medicare
|
67.9%
|
67.2%
|
67.8%
|
||
Medicaid
|
2.1%
|
2.2%
|
2.0%
|
||
Workers’
compensation
|
1.6%
|
2.1%
|
2.3%
|
||
Managed
care and other discount plans
|
23.1%
|
22.4%
|
20.5%
|
||
Other
third-party payors
|
2.7%
|
3.5%
|
4.0%
|
||
Patients
|
1.2%
|
1.0%
|
1.1%
|
||
Other
income
|
1.4%
|
1.6%
|
2.3%
|
||
Total
|
100.0%
|
100.0%
|
100.0%
|
Item 1A
.
|
Risk
Factors
|
•
|
licensure,
certification, and accreditation,
|
•
|
coding
and billing for services,
|
•
|
requirements
of the 60% compliance threshold under the 2007 Medicare
Act,
|
•
|
relationships
with physicians and other referral sources, including physician
self-referral and anti-kickback
laws,
|
•
|
quality
of medical care,
|
•
|
use
and maintenance of medical supplies and
equipment,
|
•
|
maintenance
and security of medical records,
|
•
|
acquisition
and dispensing of pharmaceuticals and controlled substances,
and
|
•
|
disposal
of medical and hazardous waste.
|
•
|
limitations,
including competition to make acquisitions in certain markets, on our
ability to identify acquisitions that meet our target
criteria,
|
•
|
limitations,
including CMS and other regulatory approval requirements, on our ability
to complete such acquisitions on reasonable terms and
valuations,
|
•
|
limitations
in obtaining financing for acquisitions at a reasonable
cost,
|
•
|
difficulties
integrating acquired operations, personnel, and information systems, and
in realizing projected efficiencies and cost
savings,
|
•
|
entry
into markets in which we may have limited or no experience,
and
|
•
|
exposure
to undisclosed or unforeseen liabilities of acquired operations, including
liabilities for failure to comply with healthcare
laws.
|
Item 1B
.
|
Unresolved
Staff Comments
|
|
Number
of Hospitals
|
||||||||
State
|
Licensed
Beds
|
Owned
|
Leased
|
Total
|
|||||
Alabama
*
|
371
|
|
1
|
5
|
|
6
|
|||
Arizona
|
315
|
|
1
|
5
|
|
6
|
|||
Arkansas
|
207
|
|
1
|
3
|
|
4
|
|||
California
|
108
|
|
1
|
1
|
|
2
|
|||
Colorado
|
64
|
|
-
|
1
|
|
1
|
|||
Florida
*
|
793
|
|
6
|
4
|
|
10
|
|||
Illinois
*
|
50
|
|
-
|
1
|
|
1
|
|||
Indiana
|
80
|
|
-
|
1
|
|
1
|
|||
Kansas
|
224
|
|
1
|
2
|
|
3
|
|||
Kentucky
*
|
80
|
|
-
|
2
|
|
2
|
|||
Louisiana
|
217
|
|
3
|
-
|
|
3
|
(1)
|
||
Maine
*
|
100
|
|
-
|
1
|
|
1
|
|||
Maryland
*
|
54
|
|
1
|
-
|
|
1
|
|||
Massachusetts
*
|
53
|
|
1
|
1
|
|
2
|
|||
Missouri
*
|
140
|
|
-
|
2
|
|
2
|
|||
Nevada
|
219
|
|
3
|
-
|
|
3
|
|||
New
Hampshire *
|
50
|
|
-
|
1
|
|
1
|
|||
New
Jersey *
|
229
|
|
1
|
2
|
|
3
|
|||
New
Mexico
|
87
|
|
1
|
-
|
|
1
|
|||
Pennsylvania
|
931
|
|
4
|
7
|
|
11
|
|||
Puerto
Rico *
|
72
|
|
-
|
2
|
|
2
|
|||
South
Carolina *
|
310
|
|
1
|
4
|
|
5
|
|||
Tennessee
*
|
370
|
|
3
|
3
|
|
6
|
|||
Texas
|
1,026
|
|
10
|
4
|
|
14
|
|||
Utah
|
84
|
1
|
-
|
1
|
|||||
Virginia
*
|
170
|
1
|
3
|
4
|
|||||
West
Virginia *
|
248
|
1
|
3
|
4
|
|||||
6,652
|
(2)
|
42
|
58
|
|
100
|
* | Certificate of Need State |
(1)
|
The
information for Louisiana includes the assets of Baton Rouge Rehab, Inc.,
including the related 80-bed hospital property, which were the subject of
a definitive sale agreement, dated December 31, 2009, and were classified
as assets held for sale as of December 31, 2009. The sale transaction
closed on January 29, 2010.
|
(2) | Excludes 211 licensed beds associated with hospitals accounted for under the equity method of accounting. |
Item 3
.
|
Legal
Proceedings
|
Item 4
.
|
Submission
of Matters to a Vote of Security
Holders
|
Item 5
.
|
Market
for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities
|
High
|
Low
|
|||||||
2008
|
||||||||
First
Quarter
|
$ | 21.70 | $ | 15.20 | ||||
Second
Quarter
|
20.20 | 16.56 | ||||||
Third
Quarter
|
19.98 | 15.01 | ||||||
Fourth
Quarter
|
18.36 | 7.20 | ||||||
2009
|
||||||||
First
Quarter
|
$ | 11.88 | $ | 6.71 | ||||
Second
Quarter
|
14.66 | 8.13 | ||||||
Third
Quarter
|
16.54 | 12.76 | ||||||
Fourth
Quarter
|
20.00 | 14.45 |
Period
|
Total
Number of Shares (or Units) Purchased
(1)
|
Average
Price Paid per Share (or Unit)
|
Total
Number of Shares (or Units) Purchased as Part of Publicly Announced Plans
or Programs
|
Maximum Number
of Shares (or
Units)
That May
Yet
Be Purchased Under the Plans or Programs
|
||||||||||||
October
1 through
October
31, 2009
|
4,374 | $ | 17.36 | – | – | |||||||||||
November
1 through
November
30, 2009
|
– | – | – | – | ||||||||||||
December
1 through
December
31, 2009
|
– | – | – | – | ||||||||||||
Total
|
4,374 | 17.36 | – | – |
(1) | Shares in this column were tendered by an employee as payment of tax liability incident to the vesting of previously awarded shares of restricted stock. |
For
the Year Ended December 31,
|
||||||||||||
Base
|
||||||||||||
Period
|
Cumulative
Total Return
|
|||||||||||
Company/Index
Name
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
||||||
HealthSouth
Corporation
|
100.00
|
78.03
|
72.13
|
66.88
|
34.90
|
59.78
|
||||||
Standard
& Poor's 500 Index
|
100.00
|
104.91
|
121.48
|
128.16
|
80.74
|
102.11
|
||||||
S&P
Health Care Services Select Industry Index
|
100.00
|
132.37
|
139.27
|
218.29
|
181.42
|
255.29
|
||||||
Morgan
Stanley Health Care Provider Index
|
100.00
|
109.28
|
112.29
|
101.25
|
78.67
|
102.33
|
Item 6
.
|
Selected
Financial Data
|
•
|
Certain
previously reported financial results have been reclassified to conform to
the current year presentation. These reclassifications primarily relate to
operations reflected as discontinued operations and the retrospective
application of accounting guidance related to noncontrolling interests.
See the “Noncontrolling Interests in Consolidated Affiliates” section of
Note 1,
Summary of
Significant Accounting Policies
, and Note 18,
Assets Held for Sale and
Results of Discontinued Operations
, to the accompanying
consolidated financial statements for additional
information.
|
•
|
Depreciation and
amortization
in 2008 includes the acceleration of approximately $10
million of depreciation associated with our corporate campus that was sold
in March 2008. See Note 5,
Property and Equipment
,
to the accompanying consolidated financial
statements.
|
•
|
The
impairment charges recorded in 2007, 2006, and 2005 primarily related to
the Digital Hospital, an incomplete 13-story building located on the
property we sold to Daniel Corporation in March 2008, and represented the
excess of costs incurred during the construction of the Digital Hospital
over the estimated fair market value of the property, including the
RiverPoint facility, a 60,000 square foot office building which shared the
construction site. The impairment of the Digital Hospital in each year was
determined using either its estimated fair value based on the estimated
net proceeds we expected to receive in a sale transaction or using a
weighted-average fair value approach that considered an alternative use
appraisal and other potential scenarios. See Note 5,
Property and Equipment
,
to the accompanying consolidated financial statements for additional
information.
|
•
|
During
2006, an Alabama Circuit Court issued a summary judgment against Richard
M. Scrushy, our former chairman and chief executive officer, on a claim
for restitution of incentive bonuses Mr. Scrushy received for years 1996
through 2002. Including pre-judgment interest, the court’s total award was
approximately $48 million. Based on this judgment, we recorded $47.8
million during 2006 as
Recovery of amounts due from
Richard M. Scrushy
, excluding approximately $5.0 million of
post-judgment interest recorded as interest
income.
|
•
|
In
2001 and 2002, we reserved approximately $38.0 million related to amounts
due from Meadowbrook Healthcare, Inc. (“Meadowbrook”), an entity formed by
one of our former chief financial officers related to net working capital
advances made to Meadowbrook in 2001 and 2002. In August 2005, we received
a payment of $37.9 million from Meadowbrook. This cash payment is included
as
Recovery of amounts
due from Meadowbrook
in our 2005 consolidated statement of
operations.
|
•
|
As
a result of the UBS Settlement, we recorded a $121.3 million gain in our
2008 consolidated statement of operations. For additional information, see
Note 22,
Settlements
, to the
accompanying consolidated financial
statements.
|
•
|
As
a result of a dispute and lease termination associated with Braintree
Rehabilitation Hospital in Braintree, Massachusetts and New England
Rehabilitation Hospital in Woburn, Massachusetts, we recorded a $30.5
million net gain on lease termination during 2005. This net gain is
included in
Occupancy
costs
in our 2005 consolidated statement of
operations.
|
•
|
Government, class action, and
related settlements expense
includes amounts related to litigation
and settlements with various entities and individuals. In each year, this
line item primarily includes amounts associated with our securities
litigation settlement. In 2005, we recorded a $215.0 million charge, to be
paid in the form of common stock and common stock warrants, as
Government, class action, and
related settlements expense
under the then-proposed settlement with
the lead plaintiffs in the federal securities class actions and the
derivative litigation, as well as with our insurance carriers, to settle
claims filed against us, certain of our former directors and officers, and
certain other parties. In each year subsequent to 2005, we adjusted this
liability to reflect the fair market value of the common stock and
warrants underlying this settlement as of each reporting date. The common
stock and warrants associated with this settlement were issued in
September 2009.
|
•
|
For
additional information related to this line item, see Item 7,
Management’s Discussion and
Analysis of Financial Condition and Results of Operations
, and Note
22,
Settlements
,
and Note 23,
Contingencies and Other
Commitments
, to the accompanying consolidated financial
statements.
|
•
|
Professional fees –
accounting, tax, and legal
includes fees arising from our prior
reporting and restatement issues. Specifically, these fees include legal
fees for litigation defense and support matters, tax preparation and
consulting fees for various tax projects, and fees for professional
services to support the preparation of our periodic reports filed with the
SEC (excluding 2009 and 2008). For additional information, see Item 7,
Management’s Discussion
and Analysis of Financial Condition and Results of Operations
, and
Note 1,
Summary of
Significant Accounting Policies
, to the accompanying consolidated
financial statements.
|
•
|
As
stated throughout this report, we have been focused on reducing debt. As a
result of various recapitalization transactions and debt prepayments, we
have recorded net losses on early debt extinguishment. Specifically,
during 2006, we recorded a $365.6 million net loss on early extinguishment
of debt due to the completion of a private offering of senior notes in
June 2006 and a series of recapitalization transactions during the first
quarter of 2006. For additional information, see Item 7,
Management’s Discussion and
Analysis of Financial Condition and Results of Operations
, and Note
8,
Long-term
Debt
, to the accompanying consolidated financial
statements.
|
•
|
As
discussed in more detail in Note 9,
Derivative Instruments
,
to the accompanying consolidated financial statements, we maintain two
interest rate swaps that effectively convert the variable rate of our
credit agreement to a fixed interest rate. Fair value adjustments and
quarterly settlements for these swaps are included in the line item
Loss on interest rate
swaps
in the consolidated statements of
operations.
|
•
|
For
information related to our
Provision for income tax
(benefit) expense
, see Item 7,
Management’s Discussion and
Analysis of Financial Condition and Results of Operations
, and Note
19,
Income Taxes
,
to the accompanying consolidated financial
statements.
|
•
|
Our
Income from discontinued
operations, net of tax
in 2007 included post-tax gains on the
divestitures of our surgery centers, outpatient, and diagnostic divisions.
For additional information, see Note 18,
Assets Held for Sale and
Results of Discontinued Operations
, to the accompanying
consolidated financial statements.
|
For
the Year Ended December 31,
|
||||||||||||||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||||||||||||||
(As
Adjusted)
|
||||||||||||||||||||
(In
Millions, Except Per Share Data)
|
||||||||||||||||||||
Income
Statement Data:
|
||||||||||||||||||||
Net
operating revenues
|
$ | 1,911.1 | $ | 1,829.5 | $ | 1,723.5 | $ | 1,680.8 | $ | 1,719.8 | ||||||||||
Salaries
and benefits
|
948.8 | 928.2 | 857.5 | 813.0 | 800.9 | |||||||||||||||
Other
operating expenses
|
271.4 | 264.9 | 241.0 | 220.3 | 253.0 | |||||||||||||||
General
and administrative expenses
|
104.5 | 105.5 | 127.9 | 141.3 | 164.3 | |||||||||||||||
Supplies
|
112.4 | 108.2 | 99.6 | 99.7 | 101.5 | |||||||||||||||
Depreciation
and amortization
|
70.9 | 82.4 | 74.8 | 83.4 | 86.2 | |||||||||||||||
Impairment
of long-lived assets
|
- | 0.6 | 15.1 | 9.7 | 30.8 | |||||||||||||||
Recovery
of amounts due from Richard M. Scrushy
|
- | - | - | (47.8 | ) | - | ||||||||||||||
Recovery
of amounts due from Meadowbrook
|
- | - | - | - | (37.9 | ) | ||||||||||||||
Gain
on UBS Settlement
|
- | (121.3 | ) | - | - | - | ||||||||||||||
Occupancy
costs
|
47.6 | 48.8 | 51.4 | 53.3 | 10.6 | |||||||||||||||
Provision
for doubtful accounts
|
33.1 | 27.0 | 33.2 | 44.9 | 31.2 | |||||||||||||||
Loss
on disposal of assets
|
3.5 | 2.0 | 5.9 | 6.4 | 11.7 | |||||||||||||||
Government,
class action, and related settlements expense
|
36.7 | (67.2 | ) | (2.8 | ) | (4.8 | ) | 215.0 | ||||||||||||
Professional
fees—accounting, tax, and legal
|
8.8 | 44.4 | 51.6 | 161.4 | 169.1 | |||||||||||||||
Loss
on early extinguishment of debt
|
12.5 | 5.9 | 28.2 | 365.6 | - | |||||||||||||||
Interest
expense and amortization of debt discounts and fees
|
125.8 | 159.5 | 229.4 | 234.0 | 234.2 | |||||||||||||||
Other
income
|
(3.4 | ) | - | (15.5 | ) | (9.4 | ) | (16.6 | ) | |||||||||||
Loss
on interest rate swaps
|
19.6 | 55.7 | 30.4 | 10.5 | - | |||||||||||||||
Equity
in net income of nonconsolidated affiliates
|
(4.6 | ) | (10.6 | ) | (10.3 | ) | (8.7 | ) | (12.3 | ) | ||||||||||
Income
(loss) from continuing operations before income tax
(benefit)
expense
|
123.5 | 195.5 | (93.9 | ) | (492.0 | ) | (321.9 | ) | ||||||||||||
Provision
for income tax (benefit) expense
|
(3.2 | ) | (70.1 | ) | (322.4 | ) | 22.4 | 19.6 | ||||||||||||
Income
(loss) from continuing operations
|
126.7 | 265.6 | 228.5 | (514.4 | ) | (341.5 | ) | |||||||||||||
Income
(loss) from discontinued operations, net of tax
|
2.1 | 16.2 | 490.2 | (16.9 | ) | (6.0 | ) | |||||||||||||
Net
income (loss)
|
128.8 | 281.8 | 718.7 | (531.3 | ) | (347.5 | ) | |||||||||||||
Less:
Net income attributable to noncontrolling interests
|
(34.0 | ) | (29.4 | ) | (65.3 | ) | (93.7 | ) | (98.5 | ) | ||||||||||
Net
income (loss) attributable to HealthSouth
|
94.8 | 252.4 | 653.4 | (625.0 | ) | (446.0 | ) | |||||||||||||
Less:
Convertible perpetual preferred stock dividends
|
(26.0 | ) | (26.0 | ) | (26.0 | ) | (22.2 | ) | - | |||||||||||
Net
income (loss) attributable to HealthSouth common
shareholders
|
$ | 68.8 | $ | 226.4 | $ | 627.4 | $ | (647.2 | ) | $ | (446.0 | ) | ||||||||
Weighted
average common shares outstanding:
|
||||||||||||||||||||
Basic
|
88.8 | 83.0 | 78.7 | 79.5 | 79.3 | |||||||||||||||
Diluted
|
103.3 | 96.4 | 92.0 | 90.3 | 79.6 | |||||||||||||||
Earnings
(loss) per common share:
|
||||||||||||||||||||
Basic:
|
||||||||||||||||||||
Income
(loss) from continuing operations attributable to
HealthSouth
common shareholders
|
$ | 0.76 | $ | 2.53 | $ | 2.17 | $ | (7.08 | ) | $ | (4.83 | ) | ||||||||
Income
(loss) from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.20 | 5.80 | (1.06 | ) | (0.79 | ) | |||||||||||||
Net
income (loss) attributable to HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.73 | $ | 7.97 | $ | (8.14 | ) | $ | (5.62 | ) | ||||||||
Diluted:
|
||||||||||||||||||||
Income
(loss) from continuing operations attributable to
HealthSouth
common shareholders
|
$ | 0.76 | $ | 2.45 | $ | 2.14 | $ | (7.08 | ) | $ | (4.83 | ) | ||||||||
Income
(loss) from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.17 | 4.96 | (1.06 | ) | (0.79 | ) | |||||||||||||
Net
income (loss) attributable to HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.62 | $ | 7.10 | $ | (8.14 | ) | $ | (5.62 | ) | ||||||||
Amounts
attributable to HealthSouth:
|
||||||||||||||||||||
Income
(loss) from continuing operations
|
$ | 93.3 | $ | 235.8 | $ | 197.1 | $ | (540.7 | ) | $ | (383.2 | ) | ||||||||
Income
(loss) from discontinued operations, net of tax
|
1.5 | 16.6 | 456.3 | (84.3 | ) | (62.8 | ) | |||||||||||||
Net
income (loss) attributable to HealthSouth
|
$ | 94.8 | $ | 252.4 | $ | 653.4 | $ | (625.0 | ) | $ | (446.0 | ) |
Item 7
.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
•
|
Leverage and
Liquidity
. Our primary sources of liquidity are cash on hand, cash
flows from operations (which were $406.1 million during the year ended
December 31, 2009, including $73.8 million in net cash proceeds related to
the UBS Settlement and the receipt of $63.7 million in income tax refunds,
as discussed below), and borrowings under our $400 million revolving
credit facility. As of December 31, 2009, we had $80.9 million in
Cash and cash
equivalents
. This amount excluded $67.8 million in
Restricted cash
and
$21.0 million of restricted marketable securities. As of December 31,
2009, no amounts were drawn on our revolving credit
facility.
|
•
|
Highly Regulated
Industry
. Over the last several years, changes in regulations
governing inpatient rehabilitation reimbursement have created challenges
for inpatient rehabilitative providers. Many of these changes have
resulted in limitations on, and in some cases, reductions in, the levels
of payments to healthcare providers. For example, and as reported
previously, while The Medicare, Medicaid and State Children’s Health
Insurance Program (SCHIP) Extension Act of 2007 signed on December 29,
2007 may have stabilized much of the volatility in patient volumes created
by setting the compliance threshold of the 75% Rule at 60%, it also
included a reduction in the pricing of services eligible for Medicare
reimbursement to a pricing level that existed in the third quarter of 2007
(the Medicare pricing “roll-back”). See Item 1,
Business
, “Sources of
Revenue,” for additional information. During the period of the Medicare
pricing roll-back, we incurred increased costs, including costs associated
with providing annual merit increases and benefits to our employees,
without a corresponding increase to our Medicare reimbursement. This
Medicare pricing roll-back expired on September 30,
2009.
|
•
|
Potential Impact of
Healthcare Reform
. Although President Obama has identified
healthcare reform as a major domestic priority, and Congress has devoted
considerable effort to drafting healthcare reform legislation, at the time
of this writing, no specific healthcare reform legislation has been
adopted. The future of healthcare reform appears uncertain at this time.
Many issues are being discussed within the context of healthcare reform,
several of which could have an impact on our business. The three issues
with the greatest potential impact are: (1) reducing annual market basket
updates to providers,
|
|
With
respect to future reductions to market basket updates, and as previously
noted, while no specific healthcare legislation has been adopted at this
time, the healthcare reform bills that have been passed by both the U.S.
Senate and the House of Representatives include some kind of reduction to
market basket updates. While we cannot be certain of the magnitude of
these potential market basket reductions, or if they will be enacted, we
will be working with other providers, as well as other interested parties,
to help ensure they do not compromise our ability to provide high-quality
services to the patients we serve.
|
•
|
Staffing
. Our
operations are dependent on the efforts, abilities, and experience of our
medical personnel, such as physical therapists, occupational therapists,
speech pathologists, nurses, and other healthcare professionals. In some
markets, the lack of availability of medical personnel is an operating
issue facing all healthcare providers, although the weak economy has
mitigated this issue to some degree. We have refined our comprehensive
benefits package to remain competitive in this challenging staffing
environment while also being consistent with our goal of being a
high-quality, cost-effective provider of inpatient rehabilitative
services. As a result of our efforts, we are experiencing improved
retention rates and reduced turnover. Going forward, recruiting and
retaining qualified personnel for our hospitals will remain a high
priority for us.
|
For
the Year Ended December 31,
|
|||||
2009
|
2008
|
2007
|
|||
Medicare
|
67.9%
|
67.2%
|
67.8%
|
||
Medicaid
|
2.1%
|
2.2%
|
2.0%
|
||
Workers’
compensation
|
1.6%
|
2.1%
|
2.3%
|
||
Managed
care and other discount plans
|
23.1%
|
22.4%
|
20.5%
|
||
Other
third-party payors
|
2.7%
|
3.5%
|
4.0%
|
||
Patients
|
1.2%
|
1.0%
|
1.1%
|
||
Other
income
|
1.4%
|
1.6%
|
2.3%
|
||
Total
|
100.0%
|
100.0%
|
100.0%
|
For
the Year Ended December 31,
|
Percentage
Change
|
|||||||||||||||||||
2009
|
2008
|
2007
|
2009
vs. 2008
|
2008
vs. 2007
|
||||||||||||||||
(As
Adjusted)
|
||||||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 1,911.1 | $ | 1,829.5 | $ | 1,723.5 | 4.5 | % | 6.2 | % | ||||||||||
Operating
expenses:
|
||||||||||||||||||||
Salaries
and benefits
|
948.8 | 928.2 | 857.5 | 2.2 | % | 8.2 | % | |||||||||||||
Other
operating expenses
|
271.4 | 264.9 | 241.0 | 2.5 | % | 9.9 | % | |||||||||||||
General
and administrative expenses
|
104.5 | 105.5 | 127.9 | (0.9 | %) | (17.5 | %) | |||||||||||||
Supplies
|
112.4 | 108.2 | 99.6 | 3.9 | % | 8.6 | % | |||||||||||||
Depreciation
and amortization
|
70.9 | 82.4 | 74.8 | (14.0 | %) | 10.2 | % | |||||||||||||
Impairment
of long-lived assets
|
- | 0.6 | 15.1 | (100.0 | %) | (96.0 | %) | |||||||||||||
Gain
on UBS Settlement
|
- | (121.3 | ) | - | (100.0 | %) | N/A | |||||||||||||
Occupancy
costs
|
47.6 | 48.8 | 51.4 | (2.5 | %) | (5.1 | %) | |||||||||||||
Provision
for doubtful accounts
|
33.1 | 27.0 | 33.2 | 22.6 | % | (18.7 | %) | |||||||||||||
Loss
on disposal of assets
|
3.5 | 2.0 | 5.9 | 75.0 | % | (66.1 | %) | |||||||||||||
Government,
class action, and related settlements expense
|
36.7 | (67.2 | ) | (2.8 | ) | (154.6 | %) | 2,300.0 | % | |||||||||||
Professional
fees—accounting, tax, and legal
|
8.8 | 44.4 | 51.6 | (80.2 | %) | (14.0 | %) | |||||||||||||
Total
operating expenses
|
1,637.7 | 1,423.5 | 1,555.2 | 15.0 | % | (8.5 | %) | |||||||||||||
Loss
on early extinguishment of debt
|
12.5 | 5.9 | 28.2 | 111.9 | % | (79.1 | %) | |||||||||||||
Interest
expense and amortization of debt discounts and fees
|
125.8 | 159.5 | 229.4 | (21.1 | %) | (30.5 | %) | |||||||||||||
Other
income
|
(3.4 | ) | - | (15.5 | ) | N/A | (100.0 | %) | ||||||||||||
Loss
on interest rate swaps
|
19.6 | 55.7 | 30.4 | (64.8 | %) | 83.2 | % | |||||||||||||
Equity
in net income of nonconsolidated affiliates
|
(4.6 | ) | (10.6 | ) | (10.3 | ) | (56.6 | %) | 2.9 | % | ||||||||||
Income
(loss) from continuing operations before income
tax
benefit
|
123.5 | 195.5 | (93.9 | ) | (36.8 | %) | (308.2 | %) | ||||||||||||
Provision
for income tax benefit
|
(3.2 | ) | (70.1 | ) | (322.4 | ) | (95.4 | %) | (78.3 | %) | ||||||||||
Income
from continuing operations
|
126.7 | 265.6 | 228.5 | (52.3 | %) | 16.2 | % | |||||||||||||
Income
from discontinued operations, net of tax
|
2.1 | 16.2 | 490.2 | (87.0 | %) | (96.7 | %) | |||||||||||||
Net
income
|
128.8 | 281.8 | 718.7 | (54.3 | %) | (60.8 | %) | |||||||||||||
Less:
Net income attributable to noncontrolling interests
|
(34.0 | ) | (29.4 | ) | (65.3 | ) | 15.6 | % | (55.0 | %) | ||||||||||
Net
income attributable to HealthSouth
|
$ | 94.8 | $ | 252.4 | $ | 653.4 | (62.4 | %) | (61.4 | %) |
For
the Year Ended December 31,
|
||||||||
2009
|
2008
|
2007
|
||||||
Salaries
and benefits
|
49.6%
|
50.7%
|
49.8%
|
|||||
Other
operating expenses
|
14.2%
|
14.5%
|
14.0%
|
|||||
General
and administrative expenses
|
5.5%
|
5.8%
|
7.4%
|
|||||
Supplies
|
5.9%
|
5.9%
|
5.8%
|
|||||
Depreciation
and amortization
|
3.7%
|
4.5%
|
4.3%
|
|||||
Impairment
of long-lived assets
|
0.0%
|
0.0%
|
0.9%
|
|||||
Gain
on UBS Settlement
|
0.0%
|
(6.6%
|
) |
0.0%
|
||||
Occupancy
costs
|
2.5%
|
2.7%
|
3.0%
|
|||||
Provision
for doubtful accounts
|
1.7%
|
1.5%
|
1.9%
|
|||||
Loss
on disposal of assets
|
0.2%
|
0.1%
|
0.3%
|
|||||
Government,
class action, and related settlements expense
|
1.9%
|
(3.7%
|
) |
(0.2%
|
) | |||
Professional
fees—accounting, tax, and legal
|
0.5%
|
2.4%
|
3.0%
|
|||||
Total
|
85.7%
|
77.8%
|
90.2%
|
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(In
Millions)
|
||||||||||||
Net
patient revenue—inpatient
|
$ | 1,743.4 | $ | 1,651.7 | $ | 1,535.9 | ||||||
Net
patient revenue—outpatient and other revenues
|
167.7 | 177.8 | 187.6 | |||||||||
Net
operating revenues
|
$ | 1,911.1 | $ | 1,829.5 | $ | 1,723.5 | ||||||
(Actual
Amounts)
|
||||||||||||
Discharges
|
112,975 | 107,184 | 100,161 | |||||||||
Outpatient
visits
|
1,122,545 | 1,218,926 | 1,308,101 | |||||||||
Average
length of stay
|
14.3
days
|
14.7
days
|
15.1
days
|
|||||||||
Occupancy
%
|
67.3% | 66.8% | 63.9% | |||||||||
#
of licensed beds
|
6,572 | 6,463 | 6,493 | |||||||||
Full-time
equivalents*
|
15,504 | 15,473 | 15,297 |
|
*
|
Excludes
393, 410, and 565 full-time equivalents for the years ended
December 31, 2009, 2008, and 2007, respectively, who are considered
part of corporate overhead with their salaries and benefits included in
General and
administrative expenses
in our consolidated statements of
operations. Full-time equivalents included in the above table represent
those who participate in or support the operations of our hospitals and
exclude an estimate of full-time equivalents related to contract
labor.
|
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(In
Millions)
|
||||||||||||
Continuing
operations:
|
||||||||||||
Interest
expense
|
$ | 119.2 | $ | 153.0 | $ | 221.6 | ||||||
Amortization
of debt discounts and fees
|
6.6 | 6.5 | 7.8 | |||||||||
Interest
expense and amortization of debt
discounts and fees
|
125.8 | 159.5 | 229.4 | |||||||||
Interest
expense for discontinued operations
|
1.3 | 1.9 | 45.9 | |||||||||
Total
interest expense and amortization of debt discounts
and
fees
|
$ | 127.1 | $ | 161.4 | $ | 275.3 |
Year
Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
HealthSouth
Corporation:
|
||||||||||||
Net
operating revenues
|
$ | 9.8 | $ | 28.3 | $ | 53.1 | ||||||
Costs
and expenses
|
13.4 | 31.6 | 53.8 | |||||||||
Impairments
|
4.0 | 10.0 | - | |||||||||
Loss
from discontinued operations
|
(7.6 | ) | (13.3 | ) | (0.7 | ) | ||||||
(Loss)
gain on disposal of assets of discontinued operations
|
(0.4 | ) | (0.1 | ) | 1.6 | |||||||
Income
tax (expense) benefit
|
(0.1 | ) | (0.1 | ) | 0.2 | |||||||
(Loss)
income from discontinued operations, net of tax
|
$ | (8.1 | ) | $ | (13.5 | ) | $ | 1.1 | ||||
Surgery
Centers:
|
||||||||||||
Net
operating revenues
|
$ | 7.4 | $ | 10.7 | $ | 381.7 | ||||||
Costs
and expenses
|
3.9 | 6.6 | 324.5 | |||||||||
Impairments
|
- | 1.2 | 4.8 | |||||||||
Income
from discontinued operations
|
3.5 | 2.9 | 52.4 | |||||||||
Gain
on disposal of assets of discontinued operations
|
0.7 | 0.2 | 1.9 | |||||||||
Gain
on divestiture of division
|
13.4 | 19.3 | 314.9 | |||||||||
Income
tax benefit
|
0.4 | 3.8 | 18.4 | |||||||||
Income
from discontinued operations, net of tax
|
$ | 18.0 | $ | 26.2 | $ | 387.6 | ||||||
Other:
|
||||||||||||
Net
operating revenues
|
$ | 0.6 | $ | 2.7 | $ | 219.3 | ||||||
Costs
and expenses
|
8.5 | (2.0 | ) | 207.0 | ||||||||
Impairments
|
- | 0.6 | 33.4 | |||||||||
(Loss)
income from discontinued operations
|
(7.9 | ) | 4.1 | (21.1 | ) | |||||||
Gain
on disposal of assets of discontinued operations
|
0.1 | - | 1.6 | |||||||||
Net
(loss) gain on divestitures of divisions
|
- | (0.6 | ) | 137.0 | ||||||||
Income
tax expense
|
- | - | (16.0 | ) | ||||||||
(Loss)
income from discontinued operations, net of tax
|
$ | (7.8 | ) | $ | 3.5 | $ | 101.5 | |||||
Total:
|
||||||||||||
Net
operating revenues
|
$ | 17.8 | $ | 41.7 | $ | 654.1 | ||||||
Costs
and expenses
|
25.8 | 36.2 | 585.3 | |||||||||
Impairments
|
4.0 | 11.8 | 38.2 | |||||||||
(Loss)
income from discontinued operations
|
(12.0 | ) | (6.3 | ) | 30.6 | |||||||
Gain
on disposal of assets of discontinued operations
|
0.4 | 0.1 | 5.1 | |||||||||
Net
gain on divestitures of divisions
|
13.4 | 18.7 | 451.9 | |||||||||
Income
tax benefit
|
0.3 | 3.7 | 2.6 | |||||||||
Income
from discontinued operations, net of tax
|
$ | 2.1 | $ | 16.2 | $ | 490.2 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
cash provided by operating activities
|
$ | 406.1 | $ | 227.2 | $ | 230.6 | ||||||
Net
cash (used in) provided by investing activities
|
(133.0 | ) | (40.0 | ) | 1,184.5 | |||||||
Net
cash used in financing activities
|
(224.3 | ) | (176.0 | ) | (1,436.6 | ) | ||||||
Effect
of exchange rate changes on cash and cash
equivalents
|
- | 0.8 | 0.1 | |||||||||
Increase
(decrease) in cash and cash equivalents
|
$ | 48.8 | $ | 12.0 | $ | (21.4 | ) |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
income
|
$ | 128.8 | $ | 281.8 | $ | 718.7 | ||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth
|
(1.5 | ) | (16.6 | ) | (456.3 | ) | ||||||
Provision
for income tax benefit
|
(3.2 | ) | (70.1 | ) | (322.4 | ) | ||||||
Loss
on interest rate swaps
|
19.6 | 55.7 | 30.4 | |||||||||
Interest
expense and amortization of debt discounts and fees
|
125.8 | 159.5 | 229.4 | |||||||||
Loss
on early extinguishment of debt
|
12.5 | 5.9 | 28.2 | |||||||||
Professional
fees—accounting, tax, and legal
|
8.8 | 44.4 | 51.6 | |||||||||
Government,
class action, and related settlements,
including the gain on UBS
Settlement (2008)
|
36.7 | (188.5 | ) | (2.8 | ) | |||||||
Net
noncash loss on disposal of assets
|
3.5 | 2.0 | 5.9 | |||||||||
Depreciation
and amortization
|
70.9 | 82.4 | 74.8 | |||||||||
Impairment
charges, including investments
|
1.4 | 2.4 | 15.1 | |||||||||
Stock-based
compensation expense
|
13.4 | 11.7 | 10.6 | |||||||||
Net
income attributable to noncontrolling interests
|
(34.0 | ) | (29.4 | ) | (65.3 | ) | ||||||
Other
|
0.3 | - | 0.4 | |||||||||
Adjusted
Consolidated EBITDA
|
$ | 383.0 | $ | 341.2 | $ | 318.3 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Adjusted
Consolidated EBITDA
|
$ | 383.0 | $ | 341.2 | $ | 318.3 | ||||||
Provision
for doubtful accounts
|
33.1 | 27.0 | 33.2 | |||||||||
Professional
fees—accounting, tax, and legal
|
(8.8 | ) | (44.4 | ) | (51.6 | ) | ||||||
Interest
expense and amortization of debt discounts and fees
|
(125.8 | ) | (159.5 | ) | (229.4 | ) | ||||||
(Gain)
loss on sale of investments
|
(0.8 | ) | 1.4 | (12.3 | ) | |||||||
UBS
Settlement proceeds, gross
|
100.0 | - | - | |||||||||
Equity
in net income of nonconsolidated affiliates
|
(4.6 | ) | (10.6 | ) | (10.3 | ) | ||||||
Net
income attributable to noncontrolling interests in
continuing
operations
|
33.4 | 29.8 | 31.4 | |||||||||
Amortization
of debt discounts and fees
|
6.6 | 6.5 | 7.8 | |||||||||
Distributions
from nonconsolidated affiliates
|
8.6 | 10.9 | 5.3 | |||||||||
Current
portion of income tax benefit
|
7.3 | 73.8 | 330.4 | |||||||||
Change
in assets and liabilities
|
(0.8 | ) | (53.1 | ) | (8.0 | ) | ||||||
Change
in government, class action, and related settlements
liability
|
(11.2 | ) | (7.4 | ) | (171.4 | ) | ||||||
Other
operating cash (used in) provided by discontinued
operations
|
(13.5 | ) | 11.4 | (10.5 | ) | |||||||
Other
|
(0.4 | ) | 0.2 | (2.3 | ) | |||||||
Net
cash provided by operating activities
|
$ | 406.1 | $ | 227.2 | $ | 230.6 |
•
|
any
obligation under certain guarantees or
contracts;
|
•
|
a
retained or contingent interest in assets transferred to an unconsolidated
entity or similar entity or similar arrangement that serves as credit,
liquidity, or market risk support to that entity for such
assets;
|
•
|
any
obligation under certain derivative instruments;
and
|
•
|
any
obligation under a material variable interest held by the registrant in an
unconsolidated entity that provides financing, liquidity, market risk, or
credit risk support to the registrant, or engages in leasing, hedging, or
research and development services with the
registrant.
|
Total
|
2010
|
2011 – 2012 | 2013 – 2014 |
2015
and Thereafter
|
||||||||||||||||
Long-term
debt obligations:
|
||||||||||||||||||||
Long-term
debt, excluding revolving
credit facility and capital lease
obligations
(a)
|
$ | 1,561.2 | $ | 7.5 | $ | 16.9 | $ | 444.4 | $ | 1,092.4 | ||||||||||
Interest
on long-term debt
(b)
|
728.2 | 103.8 | 206.9 | 185.7 | 231.8 | |||||||||||||||
Capital
lease obligations
(c)
|
157.4 | 21.1 | 35.5 | 24.8 | 76.0 | |||||||||||||||
Operating
lease obligations
(d)(e)
|
216.6 | 37.1 | 56.1 | 35.2 | 88.2 | |||||||||||||||
Purchase
obligations
(e)(f)
|
32.5 | 24.2 | 6.1 | 2.2 | - | |||||||||||||||
Other
long-term liabilities
(g)
|
3.5 | 0.3 | 0.4 | 0.4 | 2.4 | |||||||||||||||
Total
|
$ | 2,699.4 | $ | 194.0 | $ | 321.9 | $ | 692.7 | $ | 1,490.8 |
(a)
|
Included
in long-term debt are amounts owed on our bonds payable and other notes
payable. These borrowings are further explained in Note 8,
Long-term Debt,
to the
accompanying consolidated financial
statements.
|
(b)
|
Interest
on our fixed rate debt is presented using the stated interest rate.
Interest expense on our variable rate debt is estimated using the rate in
effect as of December 31, 2009. Interest related to capital lease
obligations is excluded from this line. Amounts exclude amortization of
debt discounts, amortization of loan fees, or fees for lines of credit
that would be included in interest expense in our consolidated statements
of operations. Amounts also exclude the impact of our interest rate
swaps.
|
(c)
|
Amounts
include interest portion of future minimum capital lease
payments.
|
(d)
|
We
lease many of our hospitals as well as other property and equipment under
operating leases in the normal course of business. Some of our hospital
leases require percentage rentals on patient revenues above specified
minimums and contain escalation clauses. The minimum lease payments do not
include contingent rental expense. Some lease agreements provide us with
the option to renew the lease or purchase the leased property. Our future
operating lease obligations would change if we exercised these renewal
options and if we entered into additional operating lease agreements. For
more information, see Note 5,
Property and Equipment,
to the accompanying consolidated financial statements. In addition, as of
December 31, 2009, these amounts exclude $1.6 million of operating
lease obligations associated with facilities that are reported in
discontinued operations.
|
(e)
|
Future
operating lease obligations and purchase obligations are not recognized in
our consolidated balance sheet.
|
(f)
|
Purchase
obligations include agreements to purchase goods or services that are
enforceable and legally binding on HealthSouth and that specify all
significant terms, including: fixed or minimum quantities to be purchased;
fixed, minimum, or variable price provisions; and the approximate timing
of the transaction. Purchase
|
(g)
|
Because
their future cash outflows are uncertain, the following noncurrent
liabilities are excluded from the table above: medical malpractice and
workers’ compensation risks, deferred income taxes, and our estimated
liability for unsettled litigation. For more information, see
Note 10,
Self-Insured Risks,
Note 19,
Income
Taxes,
and Note 23,
Contingencies and Other
Commitments,
to the accompanying consolidated financial statements.
Also, at December 31, 2009 we had $50.9 million of total gross
unrecognized tax benefits. In addition, we had an accrual for related
interest income of $1.9 million as of December 31, 2009. We continue
to actively pursue the maximization of our remaining state income tax
refund claims. The process of resolving these tax matters with the
applicable taxing authorities will continue in 2010. At this time, we
cannot estimate a range of the reasonably possible change that may
occur.
|
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
(In
Millions)
|
||||||||
0 –
30 Days
|
$ | 154.6 | $ | 159.4 | ||||
31
– 60 Days
|
19.3 | 24.1 | ||||||
61
– 90 Days
|
11.3 | 14.7 | ||||||
91
– 120 Days
|
6.6 | 10.2 | ||||||
120
+ Days
|
18.7 | 24.3 | ||||||
Patient
accounts receivable
|
210.5 | 232.7 | ||||||
Non-patient
accounts receivable
|
9.2 | 2.2 | ||||||
Accounts
receivable, net
|
$ | 219.7 | $ | 234.9 |
Item 7A
.
|
Quantitative
and Qualitative Disclosures about Market
Risk
|
As
of December 31, 2009
|
||||||||||||||||
Carrying
Amount
|
%
of Total
|
Estimated
Fair Value
|
%
of Total
|
|||||||||||||
Fixed
rate debt
|
$ | 781.9 | 51.0 | % | $ | 829.0 | 53.7 | % | ||||||||
Variable
rate debt
|
751.3 | 49.0 | % | 714.5 | 46.3 | % | ||||||||||
Total
long-term debt
|
$ | 1,533.2 | 100.0 | % | $ | 1,543.5 | 100.0 | % |
Item 8
.
|
Financial
Statements and Supplementary Data
|
Item 9A
.
|
Controls
and Procedures
|
Item 9B
.
|
Other
Information
|
Item 10
.
|
Directors
and Executive Officers of the
Registrant
|
Item 11
.
|
Executive
Compensation
|
Item 12
.
|
Security
Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters
|
Item 13
.
|
Certain
Relationships and Related
Transactions
|
Item 14
.
|
Principal
Accountant Fees and Services
|
4.2.2 |
Instrument
of Resignation, Appointment and Acceptance, dated as of April 9, 2003,
among HealthSouth Corporation, National City Bank, as resigning trustee,
and Wilmington Trust Company, as successor trustee, relating to
HealthSouth’s 8.375% Senior Notes due 2011.*
|
|
4.2.3 |
Amendment
to Indenture, dated as of August 27, 2003, to the Indenture dated as of
September 28, 2001 between HealthSouth Corporation and Wilmington Trust
Company, as successor trustee to National City Bank, relating to
HealthSouth’s 8.375% Senior Notes due 2011.*
|
|
4.2.4 |
Second
Supplemental Indenture, dated as of June 24, 2004, to the Indenture, dated
as of September 28, 2001, between HealthSouth Corporation and Wilmington
Trust Company, as successor trustee to National City Bank, relating to
HealthSouth’s 8.375% Senior Notes due 2011 (incorporated by reference to
Exhibit 99.4 to HealthSouth’s Current Report on Form 8-K filed on June 25,
2004).
|
|
4.2.5 |
Third
Supplemental Indenture, dated as of February 15, 2006, to the Indenture,
dated as of September 28, 2001, between HealthSouth Corporation and
Wilmington Trust Company, as successor trustee to National City Bank,
relating to HealthSouth’s 8.375% Senior Notes due 2011 (incorporated by
reference to Exhibit 4.6 to HealthSouth’s Current Report on Form 8-K filed
on February 17, 2006).
|
|
4.3.1 |
Indenture,
dated as of May 22, 2002, between HealthSouth Corporation and The Bank of
Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 7.625% Senior Notes due 2012.*
|
|
4.3.2 |
Amendment
to Indenture, dated as of August 27, 2003, to the Indenture, dated as of
May 22, 2002, between HealthSouth Corporation and The Bank of Nova Scotia
Trust Company of New York, as trustee, relating to HealthSouth’s 7.625%
Senior Notes due 2012.*
|
|
4.3.3 |
First
Supplemental Indenture, dated as of June 24, 2004, to the Indenture, dated
as of May 22, 2002, between HealthSouth Corporation and The Bank of Nova
Scotia Trust Company of New York, as trustee, relating to HealthSouth’s
7.625% Senior Notes due 2012 (incorporated by reference to Exhibit 99.5 to
HealthSouth’s Current Report on Form 8-K filed on June 25,
2004).
|
|
4.3.4 |
Second
Supplemental Indenture, dated as of February 15, 2006, to the Indenture,
dated as of May 22, 2002, between HealthSouth Corporation and The Bank of
Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 7.625% Senior Notes due 2012 (incorporated by reference to
Exhibit 4.5 to HealthSouth’s Current Report on Form 8-K filed on February
17, 2006).
|
|
4.4 |
Registration
Rights Agreement, dated February 28, 2006, between HealthSouth and the
purchasers party to the Securities Purchase Agreement, dated February 28,
2006, re: HealthSouth’s sale of 400,000 shares of 6.50% Series A
Convertible Perpetual Preferred Stock.**
|
|
4.5.1 |
Warrant
Agreement, dated as of January 16, 2004, between HealthSouth Corporation
and Wells Fargo Bank Northwest, N.A., as Warrant Agent (incorporated by
reference to Exhibit 10.2 to HealthSouth’s Current Report on Form 8-K
filed on January 20, 2004).
|
|
4.5.2 |
Registration
Rights Agreement, dated as of January 16, 2004, among HealthSouth
Corporation and the entities listed on the signature pages thereto as
Holders of Warrants and Transfer Restricted Securities (incorporated by
reference to Exhibit 10.3 to HealthSouth’s Current Report on Form 8-K
filed on January 20, 2004).
|
|
4.6 |
Warrant
Agreement, dated as of September 30, 2009, among
HealthSouth
Corporation
and Computershare Inc. and Computershare Trust Company,
N.A., jointly and severally as Warrant Agent (
incorporated by
reference to Exhibit 4.1 to HealthSouth’s Registration Statement on
Form 8-A filed on October 1, 2009
).
|
|
4.7.1 |
Indenture,
dated as of December 1, 2009, between HealthSouth Corporation
and The
Bank of Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 8.125% Senior Notes due
2020.
|
4.7.2 |
First
Supplemental Indenture, dated December 1, 2009, among HealthSouth
Corporation, the Subsidiary Guarantors (as defined therein) and The Bank
of Nova Scotia Trust Company of New York, as trustee relating to
HealthSouth’s 8.125% Senior Notes due 2020.
|
|
4.8 |
First
Supplemental Indenture, dated December 1, 2009, among HealthSouth
Corporation, the Subsidiary Guarantors (as defined therein) and The Bank
of Nova Scotia Trust Company of New York, as trustee, relating to the
Floating Rate Senior Notes due 2014 and the Indenture, dated as of June
14, 2006.
|
|
10.1 |
Stipulation
of Partial Settlement dated as of September 26, 2006, by and among
HealthSouth Corporation, the stockholder lead plaintiffs named therein,
the bondholder lead plaintiff named therein and the individual settling
defendants named therein (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on September 27,
2006).
|
|
10.2 |
Settlement
Agreement and Policy Release, dated as of September 25, 2006, by and among
HealthSouth Corporation, the settling individual defendants named therein
and the settling carriers named therein (incorporated by reference to
Exhibit 10.2 to HealthSouth’s Current Report on Form 8-K filed on
September 27, 2006).
|
|
10.3 |
Stipulation
of Settlement with Certain Individual Defendants dated as of September 25,
2006, by and among HealthSouth Corporation, plaintiffs named therein and
the individual settling defendants named therein (incorporated by
reference to Exhibit 10.3 to HealthSouth’s Current Report on Form 8-K
filed on September 27, 2006).
|
|
10.4.1 |
Amended
Class Action Settlement Agreement, dated March 6, 2006, with
representatives of the plaintiff class relating to the action consolidated
on July 2, 2003, captioned
In Re HealthSouth Corp. ERISA
Litigation
, No. CV-03-BE-1700 (N.D. Ala.) (incorporated by
reference to Exhibit 10.5.1 to HealthSouth’s Quarterly Report on Form 10-Q
filed on May 15, 2006).
|
|
10.4.2 |
First
Addendum to the Amended Class Action Settlement Agreement, dated April 11,
2006 (incorporated by reference to Exhibit 10.5.2 to HealthSouth’s
Quarterly Report on Form 10-Q filed on May 15, 2006).
|
|
10.4.3 |
Amended
Class Action Settlement Agreement, dated July 25, 2005, with
representatives of the plaintiff class relating to the action consolidated
on July 2, 2003, captioned
In Re HealthSouth Corp. ERISA
Litigation
, No. CV-03-BE-1700 (N.D. Ala.).*
|
|
10.5.1 |
HealthSouth
Corporation Amended and Restated 2004 Director Incentive Plan.**
+
|
|
10.5.2 |
Form
of Restricted Stock Unit Agreement (Amended and Restated 2004 Director
Incentive Plan).** +
|
|
10.6 |
HealthSouth
Corporation Amended and Restated Change in Control Benefits Plan
(incorporated by reference to Exhibit 10.11 to HealthSouth’s Annual Report
on Form 10-K filed on February 24, 2009).+
|
|
10.7.1 |
HealthSouth
Corporation 1995 Stock Option Plan, as amended.* +
|
|
10.7.2 |
Form
of Non-Qualified Stock Option Agreement (1995 Stock Option Plan).*
+
|
|
10.8.1 |
HealthSouth
Corporation 1997 Stock Option Plan.* +
|
|
10.8.2 |
Form
of Non-Qualified Stock Option Agreement (1997 Stock Option Plan).*
+
|
|
10.9.1 |
HealthSouth
Corporation 2002 Non-Executive Stock Option Plan.* +
|
|
10.9.2 |
Form
of Non-Qualified Stock Option Agreement (2002 Non-Executive Stock Option
Plan).* +
|
10.10 |
Description
of the HealthSouth Corporation Senior Management Compensation Recoupment
Policy (incorporated by reference to Item 5,
Other Matters
, in
HealthSouth’s Quarterly Report on Form 10-Q filed on November 4,
2009).+
|
|
10.11 |
Description
of the HealthSouth Corporation Senior Management Bonus and Long-Term
Incentive Plans (incorporated by reference to the section captioned
“Executive Compensation – Compensation Discussion and Analysis – Elements
of Executive Compensation” in HealthSouth’s Definitive Proxy Statement on
Schedule 14A filed on April 2, 2009).+
|
|
10.12 |
HealthSouth
Corporation Executive Deferred Compensation Plan.*+
|
|
10.13 |
HealthSouth
Corporation Second Amended and Restated Executive Severance Plan
(incorporated by reference to Exhibit 10.19 to HealthSouth’s Annual Report
on Form 10-K filed on February 24, 2009).+
|
|
10.14 |
Letter
of Understanding, dated as of October 31, 2007, between HealthSouth
Corporation and Jay Grinney (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on November 6,
2007).+
|
|
10.15 |
HealthSouth
Corporation 2005 Equity Incentive Plan (incorporated by reference to
Exhibit 10 to HealthSouth’s Current Report on Form 8-K, filed on November
21, 2005).+
|
|
10.16 |
Form
of Non-Qualified Stock Option Agreement (2005 Equity Incentive
Plan).**+
|
|
10.17.1 |
HealthSouth
Corporation 2008 Equity Incentive Plan (incorporated by reference to
Appendix A to HealthSouth’s Definitive Proxy Statement on Schedule 14A
filed on March 27, 2008).+
|
|
10.17.2 |
Form
of Non-Qualified Stock Option Agreement (2008 Equity Incentive
Plan)(incorporated by reference to Exhibit 10.28.2 to HealthSouth’s Annual
Report on Form 10-K filed on February 24, 2009). +
|
|
10.17.3 |
Form
of Restricted Stock Agreement (2008 Equity Incentive Plan)(incorporated by
reference to Exhibit 10.28.3 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).+
|
|
10.17.4 |
Form
of Performance Share Unit Award (2008 Equity Incentive Plan)(incorporated
by reference to Exhibit 10.28.4 to HealthSouth’s Annual Report on Form
10-K filed on February 24, 2009).+
|
|
10.18 |
HealthSouth
Corporation Nonqualified 401(k) Plan (incorporated by reference to Exhibit
99 to HealthSouth’s Current Report on Form 8-K filed on February 6,
2008).+
|
|
10.19 |
HealthSouth
Corporation Directors’ Deferred Stock Investment Plan (incorporated by
reference to Exhibit 10.30 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).+
|
|
10.20 |
Written
description of the annual compensation arrangement for non-employee
directors of HealthSouth Corporation (incorporated by reference to the
section captioned “Corporate Governance and Board Structure – Compensation
of Directors” in HealthSouth’s Definitive Proxy Statement on Schedule 14A,
filed on April 2, 2009).+
|
|
10.21 |
Form
of Indemnity Agreement entered into between HealthSouth Corporation and
the directors of HealthSouth.* +
|
|
10.22 |
Form
of letter agreement with former directors.* +
|
|
10.23 |
Settlement
Agreement, dated as of December 30, 2004, by and among HealthSouth
Corporation, the United States of America, acting through the entities
named therein and certain other parties named therein (incorporated by
reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K
filed on January 5, 2005).
|
10.24 |
Administrative
Settlement Agreement, dated as of December 30, 2004, by and among the
United States Department of Health and Human Services acting through the
Centers for Medicare & Medicaid Services and its officers and agents,
including, but not limited to, its fiscal intermediaries, and HealthSouth
Corporation (incorporated by reference to Exhibit 10.3 to HealthSouth’s
Current Report on Form 8-K filed on January 5, 2005).
|
|
10.25.1 |
Corporate
Integrity Agreement, dated as of December 30, 2004, by and among the
Office of Inspector General of the Department of Health and Human Services
and HealthSouth Corporation (incorporated by reference to Exhibit 10.2 to
HealthSouth’s Current Report on Form 8-K filed on January 5,
2005).
|
|
10.25.2 |
First
Addendum to the Corporate Integrity Agreement, dated as of October 27,
2006, by and among the Office of Inspector General of the Department of
Health and Human Services and HealthSouth Corporation (incorporated by
reference to Exhibit 10.33.2 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).
|
|
10.25.3 |
Second
Addendum to the Corporate Integrity Agreement, dated as of December 14,
2007, by and among the Office of Inspector General of the Department of
Health and Human Services and HealthSouth Corporation (incorporated by
reference to Exhibit 10.33.3 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).
|
|
10.26.1 |
Amendment
No. 2, dated as of October 23, 2009, to the Credit Agreement, dated March
10, 2006, among HealthSouth Corporation, the lenders party thereto,
JPMorgan Chase Bank, N.A., as the administrative agent and the collateral
agent, and the other parties thereto,
attaching
and effecting the Amended and Restated Credit Agreement, by and among
HealthSouth, the lenders party thereto, JPMorgan Chase Bank, N.A., as the
administrative agent and the collateral agent, Citicorp North America,
Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as
co-syndication agents; and Deutsche Bank Securities Inc., Goldman Sachs
Credit Partners L.P. and Wachovia Bank, National Association, as
co-documentation agents (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on October 27,
2009).
|
|
10.26.2 |
Collateral
and Guarantee Agreement, dated as of March 10, 2006, by and among
HealthSouth, certain of the Company’s subsidiaries and JPMorgan Chase
Bank, N.A., as collateral agent (incorporated by reference to Exhibit 10.2
to HealthSouth’s Current Report on Form 8-K filed on March 16,
2006).
|
|
10.27.1 |
Partial
Final Judgment And Order of Dismissal With Prejudice of In re: HealthSouth
Corporation Securities Litigation, dated as of January 11, 2007
(incorporated by reference to Exhibit 99.2 to HealthSouth’s Current Report
on Form 8-K filed on January 12, 2007).
|
|
10.27.2 |
Order
and Final Judgment Pursuant To A.R.C.P. Rule 54(b) Approving Pro Tanto
Settlement With Certain Defendants, dated as of January 11, 2007
(incorporated by reference to Exhibit 99.3 to HealthSouth’s Current Report
on Form 8-K filed on January 12, 2007).
|
|
10.28.1 |
Purchase
and Sale Agreement, dated January 22, 2008, by and between HealthSouth
Corporation and Daniel Realty Company, LLC (incorporated by reference to
Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on May
7, 2008).
|
|
10.28.2 |
First
Amendment to Purchase and Sale Agreement, dated January 22, 2008, by and
between HealthSouth Corporation and Daniel Realty Company, LLC
(incorporated by reference to Exhibit 10.2 to HealthSouth’s Quarterly
Report on Form 10-Q filed on May 7, 2008).
|
|
10.28.3 |
Second
Amendment to Purchase and Sale Agreement, dated February 13, 2008, by and
between HealthSouth Corporation and Daniel Realty Company, LLC
(incorporated by reference to Exhibit 10.3 to HealthSouth’s Quarterly
Report on Form 10-Q filed on May 7,
2008).
|
10.28.4 |
Third
Amendment to Purchase and Sale Agreement, dated March 31, 2008, by and
between HealthSouth Corporation and LAKD Associates, LLC (successor by
assignment to Daniel Realty Company, LLC) (incorporated by reference to
Exhibit 10.4 to HealthSouth’s Quarterly Report on Form 10-Q filed on May
7, 2008).
|
|
10.28.5 |
Lease
between LAKD HQ, LLC and HealthSouth Corporation, dated March 31, 2008,
for corporate office space (incorporated by reference to Exhibit 10.5 to
HealthSouth’s Quarterly Report on Form 10-Q filed on May 7,
2008).
|
|
10.29.1 |
Stipulation
of Settlement with UBS Securities LLC (incorporated by reference to
Exhibit 99.2 to HealthSouth’s Current Report on Form 8-K filed on January
20, 2009).
|
|
10.29.2 |
Settlement
Agreement and Stipulation regarding Fees, dated as of January 13, 2009
(incorporated by reference to Exhibit 99.3 to HealthSouth’s Current Report
on Form 8-K filed on January 20, 2009).
|
|
10.30 |
Restrictive
Covenant Agreement, dated November 23, 2009, by and between HealthSouth
Corporation and John L. Workman (incorporated by reference to Exhibit 10.1
to HealthSouth’s Current Report on Form 8-K filed on November 23,
2009).+
|
|
12 |
Computation
of Ratios.
|
|
21 |
Subsidiaries
of HealthSouth Corporation.
|
|
23 |
Consent
of PricewaterhouseCoopers LLP, Independent Registered Public Accounting
Firm.
|
|
24 |
Power
of Attorney.
|
|
31.1 |
Certification
of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of
the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
|
|
31.2 |
Certification
of Principal Financial Officer required by Rule 13a-14(a) or Rule
15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1 |
Certification
of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2 |
Certification
of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
H EALTHSOUTH C ORPORATION | |||
|
By:
|
/s/ J AY G RINNEY | |
Name: Jay Grinney | |||
Title:
President and Chief Executive Officer
Date: February 23, 2010
|
Signature
|
Capacity
|
Date
|
/s/ J AY G RINNEY | President and Chief Executive Officer and Director | February 23, 2010 |
Jay
Grinney
|
|
|
/s/ Edmund Fay | Senior Vice President and Treasurer | February 23, 2010 |
Edmund
Fay
|
(principal
financial officer)
|
|
/s/ Andrew L. Price | Chief Accounting Officer | February 23, 2010 |
Andrew
L. Price
|
(principal
accounting officer)
|
|
J ON F. H ANSON * | Chairman of the Board of Directors | February 23, 2010 |
Jon
F. Hanson
|
|
|
E DWARD A. B LECHSCHMIDT * | Director | February 23, 2010 |
Edward
A. Blechschmidt
|
||
J OHN W. C HIDSEY * | Director | February 23, 2010 |
John
W. Chidsey
|
||
D ONALD L. C ORRELL * | Director | February 23, 2010 |
Donald
L. Correll
|
||
Y VONNE M. C URL * | Director | February 23, 2010 |
Yvonne
M. Curl
|
||
C HARLES M. E LSON * | Director | February 23, 2010 |
Charles
M. Elson
|
||
L EO I. H IGDON , J R .* | Director | February 23, 2010 |
Leo
I. Higdon, Jr.
|
||
J OHN E. M AUPIN , J R .* | Director | February 23, 2010 |
John
E. Maupin, Jr.
|
|
|
L. E DWARD S HAW , J R .* | Director | February 23, 2010 |
L.
Edward Shaw, Jr.
|
*By:
|
/s/ J OHN P. W HITTINGTON |
|
|
John P. Whittington |
|
||
Attorney-in-Fact |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(As
Adjusted)
|
||||||||||||
(In
Millions, Except Per Share Data)
|
||||||||||||
Net
operating revenues
|
$ | 1,911.1 | $ | 1,829.5 | $ | 1,723.5 | ||||||
Operating
expenses:
|
||||||||||||
Salaries
and benefits
|
948.8 | 928.2 | 857.5 | |||||||||
Other
operating expenses
|
271.4 | 264.9 | 241.0 | |||||||||
General
and administrative expenses
|
104.5 | 105.5 | 127.9 | |||||||||
Supplies
|
112.4 | 108.2 | 99.6 | |||||||||
Depreciation
and amortization
|
70.9 | 82.4 | 74.8 | |||||||||
Impairment
of long-lived assets
|
- | 0.6 | 15.1 | |||||||||
Gain
on UBS Settlement
|
- | (121.3 | ) | - | ||||||||
Occupancy
costs
|
47.6 | 48.8 | 51.4 | |||||||||
Provision
for doubtful accounts
|
33.1 | 27.0 | 33.2 | |||||||||
Loss
on disposal of assets
|
3.5 | 2.0 | 5.9 | |||||||||
Government,
class action, and related settlements expense
|
36.7 | (67.2 | ) | (2.8 | ) | |||||||
Professional
fees—accounting, tax, and legal
|
8.8 | 44.4 | 51.6 | |||||||||
Total
operating expenses
|
1,637.7 | 1,423.5 | 1,555.2 | |||||||||
Loss
on early extinguishment of debt
|
12.5 | 5.9 | 28.2 | |||||||||
Interest
expense and amortization of debt discounts and fees
|
125.8 | 159.5 | 229.4 | |||||||||
Other
income
|
(3.4 | ) | - | (15.5 | ) | |||||||
Loss
on interest rate swaps
|
19.6 | 55.7 | 30.4 | |||||||||
Equity
in net income of nonconsolidated affiliates
|
(4.6 | ) | (10.6 | ) | (10.3 | ) | ||||||
Income
(loss) from continuing operations before income tax
benefit
|
123.5 | 195.5 | (93.9 | ) | ||||||||
Provision
for income tax benefit
|
(3.2 | ) | (70.1 | ) | (322.4 | ) | ||||||
Income
from continuing operations
|
126.7 | 265.6 | 228.5 | |||||||||
Income
from discontinued operations, net of tax
|
2.1 | 16.2 | 490.2 | |||||||||
Net
income
|
128.8 | 281.8 | 718.7 | |||||||||
Less:
Net income attributable to noncontrolling interests
|
(34.0 | ) | (29.4 | ) | (65.3 | ) | ||||||
Net
income attributable to HealthSouth
|
94.8 | 252.4 | 653.4 | |||||||||
Less:
Convertible perpetual preferred stock dividends
|
(26.0 | ) | (26.0 | ) | (26.0 | ) | ||||||
Net
income attributable to HealthSouth common shareholders
|
$ | 68.8 | $ | 226.4 | $ | 627.4 | ||||||
Weighted
average common shares outstanding:
|
||||||||||||
Basic
|
88.8 | 83.0 | 78.7 | |||||||||
Diluted
|
103.3 | 96.4 | 92.0 | |||||||||
Earnings
per common share:
|
||||||||||||
Basic:
|
||||||||||||
Income
from continuing operations attributable to
HealthSouth common
shareholders
|
$ | 0.76 | $ | 2.53 | $ | 2.17 | ||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.20 | 5.80 | |||||||||
Net
income per share attributable to HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.73 | $ | 7.97 | ||||||
Diluted:
|
||||||||||||
Income
from continuing operations attributable to
HealthSouth common
shareholders
|
$ | 0.76 | $ | 2.45 | $ | 2.14 | ||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.17 | 4.96 | |||||||||
Net
income per share attributable to HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.62 | $ | 7.10 | ||||||
Amounts
attributable to HealthSouth:
|
||||||||||||
Income
from continuing operations
|
$ | 93.3 | $ | 235.8 | $ | 197.1 | ||||||
Income
from discontinued operations, net of tax
|
1.5 | 16.6 | 456.3 | |||||||||
Net
income attributable to HealthSouth
|
$ | 94.8 | $ | 252.4 | $ | 653.4 |
As
of December 31,
|
|||||||||
2009
|
2008
|
||||||||
(As
Adjusted)
|
|||||||||
(In
Millions, Except Share Data)
|
|||||||||
Assets
|
|||||||||
Current
assets:
|
|||||||||
Cash
and cash equivalents
|
$ | 80.9 | $ | 32.1 | |||||
Restricted
cash
|
67.8 | 154.0 | |||||||
Restricted
marketable securities
|
2.7 | 20.3 | |||||||
Accounts
receivable, net of allowance for doubtful accounts of
$
33.1
in 2009; $30.9 in 2008
|
219.7 | 234.9 | |||||||
Prepaid
expenses and other current assets
|
54.9 | 58.6 | |||||||
Insurance
recoveries receivable
|
- | 182.8 | |||||||
Total
current assets
|
426.0 | 682.7 | |||||||
Property
and equipment, net
|
664.8 | 662.1 | |||||||
Goodwill
|
416.4 | 414.7 | |||||||
Intangible
assets, net
|
37.4 | 42.4 | |||||||
Investments
in and advances to nonconsolidated affiliates
|
29.3 | 36.7 | |||||||
Income
tax refund receivable
|
10.0 | 55.9 | |||||||
Other
long-term assets
|
97.6 | 103.7 | |||||||
Total
assets
|
$ | 1,681.5 | $ | 1,998.2 | |||||
Liabilities
and Shareholders’ Deficit
|
|||||||||
Current
liabilities
|
|||||||||
Current
portion of long-term debt
|
$ | 21.5 | $ | 23.6 | |||||
Accounts
payable
|
50.2 | 45.5 | |||||||
Accrued
payroll
|
77.9 | 89.8 | |||||||
Refunds
due patients and other third-party payors
|
53.0 | 48.8 | |||||||
Other
current liabilities
|
182.0 | 270.0 | |||||||
Government,
class action, and related settlements
|
6.6 | 268.5 | |||||||
Total
current liabilities
|
391.2 | 746.2 | |||||||
Long-term
debt, net of current portion
|
1,641.0 | 1,789.6 | |||||||
Self-insured
risks
|
100.0 | 108.6 | |||||||
Other
long-term liabilities
|
59.5 | 53.6 | |||||||
2,191.7 | 2,698.0 | ||||||||
Commitments
and contingencies
|
|||||||||
Convertible
perpetual preferred stock, $.10 par value; 1,500,000 shares
authorized; 400,000 shares issued in 2009 and 2008; liquidation
preference of $1,000 per share
|
387.4 | 387.4 | |||||||
Shareholders’
deficit:
|
|||||||||
HealthSouth
shareholders' deficit:
|
|||||||||
Common
stock, $.01 par value; 200,000,000 shares authorized;
issued:
97,238,725 in 2009; 96,890,924 in 2008
|
1.0 | 1.0 | |||||||
Capital
in excess of par value
|
2,879.9 | 2,956.5 | |||||||
Accumulated
deficit
|
(3,717.4 | ) | (3,812.2 | ) | |||||
Accumulated
other comprehensive loss
|
- | (3.2 | ) | ||||||
Treasury
stock, at cost (3,957,047 shares in 2009 and 8,872,121 shares
in
2008)
|
(137.5 | ) | (311.5 | ) | |||||
Total
HealthSouth shareholders’ deficit
|
(974.0 | ) | (1,169.4 | ) | |||||
Noncontrolling
interests
|
76.4 | 82.2 | |||||||
Total
shareholders' deficit
|
(897.6 | ) | (1,087.2 | ) | |||||
Total
liabilities and shareholders’ deficit
|
$ | 1,681.5 | $ | 1,998.2 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(As
Adjusted)
|
||||||||||||
(In
Millions)
|
||||||||||||
Net
income
|
$ | 128.8 | $ | 281.8 | $ | 718.7 | ||||||
Other
comprehensive income (loss), net of tax:
|
||||||||||||
Net
change in foreign currency translation adjustment
|
- | 0.7 | 0.1 | |||||||||
Net
change in unrealized gain (loss) on available-for-sale
securities:
|
||||||||||||
Unrealized
net holding gain (loss) arising during the period
|
1.3 | (1.5 | ) | 1.3 | ||||||||
Reclassifications
to net income
|
1.6 | (1.4 | ) | (3.8 | ) | |||||||
Net
change in unrealized gain (loss) on forward-starting interest
rate
swaps:
|
||||||||||||
Unrealized
net holding gain (loss) arising during the period
|
0.1 | (0.2 | ) | - | ||||||||
Reclassifications
to net income
|
0.2 | - | - | |||||||||
Other
comprehensive income (loss), net of tax
|
3.2 | (2.4 | ) | (2.4 | ) | |||||||
Comprehensive
income
|
132.0 | 279.4 | 716.3 | |||||||||
Comprehensive
income attributable to noncontrolling interests
|
(34.0 | ) | (29.4 | ) | (65.3 | ) | ||||||
Comprehensive
income attributable to HealthSouth
|
$ | 98.0 | $ | 250.0 | $ | 651.0 |
(In
Millions)
|
||||||||||||||||||||||||||||
HealthSouth
Common Shareholders
|
||||||||||||||||||||||||||||
Number
of Common Shares Outstanding
|
Common
Stock
|
Capital
in Excess of Par Value
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive (Loss) Income
|
Treasury
Stock
|
Noncontrolling
Interests
|
Total
|
Comprehensive
Income
|
||||||||||||||||||||
Balance
at beginning of period
|
88.0 | $ | 1.0 | $ | 2,956.5 | $ | (3,812.2 | ) | $ | (3.2 | ) | $ | (311.5 | ) | $ | 82.2 | $ | (1,087.2 | ) | |||||||||
Comprehensive
income:
|
||||||||||||||||||||||||||||
Net
income
|
- | - | - | 94.8 | - | - | 34.0 | 128.8 | $ | 128.8 | ||||||||||||||||||
Other
comprehensive income, net of tax
|
- | - | - | - | 3.2 | - | - | 3.2 | 3.2 | |||||||||||||||||||
Comprehensive
income
|
$ | 132.0 | ||||||||||||||||||||||||||
Common
stock issued under Securities Litigation Settlement
|
5.0 | - | (63.5 | ) | - | - | 175.3 | - | 111.8 | |||||||||||||||||||
Dividends
declared on convertible perpetual preferred stock
|
- | - | (26.0 | ) | - | - | - | - | (26.0 | ) | ||||||||||||||||||
Stock-based
compensation
|
- | - | 13.4 | - | - | - | - | 13.4 | ||||||||||||||||||||
Distributions
declared
|
- | - | - | - | - | - | (34.6 | ) | (34.6 | ) | ||||||||||||||||||
Other
|
0.3 | - | (0.5 | ) | - | - | (1.3 | ) | (5.2 | ) | (7.0 | ) | ||||||||||||||||
Balance
at end of period
|
93.3 | $ | 1.0 | $ | 2,879.9 | $ | (3,717.4 | ) | $ | - | $ | (137.5 | ) | $ | 76.4 | $ | (897.6 | ) |
For
the Year Ended December 31, 2008
|
||||||||||||||||||||||||||||
(As
Adjusted)
|
||||||||||||||||||||||||||||
(In
Millions)
|
||||||||||||||||||||||||||||
HealthSouth
Common Shareholders
|
||||||||||||||||||||||||||||
Number
of Common Shares Outstanding
|
Common Stock
|
Capital
in Excess of Par Value
|
Accumulated Deficit
|
Accumulated
Other Comprehensive Loss
|
Treasury
Stock
|
Noncontrolling
Interests
|
Total
|
Comprehensive
Income
|
||||||||||||||||||||
Balance
at beginning of period
|
78.7 | $ | 0.9 | $ | 2,820.4 | $ | (4,064.6 | ) | $ | (0.8 | ) | $ | (310.4 | ) | $ | 97.2 | $ | (1,457.3 | ) | |||||||||
Comprehensive
income:
|
||||||||||||||||||||||||||||
Net
income
|
- | - | - | 252.4 | - | - | 29.4 | 281.8 | $ | 281.8 | ||||||||||||||||||
Other
comprehensive loss , net of tax
|
- | - | - | - | (2.4 | ) | - | - | (2.4 | ) | (2.4 | ) | ||||||||||||||||
Comprehensive
income
|
$ | 279.4 | ||||||||||||||||||||||||||
Issuance
of common stock
|
8.8 | 0.1 | 150.1 | - | - | - | - | 150.2 | ||||||||||||||||||||
Dividends
declared on convertible perpetual preferred stock
|
- | - | (26.0 | ) | - | - | - | - | (26.0 | ) | ||||||||||||||||||
Stock-based
compensation
|
- | - | 11.7 | - | - | - | - | 11.7 | ||||||||||||||||||||
Distribution
declared
|
- | - | - | - | - | - | (32.5 | ) | (32.5 | ) | ||||||||||||||||||
Settlements
with partners
|
- | - | - | - | - | - | 4.2 | 4.2 | ||||||||||||||||||||
Government,
class action, and related settlements
|
- | - | - | - | - | - | (9.4 | ) | (9.4 | ) | ||||||||||||||||||
Transfer
of surgery centers to ASC
|
- | - | - | - | - | - | (6.8 | ) | (6.8 | ) | ||||||||||||||||||
Other
|
0.5 | - | 0.3 | - | - | (1.1 | ) | 0.1 | (0.7 | ) | ||||||||||||||||||
Balance
at end of period
|
88.0 | $ | 1.0 | $ | 2,956.5 | $ | (3,812.2 | ) | $ | (3.2 | ) | $ | (311.5 | ) | $ | 82.2 | $ | (1,087.2 | ) |
For
the Year Ended December 31, 2007
|
|||||||||||||||||||||||||||||||
(As
Adjusted)
|
|||||||||||||||||||||||||||||||
(In
Millions)
|
|||||||||||||||||||||||||||||||
HealthSouth
Common Shareholders
|
|||||||||||||||||||||||||||||||
Number
of Common Shares Outstanding
|
Common
Stock
|
Capital
in Excess of Par Value
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive Income (Loss)
|
Treasury
Stock
|
Notes
Receivable from Shareholders, Officers, and Management
Employees
|
Noncontrolling
Interests
|
Total
|
Comprehensive
Income
|
||||||||||||||||||||||
Balance
at beginning of period
|
78.7 | $ | 0.9 | $ | 2,849.5 | $ | (4,713.8 | ) | $ | 1.6 | $ | (322.7 | ) | $ | (0.1 | ) | $ | 271.1 | $ | (1,913.5 | ) | ||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||||||||
Net
income
|
- | - | - | 653.4 | - | - | - | 65.3 | 718.7 | $ | 718.7 | ||||||||||||||||||||
Other
comprehensive loss , net of tax
|
- | - | - | - | (2.4 | ) | - | - | - | (2.4 | ) | (2.4 | ) | ||||||||||||||||||
Comprehensive
income
|
$ | 716.3 | |||||||||||||||||||||||||||||
Adoption
of accounting guidance for unrecognized tax benefits
|
- | - | - | (4.2 | ) | - | - | - | - | (4.2 | ) | ||||||||||||||||||||
Dividends
declared on convertible perpetual preferred stock
|
- | - | (26.0 | ) | - | - | - | - | - | (26.0 | ) | ||||||||||||||||||||
Stock-based
compensation
|
- | - | 8.9 | - | - | - | - | - | 8.9 | ||||||||||||||||||||||
Retirement
of treasury stock
|
- | - | (14.8 | ) | - | - | 14.8 | - | - | - | |||||||||||||||||||||
Distributions
declared- continuing operations
|
- | - | - | - | - | - | - | (20.9 | ) | (20.9 | ) | ||||||||||||||||||||
Distributions
declared- discontinued operations
|
- | - | - | - | - | - | - | (22.3 | ) | (22.3 | ) | ||||||||||||||||||||
Net
investment in consolidated affiliates that
became equity method
affiliates
|
- | - | - | - | - | - | - | (9.3 | ) | (9.3 | ) | ||||||||||||||||||||
Settlements
with partners
|
- | - | - | - | - | - | - | 2.7 | 2.7 | ||||||||||||||||||||||
Government,
class action, and related settlements- continuing
operations
|
- | - | - | - | - | - | - | (6.6 | ) | (6.6 | ) | ||||||||||||||||||||
Government,
class action, and related settlements- discontinued
operations
|
- | - | - | - | - | - | - | (9.2 | ) | (9.2 | ) | ||||||||||||||||||||
Divestitures
of surgery centers, outpatient, and diagnostic divisions
|
- | - | - | - | - | - | - | (172.6 | ) | (172.6 | ) | ||||||||||||||||||||
Other
|
- | - | 2.8 | - | - | (2.5 | ) | 0.1 | (1.0 | ) | (0.6 | ) | |||||||||||||||||||
Balance
at end of period
|
78.7 | $ | 0.9 | $ | 2,820.4 | $ | (4,064.6 | ) | $ | (0.8 | ) | $ | (310.4 | ) | $ | - | $ | 97.2 | $ | (1,457.3 | ) |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(As
Adjusted)
|
||||||||||||
(In
Millions)
|
||||||||||||
Cash flows
from operating activities:
|
||||||||||||
Net
income
|
$ | 128.8 | $ | 281.8 | $ | 718.7 | ||||||
Income
from discontinued operations
|
(2.1 | ) | (16.2 | ) | (490.2 | ) | ||||||
Adjustments
to reconcile net income to net cash provided by
operating
activities—
|
||||||||||||
Provision
for doubtful accounts
|
33.1 | 27.0 | 33.2 | |||||||||
Provision
for government, class action, and related settlements
|
36.7 | (90.6 | ) | (2.8 | ) | |||||||
UBS
Settlement proceeds, gross
|
100.0 | (97.9 | ) | - | ||||||||
Depreciation
and amortization
|
70.9 | 82.4 | 74.8 | |||||||||
Amortization
of debt issue costs, debt discounts, and fees
|
6.6 | 6.5 | 7.8 | |||||||||
Impairment
of long-lived assets
|
- | 0.6 | 15.1 | |||||||||
Realized
(gain) loss on sale of investments
|
(0.8 | ) | 1.4 | (12.3 | ) | |||||||
Loss
on disposal of assets
|
3.5 | 2.0 | 5.9 | |||||||||
Loss
on early extinguishment of debt
|
12.5 | 5.9 | 28.2 | |||||||||
Loss
on interest rate swaps
|
19.6 | 55.7 | 30.4 | |||||||||
Equity
in net income of nonconsolidated affiliates
|
(4.6 | ) | (10.6 | ) | (10.3 | ) | ||||||
Distributions
from nonconsolidated affiliates
|
8.6 | 10.9 | 5.3 | |||||||||
Stock-based
compensation
|
13.4 | 11.7 | 8.9 | |||||||||
Deferred
tax provision
|
4.1 | 3.7 | 8.0 | |||||||||
Other
|
1.3 | 2.0 | (0.2 | ) | ||||||||
(Increase)
decrease in assets—
|
||||||||||||
Accounts
receivable
|
(17.8 | ) | (45.0 | ) | (38.8 | ) | ||||||
Prepaid
expenses and other assets
|
3.7 | 7.5 | 39.5 | |||||||||
Income
tax refund receivable
|
45.9 | (3.4 | ) | 162.1 | ||||||||
Increase
(decrease) in liabilities—
|
||||||||||||
Accounts
payable
|
4.8 | (4.2 | ) | (18.0 | ) | |||||||
Accrued
payroll
|
(12.4 | ) | 9.0 | (5.8 | ) | |||||||
Accrued
fees and expenses for derivative plaintiffs' attorneys
in UBS
Settlement
|
(26.2 | ) | - | - | ||||||||
Other
liabilities
|
(1.4 | ) | 2.9 | (83.3 | ) | |||||||
Refunds
due patients and other third-party payors
|
4.2 | (2.5 | ) | (41.0 | ) | |||||||
Self-insured
risks
|
(1.6 | ) | (17.4 | ) | (22.7 | ) | ||||||
Government,
class action, and related settlements
|
(11.2 | ) | (7.4 | ) | (171.4 | ) | ||||||
Net
cash (used in) provided by operating activities of
discontinued
operations
|
(13.5 | ) | 11.4 | (10.5 | ) | |||||||
Total
adjustments
|
279.4 | (38.4 | ) | 2.1 | ||||||||
Net
cash provided by operating activities
|
406.1 | 227.2 | 230.6 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
(As
Adjusted)
|
||||||||||||
(In
Millions)
|
||||||||||||
Cash
flows from investing activities:
|
||||||||||||
Capital
expenditures
|
(72.2 | ) | (55.7 | ) | (38.6 | ) | ||||||
Acquisition
of business, net of assets acquired
|
- | (14.6 | ) | - | ||||||||
Acquisition
of intangible assets
|
(0.4 | ) | (18.2 | ) | (0.1 | ) | ||||||
Proceeds
from disposal of assets
|
3.9 | 53.9 | 0.7 | |||||||||
Proceeds
from sale of restricted marketable securities
|
5.0 | 8.1 | 66.4 | |||||||||
Proceeds
from sale of investments
|
0.6 | 4.3 | - | |||||||||
Purchase
of restricted marketable securities
|
(3.8 | ) | (4.8 | ) | (23.0 | ) | ||||||
Net
change in restricted cash
|
(11.7 | ) | 7.5 | (3.3 | ) | |||||||
Net
settlements on interest rate swaps
|
(42.2 | ) | (20.7 | ) | 3.2 | |||||||
Net
investment in interest rate swap
|
(6.4 | ) | - | - | ||||||||
Other
|
(5.3 | ) | 0.6 | 0.1 | ||||||||
Net
cash (used in) provided by investing activities of discontinued
operations—
|
||||||||||||
Proceeds
from divestitures of divisions
|
- | - | 1,169.8 | |||||||||
Other
investing activities of discontinued operations
|
(0.5 | ) | (0.4 | ) | 9.3 | |||||||
Net
cash (used in) provided by investing activities
|
(133.0 | ) | (40.0 | ) | 1,184.5 | |||||||
Cash
flows from financing activities:
|
||||||||||||
Checks
in excess of bank balance
|
- | (11.4 | ) | 8.7 | ||||||||
Principal
borrowings on notes
|
15.5 | - | 12.5 | |||||||||
Proceeds
from bond issuance
|
290.0 | - | - | |||||||||
Principal
payments on debt, including pre-payments
|
(409.2 | ) | (204.8 | ) | (1,238.9 | ) | ||||||
Borrowings
on revolving credit facility
|
10.0 | 128.0 | 397.0 | |||||||||
Payments
on revolving credit facility
|
(50.0 | ) | (163.0 | ) | (492.0 | ) | ||||||
Principal
payments under capital lease obligations
|
(13.4 | ) | (12.4 | ) | (11.0 | ) | ||||||
Issuance
of common stock
|
- | 150.2 | - | |||||||||
Dividends
paid on convertible perpetual preferred stock
|
(26.0 | ) | (26.0 | ) | (26.0 | ) | ||||||
Debt
amendment and issuance costs
|
(10.6 | ) | - | (11.2 | ) | |||||||
Distributions
paid to noncontrolling interests of
consolidated
affiliates
|
(32.7 | ) | (33.4 | ) | (23.4 | ) | ||||||
Other
|
0.8 | 0.6 | 0.6 | |||||||||
Net
cash provided by (used in) financing activities of
discontinued
operations
|
1.3 | (3.8 | ) | (52.9 | ) | |||||||
Net
cash used in financing activities
|
(224.3 | ) | (176.0 | ) | (1,436.6 | ) | ||||||
Effect
of exchange rate changes on cash and cash equivalents
|
- | 0.8 | 0.1 | |||||||||
Increase
(decrease) in cash and cash equivalents
|
48.8 | 12.0 | (21.4 | ) | ||||||||
Cash
and cash equivalents at beginning of year
|
32.1 | 19.8 | 27.2 | |||||||||
Cash
and cash equivalents of divisions and facilities held for
sale at beginning of year
|
0.1 | 0.4 | 14.4 | |||||||||
Less:
Cash and cash equivalents of divisions and facilities held
for sale at end of year
|
(0.1 | ) | (0.1 | ) | (0.4 | ) | ||||||
Cash
and cash equivalents at end of year
|
$ | 80.9 | $ | 32.1 | $ | 19.8 |
•
|
licensure,
certification, and accreditation,
|
•
|
coding
and billing for services,
|
•
|
requirements
of the 60% compliance threshold under The Medicare, Medicaid and State
Children’s Health Insurance Program (SCHIP) Extension Act of 2007 (the
“2007 Medicare Act”),
|
•
|
relationships
with physicians and other referral sources, including physician
self-referral and anti-kickback
laws,
|
•
|
quality
of medical care,
|
•
|
use
and maintenance of medical supplies and
equipment,
|
•
|
maintenance
and security of medical records,
|
•
|
acquisition
and dispensing of pharmaceuticals and controlled substances,
and
|
•
|
disposal
of medical and hazardous waste.
|
As
of December 31,
|
|||
2009
|
2008
|
||
Medicare
|
55.5%
|
55.8%
|
|
Medicaid
|
3.3%
|
3.6%
|
|
Workers’
compensation
|
3.2%
|
3.5%
|
|
Managed
care and other discount plans
|
31.5%
|
32.1%
|
|
Other
third-party payors
|
4.7%
|
3.6%
|
|
Patients
|
1.8%
|
1.4%
|
|
100.0%
|
100.0%
|
Years
|
|
Buildings
|
15
to 30
|
Leasehold
improvements
|
2
to 15
|
Furniture,
fixtures, and equipment
|
3
to 10
|
Assets
under capital lease obligations:
|
|
Real
estate
|
15
to 20
|
Equipment
|
3
to 5
|
Estimated
Useful Life and Amortization Basis
|
||
Certificates
of need
|
13
to 30 years using straight-line basis
|
|
Licenses
|
10
to 20 years using straight-line basis
|
|
Noncompete
agreements
|
3
to 18 years using straight-line basis
|
|
Market
access assets
|
20
years using accelerated basis
|
•
|
Level 1
– Observable
inputs such as quoted prices in active
markets;
|
•
|
Level 2
– Inputs, other
than the quoted prices in active markets, that are observable either
directly or indirectly; and
|
•
|
Level 3
– Unobservable
inputs in which there is little or no market data, which require the
reporting entity to develop its own
assumptions.
|
•
|
Market approach
–
Prices and other relevant information generated by market transactions
involving identical or comparable assets or
liabilities;
|
•
|
Cost approach
– Amount
that would be required to replace the service capacity of an asset (i.e.,
replacement cost); and
|
•
|
Income approach
–
Techniques to convert future amounts to a single present amount based on
market expectations (including present value techniques, option-pricing
models, and lattice models).
|
Cash
& Cash Equivalents
|
Restricted
Cash
|
Restricted
Marketable Securities
|
Total
|
|||||||||||||
Cash
|
$ | 80.9 | $ | 67.8 | $ | - | $ | 148.7 | ||||||||
Equity
securities
|
- | - | 21.0 | 21.0 | ||||||||||||
Total
|
$ | 80.9 | $ | 67.8 | $ | 21.0 | $ | 169.7 |
Cash
& Cash Equivalents
|
Restricted
Cash
|
Restricted
Marketable Securities
|
Total
|
|||||||||||||
Cash
|
$ | 32.1 | $ | 154.0 | $ | - | $ | 186.1 | ||||||||
Equity
securities
|
- | - | 20.3 | 20.3 | ||||||||||||
Total
|
$ | 32.1 | $ | 154.0 | $ | 20.3 | $ | 206.4 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Escrow
related to UBS Settlement
|
$ | - | $ | 97.9 | ||||
Affiliate
cash
|
31.9 | 33.4 | ||||||
Self-insured
captive funds
|
33.7 | 20.4 | ||||||
Paid-loss
deposit funds
|
2.2 | 2.3 | ||||||
Total
restricted cash
|
$ | 67.8 | $ | 154.0 |
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Fair
Value
|
|||||||||||||
Equity
securities
|
$ | 19.6 | $ | 1.5 | $ | (0.1 | ) | $ | 21.0 |
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Fair
Value
|
|||||||||||||
Equity
securities
|
$ | 21.9 | $ | 0.4 | $ | (2.0 | ) | $ | 20.3 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Proceeds
from sales of restricted
available-for-sale
securities
|
$ | 5.0 | $ | 8.1 | $ | 66.4 | ||||||
Gross
realized gains
|
$ | 0.9 | $ | 0.2 | $ | 4.1 | ||||||
Gross
realized losses
|
$ | (1.3 | ) | $ | (1.5 | ) | $ | (0.4 | ) |
As
of
December 31
,
2009
|
As
of
December 31
,
2008
|
|||||||
Less
than 12 months:
|
||||||||
Fair
value
|
$ | 0.2 | $ | 15.5 | ||||
Gross
unrealized losses
|
$ | - | $ | (1.9 | ) | |||
12
months or greater:
|
||||||||
Fair
value
|
$ | 0.2 | $ | 0.1 | ||||
Gross
unrealized losses
|
$ | (0.1 | ) | $ | (0.1 | ) | ||
Total:
|
||||||||
Fair
value
|
$ | 0.4 | $ | 15.6 | ||||
Gross
unrealized losses
|
$ | (0.1 | ) | $ | (2.0 | ) |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Patient
accounts receivable
|
$ | 243.6 | $ | 263.6 | ||||
Less:
Allowance for doubtful accounts
|
(33.1 | ) | (30.9 | ) | ||||
Patient
accounts receivable, net
|
210.5 | 232.7 | ||||||
Other
accounts receivable
|
9.2 | 2.2 | ||||||
Accounts
receivable, net
|
$ | 219.7 | $ | 234.9 |
For the Year Ended December
31,
|
Balance
at Beginning of Period
|
Additions
and Charges to Expense
|
Deductions
and Accounts Written Off
|
Balance
at End of Period
|
||||||||||||
2009
|
$ | 30.9 | $ | 33.1 | $ | (30.9 | ) | $ | 33.1 | |||||||
2008
|
$ | 37.4 | $ | 27.0 | $ | (33.5 | ) | $ | 30.9 | |||||||
2007
|
$ | 35.1 | $ | 33.2 | $ | (30.9 | ) | $ | 37.4 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Land
|
$ | 66.5 | $ | 65.8 | ||||
Buildings
|
904.6 | 873.9 | ||||||
Leasehold
improvements
|
35.5 | 29.0 | ||||||
Furniture,
fixtures, and equipment
|
353.2 | 339.0 | ||||||
1,359.8 | 1,307.7 | |||||||
Less:
Accumulated depreciation and amortization
|
(709.7 | ) | (657.3 | ) | ||||
650.1 | 650.4 | |||||||
Construction
in progress
|
14.7 | 11.7 | ||||||
Property
and equipment, net
|
$ | 664.8 | $ | 662.1 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Fully
depreciated assets
|
$ | 238.7 | $ | 230.4 | ||||
Assets
under capital lease obligations:
|
||||||||
Buildings
|
$ | 201.7 | $ | 201.7 | ||||
Equipment
|
0.2 | 0.2 | ||||||
201.9 | 201.9 | |||||||
Accumulated
amortization
|
(119.8 | ) | (107.5 | ) | ||||
Assets
under capital lease obligations, net
|
$ | 82.1 | $ | 94.4 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Depreciation
expense
|
$ | 51.6 | $ | 65.3 | $ | 59.2 | ||||||
Amortization
expense
|
$ | 12.3 | $ | 12.0 | $ | 11.4 | ||||||
Rent
expense:
|
||||||||||||
Minimum
rent payments
|
$ | 35.4 | $ | 37.7 | $ | 38.3 | ||||||
Contingent
and other rents
|
27.7 | 25.7 | 26.2 | |||||||||
Other
|
4.5 | 4.1 | 4.3 | |||||||||
Total
rent expense
|
$ | 67.6 | $ | 67.5 | $ | 68.8 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Straight-line
rental accrual
|
$ | 8.6 | $ | 8.8 |
Year Ending December 31,
|
Operating
Leases
|
Capital
Lease Obligations
|
Total
|
|||||||||
2010
|
$ | 37.1 | $ | 21.1 | $ | 58.2 | ||||||
2011
|
31.1 | 19.1 | 50.2 | |||||||||
2012
|
25.0 | 16.4 | 41.4 | |||||||||
2013
|
20.3 | 14.5 | 34.8 | |||||||||
2014
|
14.9 | 10.3 | 25.2 | |||||||||
2015
and thereafter
|
88.2 | 76.0 | 164.2 | |||||||||
$ | 216.6 | 157.4 | $ | 374.0 | ||||||||
Less:
Interest portion
|
(56.1 | ) | ||||||||||
Obligations
under capital leases
|
$ | 101.3 |
Amount
|
||||
Goodwill
as of December 31, 2006
|
$ | 406.1 | ||
- | ||||
Goodwill
as of December 31, 2007
|
406.1 | |||
Acquisition
|
8.6 | |||
Goodwill
as of December 31, 2008
|
414.7 | |||
Acquisition
of interest in joint venture entity
|
2.6 | |||
Allocation
to discontinued operations related to expected sale of
hospital
|
(0.9 | ) | ||
Goodwill
as of December 31, 2009
|
$ | 416.4 |
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
|
||||||||||
Certificates
of need:
|
||||||||||||
2009
|
$ | 6.2 | $ | (1.9 | ) | $ | 4.3 | |||||
2008
|
5.8 | (1.7 | ) | 4.1 | ||||||||
Licenses:
|
||||||||||||
2009
|
$ | 49.8 | $ | (36.9 | ) | $ | 12.9 | |||||
2008
|
49.8 | (34.5 | ) | 15.3 | ||||||||
Noncompete
agreements:
|
||||||||||||
2009
|
$ | 18.8 | $ | (9.3 | ) | $ | 9.5 | |||||
2008
|
17.0 | (6.7 | ) | 10.3 | ||||||||
Market
access assets:
|
||||||||||||
2009
|
$ | 13.2 | $ | (2.5 | ) | $ | 10.7 | |||||
2008
|
13.2 | (0.5 | ) | 12.7 | ||||||||
Total
intangible assets:
|
||||||||||||
2009
|
$ | 88.0 | $ | (50.6 | ) | $ | 37.4 | |||||
2008
|
85.8 | (43.4 | ) | 42.4 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Amortization
expense
|
$ | 7.0 | $ | 5.1 | $ | 4.2 |
Year Ending December 31,
|
Estimated
Amortization Expense
|
|||
2010
|
$ | 6.7 | ||
2011
|
6.2 | |||
2012
|
3.9 | |||
2013
|
3.8 | |||
2014
|
2.9 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Equity
method investments:
|
||||||||
Capital
contributions
|
$ | 7.2 | $ | 10.2 | ||||
Cumulative
share of income
|
77.9 | 73.3 | ||||||
Cumulative
share of distributions
|
(59.0 | ) | (50.4 | ) | ||||
26.1 | 33.1 | |||||||
Cost
method investments:
|
||||||||
Capital
contributions, net of distributions and impairments
|
3.2 | 3.6 | ||||||
Total
investments in and advances to nonconsolidated affiliates
|
$ | 29.3 | $ | 36.7 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Assets—
|
||||||||
Current
|
$ | 17.3 | $ | 19.1 | ||||
Noncurrent
|
71.7 | 72.8 | ||||||
Total
assets
|
$ | 89.0 | $ | 91.9 | ||||
Liabilities
and equity—
|
||||||||
Current
liabilities
|
$ | 7.2 | $ | 5.9 | ||||
Noncurrent
liabilities
|
7.8 | 7.7 | ||||||
Partners’
capital and shareholders’ equity—
|
||||||||
HealthSouth
|
26.1 | 33.1 | ||||||
Outside
partners
|
47.9 | 45.2 | ||||||
Total
liabilities and equity
|
$ | 89.0 | $ | 91.9 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
operating revenues
|
$ | 73.1 | $ | 68.8 | $ | 65.7 | ||||||
Operating
expenses
|
(47.2 | ) | (44.7 | ) | (42.2 | ) | ||||||
Income
from continuing operations, net of tax
|
20.5 | 19.4 | 18.8 | |||||||||
Net
income
|
20.5 | 19.4 | 18.8 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Advances
under $400 million revolving credit facility
|
$ | - | $ | 40.0 | ||||
Term
loan facility
|
751.3 | 783.6 | ||||||
Bonds
payable—
|
||||||||
Floating
Rate Senior Notes due 2014
|
- | 366.0 | ||||||
10.75%
Senior Notes due 2016
|
494.9 | 494.3 | ||||||
8.125%
Senior Notes due 2020
|
285.2 | - | ||||||
Other
bonds payable
|
1.8 | 1.8 | ||||||
Other
notes payable
|
28.0 | 12.8 | ||||||
Capital
lease obligations
|
101.3 | 114.7 | ||||||
1,662.5 | 1,813.2 | |||||||
Less:
Current portion
|
(21.5 | ) | (23.6 | ) | ||||
Long-term
debt, net of current portion
|
$ | 1,641.0 | $ | 1,789.6 |
Year Ending December 31,
|
Face
Amount
|
Net
Amount
|
||||||
2010
|
$ | 21.5 | $ | 21.5 | ||||
2011
|
20.8 | 20.8 | ||||||
2012
|
20.2 | 20.2 | ||||||
2013
|
451.5 | 451.5 | ||||||
2014
|
9.4 | 9.4 | ||||||
Thereafter
|
1,149.6 | 1,139.1 | ||||||
Total
|
$ | 1,673.0 | $ | 1,662.5 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Continuing
operations:
|
||||||||||||
Interest
expense
|
$ | 119.2 | $ | 153.0 | $ | 221.6 | ||||||
Amortization
of debt discounts and fees
|
6.6 | 6.5 | 7.8 | |||||||||
Interest
expense and amortization of debt
discounts and fees
|
125.8 | 159.5 | 229.4 | |||||||||
Interest
expense for discontinued operations
|
1.3 | 1.9 | 45.9 | |||||||||
Total
interest expense and amortization of debt discounts
and
fees
|
$ | 127.1 | $ | 161.4 | $ | 275.3 |
·
|
In
March 2007, the credit agreement was amended to lower the applicable
margin and modify certain other covenants, which included gaining the
appropriate lender approvals required for our 2007 divestiture
activities.
|
·
|
In
October 2009, the credit agreement was amended to extend the maturity of a
portion of the loans under the credit agreement and to amend certain other
provisions. Other amendments allow us to issue senior secured and
unsecured notes in the bond market and increase amounts we can spend for
acquisitions and selected debt
repurchases.
|
Period
|
Redemption
Price*
|
2011
|
105.375%
|
2012
|
103.583%
|
2013
|
101.792%
|
2014
and thereafter
|
100.000%
|
*
Expressed in percentage of principal amount
|
Period
|
Redemption
Price*
|
2015
|
104.063%
|
2016
|
102.708%
|
2017
|
101.354%
|
2018
and thereafter
|
100.000%
|
*
Expressed in percentage of principal amount
|
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Unrealized
loss on available-for-sale securities
|
$ | (0.1 | ) | $ | (3.0 | ) | ||
Unrealized
gain (loss) on interest rate swaps
|
0.1 | (0.2 | ) | |||||
Total
|
$ | - | $ | (3.2 | ) |
Fair Value Measurements at Reporting Date Using | ||||||||||||||||||||
As of December 31, 2009 |
Fair
Value
|
Quoted
Prices in Active Markets for Identical Assets
(Level
1)
|
Significant
Other Observable Inputs
(Level
2)
|
Significant
Unobservable Inputs
(Level
3)
|
Valuation
Technique
(1)
|
|||||||||||||||
Current portion of restricted marketable securities | $ | 2.7 | $ | 2.7 | $ | - | $ | - | M | |||||||||||
Prepaid
expenses and other current assets:
|
||||||||||||||||||||
June 2009 trading swap | 4.7 | - | 4.7 | - | I | |||||||||||||||
Other long-term assets: | ||||||||||||||||||||
Restricted marketable securities | 18.3 | 18.3 | - | - | M | |||||||||||||||
December 2008 forward-starting swap | 0.4 | - | 0.4 | - | I | |||||||||||||||
June 2009 trading swap | 0.9 | - | 0.9 | - | I | |||||||||||||||
Other current liabilities: | ||||||||||||||||||||
March 2006 trading swap | (54.8 | ) | - | (54.8 | ) | - | I | |||||||||||||
March 2009 forward-starting swap | (0.3 | ) | - | (0.3 | ) | - | I |
As of December 31, 2008 | ||||||||||||||||||||
Current portion of restricted marketable securities | $ | 20.3 | $ | 20.3 | $ | - | $ | - | M | |||||||||||
Prepaid expenses and other current assets: | ||||||||||||||||||||
Marketable securities | 0.2 | 0.2 | - | - | M | |||||||||||||||
Other current liabilities: | ||||||||||||||||||||
March 2006 trading swap | (78.2 | ) | - | (78.2 | ) | - | I | |||||||||||||
December 2008 forward-starting swap | (0.2 | ) | - | (0.2 | ) | - | I | |||||||||||||
Government, class action, and related settlements: | ||||||||||||||||||||
Securities Litigation Settlement liability - common stock | (55.1 | ) | (55.1 | ) | - | - | M | |||||||||||||
Securities Litigation Settlement liability - common stock warrants | (19.5 | ) | - | (19.5 | ) | - | I |
(1)
|
The
three valuation techniques are: market approach (M), cost
approach (C), and income
approach (I).
|
Fair
Value Measurements at Reporting
|
||||||||||||||||||||
Date
Using
|
Total
Losses
|
|||||||||||||||||||
Net
Carrying
Value
as of
December 31
,
2009
|
Quoted
Prices in Active Markets for Identical Assets
(Level
1)
|
Significant
Other Observable Inputs
(Level
2)
|
Significant
Unobservable Inputs
(Level
3)
|
Year
Ended
December 31
,
2009
|
||||||||||||||||
Investments
in and advances
to nonconsolidated affiliates
|
$ | 1.7 | $ | - | $ | - | $ | 1.7 | $ | 0.3 | ||||||||||
Other
long-term assets:
|
||||||||||||||||||||
Assets
held for sale
|
14.2 | - | 14.2 | - | 0.9 |
As
of December 31, 2009
|
As
of December 31, 2008
|
|||||||||||||||
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
|||||||||||||
Interest
rate swap agreements:
|
||||||||||||||||
March
2006 trading swap
|
$ | (54.8 | ) | $ | (54.8 | ) | $ | (78.2 | ) | $ | (78.2 | ) | ||||
December
2008 forward-starting swap
|
0.4 | 0.4 | (0.2 | ) | (0.2 | ) | ||||||||||
March
2009 forward-starting swap
|
(0.3 | ) | (0.3 | ) | - | - | ||||||||||
June
2009 trading swap
|
5.6 | 5.6 | - | - | ||||||||||||
Long-term
debt:
|
||||||||||||||||
Advances
under $400 million revolving
credit facility
|
- | - | 40.0 | 28.4 | ||||||||||||
Term
loan facility
|
751.3 | 714.5 | 783.6 | 597.5 | ||||||||||||
Floating
Rate Senior Notes due 2014
|
- | - | 366.0 | 292.1 | ||||||||||||
10.75%
Senior Notes due 2016
|
494.9 | 542.5 | 494.3 | 459.0 | ||||||||||||
8.125%
Senior Notes due 2020
|
285.2 | 284.7 | - | - | ||||||||||||
Other
bonds payable
|
1.8 | 1.8 | 1.8 | 1.8 | ||||||||||||
Other
notes payable
|
28.0 | 28.0 | 12.8 | 12.8 | ||||||||||||
Financial
commitments:
|
||||||||||||||||
Letters
of credit
|
- | 95.2 | - | 152.7 |
For
the Year Ended December 31,
|
|||||||
2009
|
2008
|
2007
|
|||||
Expected
volatility
|
45.0
|
% |
39.5
|
% |
42.0
|
% | |
Risk-free
interest rate
|
2.7
|
% |
3.2
|
% |
4.5
|
% | |
Expected
life (years)
|
6.5
|
6.4
|
4.6
|
||||
Dividend
yield
|
0.0
|
% |
0.0
|
% |
0.0
|
% |
Shares
(In
Thousands)
|
Weighted-
Average Exercise Price per Share
|
Remaining
Life (Years)
|
Aggregate
Intrinsic Value
(In
Millions)
|
|||||||||||||
Outstanding,
December 31, 2008
|
2,352 | $ | 25.46 | |||||||||||||
Granted
|
404 | 9.57 | ||||||||||||||
Exercised
|
- | - | ||||||||||||||
Forfeitures
|
(130 | ) | 13.21 | |||||||||||||
Expirations
|
(112 | ) | 40.23 | |||||||||||||
Outstanding,
December 31, 2009
|
2,514 | 22.88 | 6.1 | $ | 3.8 | |||||||||||
Exercisable,
December 31, 2009
|
1,833 | 25.89 | 5.2 | 0.3 |
Shares
|
Weighted-Average
Grant Date Fair Value
|
|||||||
Nonvested
shares at December 31, 2008
|
557 | $ | 17.27 | |||||
Granted
|
348 | 7.85 | ||||||
Vested
|
(170 | ) | 19.20 | |||||
Forfeited
|
(51 | ) | 14.70 | |||||
Nonvested
shares at December 31, 2009
|
684 | 12.20 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
operating revenues
|
$ | 17.8 | $ | 41.7 | $ | 654.1 | ||||||
Costs
and expenses
|
25.8 | 36.2 | 585.3 | |||||||||
Impairments
|
4.0 | 11.8 | 38.2 | |||||||||
(Loss)
income from discontinued operations
|
(12.0 | ) | (6.3 | ) | 30.6 | |||||||
Gain
on disposal of assets of discontinued operations
|
0.4 | 0.1 | 5.1 | |||||||||
Gain
on divestitures of divisions
|
13.4 | 18.7 | 451.9 | |||||||||
Income
tax benefit
|
0.3 | 3.7 | 2.6 | |||||||||
Income
from discontinued operations, net of tax
|
$ | 2.1 | $ | 16.2 | $ | 490.2 |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Assets:
|
||||||||
Current
assets
|
$ | 1.4 | $ | 3.8 | ||||
Long-term
assets
|
14.2 | 37.1 | ||||||
Total
assets
|
$ | 15.6 | $ | 40.9 | ||||
Liabilities:
|
||||||||
Current
liabilities
|
$ | 4.2 | $ | 37.5 | ||||
Long-term
liabilities
|
1.3 | 4.7 | ||||||
Total
long-term liabilities
|
$ | 5.5 | $ | 42.2 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
operating revenues
|
$ | 7.4 | $ | 10.7 | $ | 381.7 | ||||||
Costs
and expenses
|
3.9 | 6.6 | 324.5 | |||||||||
Impairments
|
- | 1.2 | 4.8 | |||||||||
Income
from discontinued operations
|
3.5 | 2.9 | 52.4 | |||||||||
Gain
on disposal of assets of discontinued operations
|
0.7 | 0.2 | 1.9 | |||||||||
Gain
on divestiture of division
|
13.4 | 19.3 | 314.9 | |||||||||
Income
tax benefit
|
0.4 | 3.8 | 18.4 | |||||||||
Income
from discontinued operations, net of tax
|
$ | 18.0 | $ | 26.2 | $ | 387.6 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
operating revenues
|
$ | 0.5 | $ | 1.6 | $ | 127.3 | ||||||
Costs
and expenses
|
7.7 | (4.6 | ) | 110.2 | ||||||||
Impairments
|
- | - | 0.2 | |||||||||
(Loss)
income from discontinued operations
|
(7.2 | ) | 6.2 | 16.9 | ||||||||
Loss
on disposal of assets of discontinued operations
|
- | - | (1.3 | ) | ||||||||
Gain
on divestiture of division
|
- | - | 145.3 | |||||||||
Income
tax expense
|
- | - | (16.0 | ) | ||||||||
(Loss)
income from discontinued operations, net of tax
|
$ | (7.2 | ) | $ | 6.2 | $ | 144.9 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
operating revenues
|
$ | 0.1 | $ | 1.1 | $ | 92.0 | ||||||
Costs
and expenses
|
0.8 | 2.6 | 96.8 | |||||||||
Impairments
|
- | 0.6 | 33.2 | |||||||||
Loss
from discontinued operations
|
(0.7 | ) | (2.1 | ) | (38.0 | ) | ||||||
Gain
on disposal of assets of discontinued operations
|
0.1 | - | 2.9 | |||||||||
Loss
on divestiture of division
|
- | (0.6 | ) | (8.3 | ) | |||||||
Loss
from discontinued operations, net of tax
|
$ | (0.6 | ) | $ | (2.7 | ) | $ | (43.4 | ) |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Income
(loss) from continuing operations before
income tax
benefit
|
$ | 123.5 | $ | 195.5 | $ | (93.9 | ) |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Current:
|
||||||||||||
Federal
|
$ | 1.8 | $ | (7.6 | ) | $ | (300.2 | ) | ||||
State
and local
|
(9.1 | ) | (66.2 | ) | (30.2 | ) | ||||||
Total
current benefit
|
(7.3 | ) | (73.8 | ) | (330.4 | ) | ||||||
Deferred:
|
||||||||||||
Federal
|
3.0 | 2.7 | 5.5 | |||||||||
State
and local
|
1.1 | 1.0 | 2.5 | |||||||||
Total
deferred expense
|
4.1 | 3.7 | 8.0 | |||||||||
Total
income tax benefit related to continuing
operations
|
$ | (3.2 | ) | $ | (70.1 | ) | $ | (322.4 | ) |
For
the Year Ended December 31,
|
|||||||
2009
|
2008
|
2007
|
|||||
Tax
expense (benefit) at statutory rate
|
35.0%
|
35.0%
|
(35.0%
|
) | |||
Increase
(decrease) in tax rate resulting from:
|
|||||||
State
income taxes, net of federal tax benefit
|
3.5%
|
4.9%
|
(9.2%
|
) | |||
Indefinite-lived
assets
|
1.3%
|
2.0%
|
6.3%
|
||||
Interest,
net
|
(1.0%
|
) |
(8.8%
|
) |
(135.3%
|
) | |
Settlement
of tax claims
|
(6.0%
|
) |
(34.4%
|
) |
(162.6%
|
) | |
Decrease
in valuation allowance
|
(42.7%
|
) |
(38.7%
|
) |
(33.2%
|
) | |
Noncontrolling
interests
|
9.3%
|
5.3%
|
24.3%
|
||||
Other,
net
|
(2.0%
|
) |
(1.2%
|
) |
1.4%
|
||
Income
tax benefit
|
(2.6%
|
) |
(35.9%
|
) |
(343.3%
|
) |
As
of December 31,
|
||||||||
2009
|
2008
|
|||||||
Deferred
income tax assets:
|
||||||||
Net
operating loss
|
$ | 769.8 | $ | 798.2 | ||||
Allowance
for doubtful accounts
|
15.3 | 47.6 | ||||||
Accrual
for government, class action, and related settlements
|
2.6 | 29.8 | ||||||
Insurance
reserve
|
31.7 | 38.7 | ||||||
Other
accruals
|
15.0 | 15.3 | ||||||
Property,
net
|
32.5 | 33.1 | ||||||
Intangibles
|
6.8 | 3.1 | ||||||
Alternative
minimum tax
|
13.7 | 15.3 | ||||||
Stock-based
compensation
|
17.4 | 13.3 | ||||||
Total
deferred income tax assets
|
904.8 | 994.4 | ||||||
Less:
Valuation allowance
|
(892.7 | ) | (969.6 | ) | ||||
Net
deferred income tax assets
|
12.1 | 24.8 | ||||||
Deferred
income tax liabilities:
|
||||||||
Indefinite-lived
intangibles
|
(32.8 | ) | (31.5 | ) | ||||
Carrying
value of partnerships
|
(10.1 | ) | (20.1 | ) | ||||
Other
|
(1.9 | ) | (2.1 | ) | ||||
Total
deferred income tax liabilities
|
(44.8 | ) | (53.7 | ) | ||||
Net
deferred income tax liabilities
|
(32.7 | ) | (28.9 | ) | ||||
Less:
Current deferred tax assets
|
0.5 | 0.8 | ||||||
Noncurrent
deferred tax liabilities
|
$ | (33.2 | ) | $ | (29.7 | ) |
Gross
Unrecognized Income Tax Benefits
|
Accrued
Interest and Penalties
|
|||||||
Balance
at January 1, 2007
|
$ | 267.4 | $ | 9.8 | ||||
Gross
amount of increases in unrecognized tax
benefits related to prior
periods
|
33.6 | 3.5 | ||||||
Gross
amount of decreases in unrecognized tax
benefits related to prior
periods
|
(26.0 | ) | (1.6 | ) | ||||
Gross
amount of increases in unrecognized tax
benefits related to the
current period
|
0.1 | - | ||||||
Decreases
in unrecognized tax benefits relating
to settlements with taxing
authorities
|
(134.2 | ) | - | |||||
Reductions
to unrecognized tax benefits as a
result of a lapse of the
applicable statute of limitations
|
(2.7 | ) | - | |||||
Balance
at December 31, 2007
|
138.2 | 11.7 | ||||||
Gross
amount of increases in unrecognized tax
benefits related to prior
periods
|
4.0 | 0.5 | ||||||
Decreases
in unrecognized tax benefits relating
to settlements with taxing
authorities
|
(78.8 | ) | (7.2 | ) | ||||
Reductions
to unrecognized tax benefits as a
result of a lapse of the
applicable statute of limitations
|
(2.3 | ) | (2.1 | ) | ||||
Balance
at December 31, 2008
|
61.1 | 2.9 | ||||||
Gross
amount of increases in unrecognized tax
benefits related to prior
periods
|
0.1 | 0.1 | ||||||
Increases
in unrecognized tax benefits relating
to settlements with taxing
authorities
|
2.7 | - | ||||||
Decreases
in unrecognized tax benefits relating
to settlements with taxing
authorities
|
(8.5 | ) | - | |||||
Reductions
to unrecognized tax benefits as a
result of a lapse of the
applicable statute of limitations
|
(4.5 | ) | (1.1 | ) | ||||
Balance
at December 31, 2009
|
$ | 50.9 | $ | 1.9 |
For
the Year Ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Basic:
|
||||||||||||
Numerator:
|
||||||||||||
Income
from continuing operations
|
$ | 126.7 | $ | 265.6 | $ | 228.5 | ||||||
Less:
Net income attributable to noncontrolling
interests included in
continuing operations
|
(33.4 | ) | (29.8 | ) | (31.4 | ) | ||||||
Less:
Convertible perpetual preferred stock dividends
|
(26.0 | ) | (26.0 | ) | (26.0 | ) | ||||||
Income
from continuing operations attributable
to HealthSouth common
shareholders
|
67.3 | 209.8 | 171.1 | |||||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
1.5 | 16.6 | 456.3 | |||||||||
Net
income attributable to HealthSouth
common
shareholders
|
$ | 68.8 | $ | 226.4 | $ | 627.4 | ||||||
Denominator:
|
||||||||||||
Basic
weighted average common shares outstanding
|
88.8 | 83.0 | 78.7 | |||||||||
Basic
earnings per common share:
|
||||||||||||
Income
from continuing operations attributable to
HealthSouth common
shareholders
|
$ | 0.76 | $ | 2.53 | $ | 2.17 | ||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.20 | 5.80 | |||||||||
Net
income per share attributable to
HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.73 | $ | 7.97 | ||||||
Diluted:
|
||||||||||||
Numerator:
|
||||||||||||
Income
from continuing operations
|
$ | 126.7 | $ | 265.6 | $ | 228.5 | ||||||
Less:
Net income attributable to noncontrolling
interests included in
continuing operations
|
(33.4 | ) | (29.8 | ) | (31.4 | ) | ||||||
Income
from continuing operations attributable
to HealthSouth common
shareholders
|
93.3 | 235.8 | 197.1 | |||||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
1.5 | 16.6 | 456.3 | |||||||||
Net
income attributable to HealthSouth
common
shareholders
|
$ | 94.8 | $ | 252.4 | $ | 653.4 | ||||||
Denominator:
|
||||||||||||
Diluted
weighted average common shares outstanding
|
103.3 | 96.4 | 92.0 | |||||||||
Diluted
earnings per common share:
|
||||||||||||
Income
from continuing operations attributable to
HealthSouth common
shareholders
|
$ | 0.76 | $ | 2.45 | $ | 2.14 | ||||||
Income
from discontinued operations, net of tax,
attributable to
HealthSouth common shareholders
|
0.01 | 0.17 | 4.96 | |||||||||
Net
income per share attributable to
HealthSouth common
shareholders
|
$ | 0.77 | $ | 2.62 | $ | 7.10 |
•
|
form
an executive compliance committee (made up of our chief compliance officer
and other executive management members), which shall participate in the
formulation and implementation of HealthSouth’s compliance
program;
|
•
|
require
certain independent contractors to abide by our Standards of Business
Conduct;
|
•
|
provide
general compliance training to all HealthSouth personnel as well as
specialized training to personnel responsible for billing, coding, and
cost reporting relating to federal healthcare
programs;
|
•
|
report
and return overpayments received from federal healthcare
programs;
|
•
|
notify
the HHS-OIG of any new investigations or legal proceedings initiated by a
governmental entity involving an allegation of fraud or criminal conduct
against HealthSouth;
|
•
|
notify
the HHS-OIG of the purchase, sale, closure, establishment, or relocation
of facilities furnishing items or services that are reimbursed under
federal healthcare programs; and
|
•
|
submit
annual reports to the HHS-OIG regarding our compliance with the
CIA.
|
•
|
Complaints
based on purchases of our common stock were grouped under the caption
In re HealthSouth Corp.
Stockholder Litigation
, Consolidated Case No. CV-03-BE-1501-S (the
“Stockholder Securities Action”), which was further divided into
complaints based on purchases of our common stock in the open market
(grouped under the caption
In re HealthSouth Corp.
Stockholder Litigation,
Consolidated Case No. CV-03-BE-1501-S)
and claims based on the receipt of our common stock in mergers (grouped
under the caption
HealthSouth Merger
Cases
, Consolidated Case No. CV-98-2777-S). Although the plaintiffs
in the
HealthSouth
Merger Cases
have separate counsel and have filed separate claims,
the
HealthSouth Merger
Cases
are otherwise consolidated with the Stockholder Securities
Action for all purposes.
|
•
|
Complaints
based on purchases of our debt securities were grouped under the caption
In re HealthSouth Corp.
Bondholder Litigation
, Consolidated Case No. CV-03-BE-1502-S (the
“Bondholder Securities Action”).
|
2009
|
||||||||||||||||||||
First
(a)
|
Second
(a)
|
Third
(a)
|
Fourth
|
Total
|
||||||||||||||||
(In
Millions, Except Per Share Data)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 472.9 | $ | 481.6 | $ | 470.4 | $ | 486.2 | $ | 1,911.1 | ||||||||||
Operating
earnings
(b)
|
86.9 | 25.7 | 61.0 | 71.0 | 244.6 | |||||||||||||||
Income
from continuing operations
|
56.2 | 2.3 | 33.9 | 34.3 | 126.7 | |||||||||||||||
(Loss)
income from discontinued operations, net of tax
|
(2.7 | ) | 1.3 | (9.1 | ) | 12.6 | 2.1 | |||||||||||||
Net
income
|
53.5 | 3.6 | 24.8 | 46.9 | 128.8 | |||||||||||||||
Net
income attributable to noncontrolling interests
|
(8.6 | ) | (9.1 | ) | (8.0 | ) | (8.3 | ) | (34.0 | ) | ||||||||||
Net
income (loss) attributable to HealthSouth
|
$ | 44.9 | $ | (5.5 | ) | $ | 16.8 | $ | 38.6 | $ | 94.8 | |||||||||
Basic
and diluted earnings per common share:
|
||||||||||||||||||||
Income
(loss) from continuing operations
attributable to HealthSouth
common shareholders
|
$ | 0.47 | $ | (0.15 | ) | $ | 0.22 | $ | 0.22 | $ | 0.76 | |||||||||
(Loss)
income from discontinued operations, net
of tax, attributable to
HealthSouth common shareholders
|
(0.03 | ) | 0.01 | (0.10 | ) | 0.13 | 0.01 | |||||||||||||
Net
income (loss) per share attributable to HealthSouth
common
shareholders
|
$ | 0.44 | $ | (0.14 | ) | $ | 0.12 | $ | 0.35 | $ | 0.77 | |||||||||
2008 | ||||||||||||||||||||
First
(a)
|
Second
(a)
|
Third
(a)
|
Fourth
(a)
|
Total
|
||||||||||||||||
(In
Millions, Except Per Share Data)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 461.8 | $ | 454.1 | $ | 452.8 | $ | 460.8 | $ | 1,829.5 | ||||||||||
Operating
earnings
(b)
|
88.4 | 66.4 | 37.4 | 194.6 | 386.8 | |||||||||||||||
Income
from continuing operations
|
12.3 | 56.6 | 15.7 | 181.0 | 265.6 | |||||||||||||||
Income
(loss) from discontinued operations, net of tax,
|
14.1 | (4.2 | ) | (2.9 | ) | 9.2 | 16.2 | |||||||||||||
Net
income
|
26.4 | 52.4 | 12.8 | 190.2 | 281.8 | |||||||||||||||
Net
income attributable to noncontrolling interests
|
(6.6 | ) | (8.3 | ) | (6.2 | ) | (8.3 | ) | (29.4 | ) | ||||||||||
Net
income attributable to HealthSouth
|
$ | 19.8 | $ | 44.1 | $ | 6.6 | $ | 181.9 | $ | 252.4 | ||||||||||
Basic
nd diluted earnings per common share:
|
||||||||||||||||||||
Basic:
(c)
|
||||||||||||||||||||
(Loss)
income from continuing operations
attributable to HealthSouth
common shareholders
|
$ | (0.02 | ) | $ | 0.52 | $ | 0.04 | $ | 1.91 | $ | 2.53 | |||||||||
Income
(loss) from discontinued operations, net
of tax, attributable to
HealthSouth common shareholders
|
0.19 | (0.05 | ) | (0.04 | ) | 0.10 | 0.20 | |||||||||||||
Net
income per share attributable to HealthSouth
common
shareholders
|
$ | 0.17 | $ | 0.47 | $ | 0.00 | $ | 2.01 | $ | 2.73 | ||||||||||
Diluted:
(d)
|
||||||||||||||||||||
(Loss)
income from continuing operations
attributable to HealthSouth
common shareholders
|
$ | (0.02 | ) | $ | 0.52 | $ | 0.04 | $ | 1.72 | $ | 2.45 | |||||||||
Income
(loss) from discontinued operations, net
|
||||||||||||||||||||
Income
(loss) from discontinued operations, net
of tax, attributable to
HealthSouth common shareholders
|
0.19 | (0.05 | ) | (0.04 | ) | 0.09 | 0.17 | |||||||||||||
Net
income per share attributable to HealthSouth
common
shareholders
|
$ | 0.17 | $ | 0.47 | $ | 0.00 | $ | 1.81 | $ | 2.62 |
(a)
|
Amounts
are presented using facilities identified as of December 31, 2009 that met
the requirements to be reported as discontinued
operations.
|
(b)
|
We
define operating earnings as income from continuing operations
attributable to HealthSouth before (1) loss on early extinguishment
of debt; (2) interest expense and amortization of debt discounts and
fees; (3) other income; (4) loss on interest rate swaps, and
(5) income tax expense or benefit
.
|
(c)
|
Basic
per share amounts may not sum due to the weighted average common shares
outstanding each quarter compared to the weighted average common shares
outstanding during the entire year.
|
(d)
|
Total
diluted earnings per common share will not sum due to antidilution in the
quarters ended March 31, 2008, June 30, 2008, and September 30,
2008.
|
For
the Year Ended December 31, 2009
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 77.6 | $ | 1,330.9 | $ | 539.8 | $ | (37.2 | ) | $ | 1,911.1 | |||||||||
Operating
expenses:
|
||||||||||||||||||||
Salaries
and benefits
|
50.9 | 644.7 | 265.5 | (12.3 | ) | 948.8 | ||||||||||||||
Other
operating expenses
|
21.5 | 181.8 | 83.5 | (15.4 | ) | 271.4 | ||||||||||||||
General
and administrative
expenses
|
104.5 | - | - | - | 104.5 | |||||||||||||||
Supplies
|
6.5 | 76.9 | 29.0 | - | 112.4 | |||||||||||||||
Depreciation
and amortization
|
8.9 | 47.7 | 14.3 | - | 70.9 | |||||||||||||||
Occupancy
costs
|
3.9 | 35.9 | 17.1 | (9.3 | ) | 47.6 | ||||||||||||||
Provision
for doubtful accounts
|
2.5 | 22.2 | 8.4 | - | 33.1 | |||||||||||||||
Loss
on disposal of assets
|
- | 3.4 | 0.1 | - | 3.5 | |||||||||||||||
Government,
class action, and
related settlements expense
|
36.7 | - | - | - | 36.7 | |||||||||||||||
Professional
fees—accounting,
tax, and legal
|
8.8 | - | - | - | 8.8 | |||||||||||||||
Total
operating expenses
|
244.2 | 1,012.6 | 417.9 | (37.0 | ) | 1,637.7 | ||||||||||||||
Loss
on early extinguishment of debt
|
12.5 | - | - | - | 12.5 | |||||||||||||||
Interest
expense and amortization of
debt discounts and fees
|
114.5 | 8.6 | 3.1 | (0.4 | ) | 125.8 | ||||||||||||||
Other
expense (income)
|
0.7 | (0.4 | ) | (4.1 | ) | 0.4 | (3.4 | ) | ||||||||||||
Loss
on interest rate swaps
|
19.6 | - | - | - | 19.6 | |||||||||||||||
Equity
in net income of nonconsolidated
affiliates
|
(1.9 | ) | (2.5 | ) | (0.2 | ) | - | (4.6 | ) | |||||||||||
Equity
in net income of consolidated
affiliates—
|
||||||||||||||||||||
Gain
on sale of consolidated
affiliate
|
(13.4 | ) | - | - | 13.4 | - | ||||||||||||||
Income
from operations of
consolidated affiliates
|
(165.6 | ) | (13.3 | ) | (3.2 | ) | 182.1 | - | ||||||||||||
Management
fees
|
(84.5 | ) | 65.5 | 19.0 | - | - | ||||||||||||||
(Loss)
income from continuing
operations before income tax (benefit)
expense
|
(48.5 | ) | 260.4 | 107.3 | (195.7 | ) | 123.5 | |||||||||||||
Provision
for income tax (benefit)
expense
|
(153.1 | ) | 120.8 | 29.1 | - | (3.2 | ) | |||||||||||||
Income
from continuing
operations
|
104.6 | 139.6 | 78.2 | (195.7 | ) | 126.7 | ||||||||||||||
(Loss)
income from discontinued
operations, net of income tax
benefit
|
(9.8 | ) | (3.3 | ) | 1.6 | 13.6 | 2.1 | |||||||||||||
Net
Income
|
94.8 | 136.3 | 79.8 | (182.1 | ) | 128.8 | ||||||||||||||
Less:
Net income attributable to
noncontrolling interests
|
- | - | (34.0 | ) | - | (34.0 | ) | |||||||||||||
Net
income attributable
to
HealthSouth
|
$ | 94.8 | $ | 136.3 | $ | 45.8 | $ | (182.1 | ) | $ | 94.8 |
For
the Year Ended December 31, 2008
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 78.3 | $ | 1,274.5 | $ | 503.8 | $ | (27.1 | ) | $ | 1,829.5 | |||||||||
Operating
expenses:
|
||||||||||||||||||||
Salaries
and benefits
|
50.1 | 633.4 | 252.8 | (8.1 | ) | 928.2 | ||||||||||||||
Other
operating expenses
|
19.3 | 180.4 | 75.0 | (9.8 | ) | 264.9 | ||||||||||||||
General
and administrative
expenses
|
105.5 | - | - | - | 105.5 | |||||||||||||||
Supplies
|
6.9 | 73.4 | 27.9 | - | 108.2 | |||||||||||||||
Depreciation
and amortization
|
22.4 | 45.1 | 14.9 | - | 82.4 | |||||||||||||||
Impairment
of long-lived assets
|
- | 0.6 | - | - | 0.6 | |||||||||||||||
Gain
on UBS Settlement
|
(121.3 | ) | - | - | - | (121.3 | ) | |||||||||||||
Occupancy
costs
|
3.8 | 37.2 | 16.6 | (8.8 | ) | 48.8 | ||||||||||||||
Provision
for doubtful accounts
|
1.1 | 20.6 | 5.3 | - | 27.0 | |||||||||||||||
(Gain)
loss on disposal of assets
|
(0.2 | ) | 2.0 | 0.2 | - | 2.0 | ||||||||||||||
Government,
class action, and
related settlements expense
|
(68.4 | ) | (0.2 | ) | 1.4 | - | (67.2 | ) | ||||||||||||
Professional
fees—accounting,
tax, and legal
|
44.4 | - | - | - | 44.4 | |||||||||||||||
Total
operating expenses
|
63.6 | 992.5 | 394.1 | (26.7 | ) | 1,423.5 | ||||||||||||||
Loss
on early extinguishment of debt
|
5.9 | - | - | - | 5.9 | |||||||||||||||
Interest
expense and amortization of
debt discounts and fees
|
147.8 | 8.6 | 4.2 | (1.1 | ) | 159.5 | ||||||||||||||
Other
expense (income)
|
1.4 | (0.3 | ) | (2.2 | ) | 1.1 | - | |||||||||||||
Loss
on interest rate swap
|
55.7 | - | - | - | 55.7 | |||||||||||||||
Equity
in net income of nonconsolidated
affiliates
|
(2.4 | ) | (7.9 | ) | (0.3 | ) | - | (10.6 | ) | |||||||||||
Equity
in net income of consolidated
affiliates—
|
||||||||||||||||||||
Gain
on sale of consolidated
affiliates
|
(18.8 | ) | - | - | 18.8 | - | ||||||||||||||
Income
from operations of
|
||||||||||||||||||||
Income
from operations of
consolidated affiliates
|
(138.4 | ) | (16.4 | ) | (1.8 | ) | 156.6 | - | ||||||||||||
Management
fees
|
(83.1 | ) | 63.5 | 19.6 | - | - | ||||||||||||||
Income
from continuing
operations before income tax (benefit)
expense
|
46.6 | 234.5 | 90.2 | (175.8 | ) | 195.5 | ||||||||||||||
Provision
for income tax (benefit)
expense
|
(206.2 | ) | 111.1 | 25.0 | - | (70.1 | ) | |||||||||||||
Income
from continuing
operations
|
252.8 | 123.4 | 65.2 | (175.8 | ) | 265.6 | ||||||||||||||
(Loss)
income from discontinued
operations, net of income tax
benefit
|
(0.4 | ) | (7.1 | ) | 4.6 | 19.1 | 16.2 | |||||||||||||
Net
Income
|
252.4 | 116.3 | 69.8 | (156.7 | ) | 281.8 | ||||||||||||||
Less:
Net income attributable to
noncontrolling interests
|
- | - | (29.4 | ) | - | (29.4 | ) | |||||||||||||
Net
income attributable
to
HealthSouth
|
$ | 252.4 | $ | 116.3 | $ | 40.4 | $ | (156.7 | ) | $ | 252.4 |
For
the Year Ended December 31, 2007
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
operating revenues
|
$ | 81.1 | $ | 1,179.8 | $ | 492.5 | $ | (29.9 | ) | $ | 1,723.5 | |||||||||
Operating
expenses:
|
||||||||||||||||||||
Salaries
and benefits
|
49.8 | 581.9 | 231.4 | (5.6 | ) | 857.5 | ||||||||||||||
Other
operating expenses
|
25.9 | 161.5 | 64.9 | (11.3 | ) | 241.0 | ||||||||||||||
General
and administrative
expenses
|
127.9 | - | - | - | 127.9 | |||||||||||||||
Supplies
|
6.7 | 68.0 | 24.9 | - | 99.6 | |||||||||||||||
Depreciation
and amortization
|
17.6 | 41.0 | 16.2 | - | 74.8 | |||||||||||||||
Impairment
of long-lived assets
|
15.0 | 0.1 | - | - | 15.1 | |||||||||||||||
Occupancy
costs
|
1.7 | 41.0 | 16.2 | (7.5 | ) | 51.4 | ||||||||||||||
Provision
for doubtful accounts
|
3.4 | 21.9 | 7.9 | - | 33.2 | |||||||||||||||
Loss
(gain) on disposal of assets
|
3.7 | 3.0 | (0.8 | ) | - | 5.9 | ||||||||||||||
Government,
class action, and
related settlements expense
|
(2.4 | ) | (0.4 | ) | - | - | (2.8 | ) | ||||||||||||
Professional
fees—accounting,
tax, and legal
|
51.1 | 0.5 | - | - | 51.6 | |||||||||||||||
Total
operating expenses
|
300.4 | 918.5 | 360.7 | (24.4 | ) | 1,555.2 | ||||||||||||||
Loss
on early extinguishment of debt
|
28.2 | - | - | - | 28.2 | |||||||||||||||
Interest
expense and amortization of
debt discounts and fees
|
219.5 | 8.0 | 4.1 | (2.2 | ) | 229.4 | ||||||||||||||
Other
income
|
(8.4 | ) | (0.2 | ) | (9.1 | ) | 2.2 | (15.5 | ) | |||||||||||
Loss
on interest rate swap
|
30.4 | - | - | - | 30.4 | |||||||||||||||
Equity
in net income of nonconsolidated
affiliates
|
(2.5 | ) | (7.6 | ) | (0.2 | ) | - | (10.3 | ) | |||||||||||
Equity
in net income of consolidated
affiliates—
|
||||||||||||||||||||
Gain
on sale of consolidated
affiliates
|
(451.9 | ) | - | - | 451.9 | - | ||||||||||||||
(Income)
loss from operations of
consolidated affiliates
|
(143.9 | ) | 22.0 | (0.5 | ) | 122.4 | - | |||||||||||||
Management
fees
|
(99.6 | ) | 58.4 | 41.2 | - | - | ||||||||||||||
Income
from continuing
operations before income tax (benefit)
expense
|
208.9 | 180.7 | 96.3 | (579.8 | ) | (93.9 | ) | |||||||||||||
Provision
for income tax (benefit)
expense
|
(444.3 | ) | 88.7 | 33.2 | - | (322.4 | ) | |||||||||||||
Income
from continuing
operations
|
653.2 | 92.0 | 63.1 | (579.8 | ) | 228.5 | ||||||||||||||
Income
from discontinued
operations, net of income tax
benefit
|
0.2 | 16.6 | 16.1 | 457.3 | 490.2 | |||||||||||||||
Net
Income
|
653.4 | 108.6 | 79.2 | (122.5 | ) | 718.7 | ||||||||||||||
Less:
Net income attributable to
noncontrolling interests
|
- | - | (65.3 | ) | - | (65.3 | ) | |||||||||||||
Net
income attributable
to
HealthSouth
|
$ | 653.4 | $ | 108.6 | $ | 13.9 | $ | (122.5 | ) | $ | 653.4 |
As
of December 31, 2009
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Assets
|
||||||||||||||||||||
Current
assets:
|
||||||||||||||||||||
Cash
and cash equivalents
|
$ | 76.2 | $ | 1.8 | $ | 2.9 | $ | - | $ | 80.9 | ||||||||||
Restricted
cash
|
2.3 | - | 65.5 | - | 67.8 | |||||||||||||||
Restricted
marketable securities
|
- | - | 2.7 | - | 2.7 | |||||||||||||||
Accounts
receivable, net
|
10.1 | 146.2 | 63.4 | - | 219.7 | |||||||||||||||
Prepaid
expenses and other current assets
|
35.2 | 63.2 | 45.0 | (88.5 | ) | 54.9 | ||||||||||||||
Total
current assets
|
123.8 | 211.2 | 179.5 | (88.5 | ) | 426.0 | ||||||||||||||
Property
and equipment, net
|
40.1 | 479.2 | 145.5 | - | 664.8 | |||||||||||||||
Goodwill
|
- | 266.1 | 150.3 | - | 416.4 | |||||||||||||||
Intangible
assets, net
|
0.4 | 29.8 | 7.2 | - | 37.4 | |||||||||||||||
Investments
in and advances to
nonconsolidated affiliates
|
3.0 | 22.4 | 3.9 | - | 29.3 | |||||||||||||||
Income
tax refund receivable
|
10.0 | - | - | - | 10.0 | |||||||||||||||
Other
long-term assets
|
55.5 | 217.8 | 70.6 | (246.3 | ) | 97.6 | ||||||||||||||
Intercompany
receivable
|
1,052.4 | - | - | (1,052.4 | ) | - | ||||||||||||||
Total
assets
|
$ | 1,285.2 | $ | 1,226.5 | $ | 557.0 | $ | (1,387.2 | ) | $ | 1,681.5 | |||||||||
Liabilities
and Shareholders’ (Deficit) Equity
|
||||||||||||||||||||
Current
liabilities:
|
||||||||||||||||||||
Current
portion of long-term debt
|
$ | 9.7 | $ | 10.0 | $ | 1.8 | $ | - | $ | 21.5 | ||||||||||
Accounts
payable
|
12.5 | 27.9 | 9.8 | - | 50.2 | |||||||||||||||
Accrued
expenses and other current liabilities
|
207.2 | 48.9 | 56.8 | - | 312.9 | |||||||||||||||
Government,
class action, and
related settlements
|
6.6 | - | - | - | 6.6 | |||||||||||||||
Total
current liabilities
|
236.0 | 86.8 | 68.4 | - | 391.2 | |||||||||||||||
Long-term
debt, net of current portion
|
1,552.9 | 86.1 | 27.0 | (25.0 | ) | 1,641.0 | ||||||||||||||
Other
long-term liabilities
|
82.9 | 11.3 | 69.5 | (4.2 | ) | 159.5 | ||||||||||||||
Intercompany
payable
|
- | 377.7 | 1,469.1 | (1,846.8 | ) | - | ||||||||||||||
1,871.8 | 561.9 | 1,634.0 | (1,876.0 | ) | 2,191.7 | |||||||||||||||
Commitments
and contingencies
|
||||||||||||||||||||
Convertible
perpetual preferred stock
|
387.4 | - | - | - | 387.4 | |||||||||||||||
Shareholders'
(deficit) equity
|
||||||||||||||||||||
HealthSouth
shareholders' (deficit) equity
|
(974.0 | ) | 664.6 | (1,153.4 | ) | 488.8 | (974.0 | ) | ||||||||||||
Noncontrolling
interests
|
- | - | 76.4 | - | 76.4 | |||||||||||||||
Total
shareholders' (deficit) equity
|
(974.0 | ) | 664.6 | (1,077.0 | ) | 488.8 | (897.6 | ) | ||||||||||||
Total liabilities and
shareholders' (deficit)
equity
|
$ | 1,285.2 | $ | 1,226.5 | $ | 557.0 | $ | (1,387.2 | ) | $ | 1,681.5 |
As
of December 31, 2008
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Assets
|
||||||||||||||||||||
Current
assets:
|
||||||||||||||||||||
Cash
and cash equivalents
|
$ | 23.1 | $ | 0.9 | $ | 8.1 | $ | - | $ | 32.1 | ||||||||||
Restricted
cash
|
100.2 | - | 53.8 | - | 154.0 | |||||||||||||||
Restricted
marketable securities
|
- | - | 20.3 | - | 20.3 | |||||||||||||||
Accounts
receivable, net
|
11.3 | 161.3 | 62.3 | - | 234.9 | |||||||||||||||
Prepaid
expense and other current assets
|
37.6 | 63.9 | 45.6 | (88.5 | ) | 58.6 | ||||||||||||||
Insurance
recoveries receivable
|
182.8 | - | - | - | 182.8 | |||||||||||||||
Total
current assets
|
355.0 | 226.1 | 190.1 | (88.5 | ) | 682.7 | ||||||||||||||
Property
and equipment, net
|
42.0 | 465.4 | 154.7 | - | 662.1 | |||||||||||||||
Goodwill
|
- | 267.0 | 147.7 | - | 414.7 | |||||||||||||||
Intangible
assets, net
|
- | 34.8 | 7.6 | - | 42.4 | |||||||||||||||
Investments
in and advances to
nonconsolidated affiliates
|
2.8 | 29.6 | 4.3 | - | 36.7 | |||||||||||||||
Income
tax refund receivable
|
55.9 | - | - | - | 55.9 | |||||||||||||||
Other
long-term assets
|
57.9 | 219.9 | 77.9 | (252.0 | ) | 103.7 | ||||||||||||||
Intercompany
receivable
|
1,095.3 | - | - | (1,095.3 | ) | - | ||||||||||||||
Total
assets
|
$ | 1,608.9 | $ | 1,242.8 | $ | 582.3 | $ | (1,435.8 | ) | $ | 1,998.2 | |||||||||
Liabilities
and Shareholders’ (Deficit) Equity
|
||||||||||||||||||||
Current
liabilities:
|
||||||||||||||||||||
Current
portion of long-term debt
|
$ | 10.2 | $ | 11.8 | $ | 1.6 | $ | - | $ | 23.6 | ||||||||||
Accounts
payable
|
11.6 | 24.8 | 9.1 | - | 45.5 | |||||||||||||||
Accrued
expenses and other current liabilities
|
300.9 | 62.2 | 55.5 | (10.0 | ) | 408.6 | ||||||||||||||
Government,
class action, and
related settlements
|
268.5 | - | - | - | 268.5 | |||||||||||||||
Total
current liabilities
|
591.2 | 98.8 | 66.2 | (10.0 | ) | 746.2 | ||||||||||||||
Long-term
debt, net of current portion
|
1,706.5 | 83.3 | 28.8 | (29.0 | ) | 1,789.6 | ||||||||||||||
Other
long-term liabilities
|
93.2 | 12.1 | 62.8 | (5.9 | ) | 162.2 | ||||||||||||||
Intercompany
payable
|
- | 474.5 | 1,526.7 | (2,001.2 | ) | - | ||||||||||||||
2,390.9 | 668.7 | 1,684.5 | (2,046.1 | ) | 2,698.0 | |||||||||||||||
Commitments
and contingencies
|
||||||||||||||||||||
Convertible
perpetual preferred stock
|
387.4 | - | - | - | 387.4 | |||||||||||||||
Shareholders'
(deficit) equity
|
||||||||||||||||||||
HealthSouth
shareholders' (deficit) equity
|
(1,169.4 | ) | 574.1 | (1,184.4 | ) | 610.3 | (1,169.4 | ) | ||||||||||||
Noncontrolling
interests
|
- | - | 82.2 | - | 82.2 | |||||||||||||||
Total
shareholders' (deficit) equity
|
(1,169.4 | ) | 574.1 | (1,102.2 | ) | 610.3 | (1,087.2 | ) | ||||||||||||
Total liabilities and
shareholders' (deficit)
equity
|
$ | 1,608.9 | $ | 1,242.8 | $ | 582.3 | $ | (1,435.8 | ) | $ | 1,998.2 |
For
the Year Ended December 31, 2009
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
cash provided by operating
activities
|
$ | 261.5 | $ | 203.0 | $ | 117.8 | $ | (176.2 | ) | $ | 406.1 | |||||||||
Cash
flows from investing activities:
|
||||||||||||||||||||
Capital
expenditures
|
(11.1 | ) | (53.4 | ) | (7.7 | ) | - | (72.2 | ) | |||||||||||
Acquisition
of intangible assets
|
(0.4 | ) | - | - | - | (0.4 | ) | |||||||||||||
Proceeds
from disposal of assets
|
- | 3.9 | - | - | 3.9 | |||||||||||||||
Proceeds
from sale of restricted
marketable securities
|
- | - | 5.0 | - | 5.0 | |||||||||||||||
Proceeds
from sale of investments
|
0.6 | - | - | - | 0.6 | |||||||||||||||
Purchase
of restricted investments
|
- | - | (3.8 | ) | - | (3.8 | ) | |||||||||||||
Net
change in restricted cash
|
- | - | (11.7 | ) | - | (11.7 | ) | |||||||||||||
Net
settlements on interest rate swap
|
(42.2 | ) | - | - | - | (42.2 | ) | |||||||||||||
Net
investment in interest rate swap
|
(6.4 | ) | - | - | - | (6.4 | ) | |||||||||||||
Other
|
(1.3 | ) | (2.0 | ) | (2.0 | ) | - | (5.3 | ) | |||||||||||
Net
cash provided by (used in) investing
activities of discontinued
operations
|
0.1 | (0.6 | ) | - | - | (0.5 | ) | |||||||||||||
Net
cash used in investing
activities
|
(60.7 | ) | (52.1 | ) | (20.2 | ) | - | (133.0 | ) | |||||||||||
Cash
flows from financing activities:
|
||||||||||||||||||||
Principal
borrowings on notes
|
- | 15.5 | - | - | 15.5 | |||||||||||||||
Proceeds
from bond issuance
|
290.0 | - | - | - | 290.0 | |||||||||||||||
Principal
payments on debt, including
pre-payments
|
(413.0 | ) | (0.2 | ) | - | 4.0 | (409.2 | ) | ||||||||||||
Borrowings
on revolving credit facility
|
10.0 | - | - | - | 10.0 | |||||||||||||||
Payments
on revolving credit facility
|
(50.0 | ) | - | - | - | (50.0 | ) | |||||||||||||
Principal
payments under capital lease
obligations
|
(0.5 | ) | (11.2 | ) | (1.7 | ) | - | (13.4 | ) | |||||||||||
Issuance
of common stock
|
- | - | - | - | - | |||||||||||||||
Dividends
paid on convertible perpetual
preferred stock
|
(26.0 | ) | - | - | - | (26.0 | ) | |||||||||||||
Debt
issuance costs
|
(10.6 | ) | - | - | - | (10.6 | ) | |||||||||||||
Distributions
to noncontrolling interests of
consolidated
affiliates
|
- | - | (32.7 | ) | - | (32.7 | ) | |||||||||||||
Other
|
- | - | 0.8 | - | 0.8 | |||||||||||||||
Change
in intercompany advances
|
52.9 | (154.1 | ) | (71.0 | ) | 172.2 | - | |||||||||||||
Net
cash (used in) provided by financing
activities of discontinued
operations
|
(0.5 | ) | - | 1.8 | - | 1.3 | ||||||||||||||
Net
cash used in financing
activities
|
(147.7 | ) | (150.0 | ) | (102.8 | ) | 176.2 | (224.3 | ) | |||||||||||
Effect
of exchange rate on cash and
cash
equivalents
|
- | - | - | - | - | |||||||||||||||
Increase
(decrease) in cash and cash
equivalents
|
53.1 | 0.9 | (5.2 | ) | - | 48.8 | ||||||||||||||
Cash
and cash equivalents at
beginning
of year
|
23.1 | 0.9 | 8.1 | - | 32.1 | |||||||||||||||
Cash
and cash equivalents of
divisions
and facilities held for sale at beginning of
year
|
- | 0.1 | - | - | 0.1 | |||||||||||||||
Less:
Cash and cash
equivalents
of
divisions and
facilities held for sale at end of year
|
- | (0.1 | ) | - | - | (0.1 | ) | |||||||||||||
Cash
and cash equivalents at end of
year
|
$ | 76.2 | $ | 1.8 | $ | 2.9 | $ | - | $ | 80.9 |
For
the Year Ended December 31, 2008
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
cash provided by operating
activities
|
$ | 106.8 | $ | 169.6 | $ | 114.8 | $ | (164.0 | ) | $ | 227.2 | |||||||||
Cash
flows from investing activities:
|
||||||||||||||||||||
Capital
expenditures
|
(20.4 | ) | (27.1 | ) | (8.2 | ) | - | (55.7 | ) | |||||||||||
Acquisition
of business, net of assets
acquired
|
- | (14.6 | ) | - | - | (14.6 | ) | |||||||||||||
Acquisition
of intangible assets
|
- | (18.2 | ) | - | - | (18.2 | ) | |||||||||||||
Proceeds
from disposal of assets
|
43.9 | 6.7 | 3.3 | - | 53.9 | |||||||||||||||
Proceeds
from sale of restricted
marketable securities
|
- | - | 8.1 | - | 8.1 | |||||||||||||||
Proceeds
from sale of investments
|
- | - | 4.3 | - | 4.3 | |||||||||||||||
Purchase
of restricted investments
|
- | - | (4.8 | ) | - | (4.8 | ) | |||||||||||||
Net
change in restricted cash
|
0.2 | - | 7.3 | - | 7.5 | |||||||||||||||
Net
settlements on interest rate swap
|
(20.7 | ) | - | - | - | (20.7 | ) | |||||||||||||
Other
|
- | - | 0.6 | - | 0.6 | |||||||||||||||
Net
cash (used in) provided by investing
activities of discontinued
operations
|
- | (0.6 | ) | 0.2 | - | (0.4 | ) | |||||||||||||
Net
cash provided by (used in)
investing activities
|
3.0 | (53.8 | ) | 10.8 | - | (40.0 | ) | |||||||||||||
Cash
flows from financing activities:
|
||||||||||||||||||||
Check
in excess of bank balance
|
(16.7 | ) | - | - | 5.3 | (11.4 | ) | |||||||||||||
Principal
payments on debt, including
pre-payments
|
(211.6 | ) | (0.7 | ) | (3.6 | ) | 11.1 | (204.8 | ) | |||||||||||
Borrowings
on revolving credit facility
|
128.0 | - | - | - | 128.0 | |||||||||||||||
Payments
on revolving credit facility
|
(163.0 | ) | - | - | - | (163.0 | ) | |||||||||||||
Principal
payments under capital lease
obligations
|
(0.2 | ) | (10.7 | ) | (1.5 | ) | - | (12.4 | ) | |||||||||||
Issuance
of common stock
|
150.2 | - | - | - | 150.2 | |||||||||||||||
Dividends
paid on convertible perpetual
preferred stock
|
(26.0 | ) | - | - | - | (26.0 | ) | |||||||||||||
Distributions
to noncontrolling interests of
consolidated
affiliates
|
- | - | (33.4 | ) | - | (33.4 | ) | |||||||||||||
Other
|
(0.2 | ) | - | 0.8 | - | 0.6 | ||||||||||||||
Change
in intercompany advances
|
53.1 | (117.3 | ) | (88.7 | ) | 152.9 | - | |||||||||||||
Net
cash used in financing activities of
discontinued
operations
|
(2.4 | ) | - | (1.4 | ) | - | (3.8 | ) | ||||||||||||
Net
cash used in financing
activities
|
(88.8 | ) | (128.7 | ) | (127.8 | ) | 169.3 | (176.0 | ) | |||||||||||
Effect
of exchange rate on cash and
cash
equivalents
|
- | - | 0.8 | - | 0.8 | |||||||||||||||
Increase
(decrease) in cash and cash
|
||||||||||||||||||||
Increase
(decrease) in cash and cash
equivalents
|
21.0 | (12.9 | ) | (1.4 | ) | 5.3 | 12.0 | |||||||||||||
Cash
and cash equivalents at
beginning
of year
|
2.1 | 13.9 | 9.1 | (5.3 | ) | 19.8 | ||||||||||||||
Cash
and cash equivalents of
divisions
and facilities held for sale at beginning of
year
|
- | - | 0.4 | - | 0.4 | |||||||||||||||
Less:
Cash and cash equivalents of
divisions and facilities held for sale at end of
year
|
- | (0.1 | ) | - | - | (0.1 | ) | |||||||||||||
Cash
and cash equivalents at end of
year
|
$ | 23.1 | $ | 0.9 | $ | 8.1 | $ | - | $ | 32.1 |
For
the Year Ended December 31, 2007
|
||||||||||||||||||||
HealthSouth
Corporation
|
Guarantor
Subsidiaries
|
Non
Guarantor Subsidiaries
|
Eliminating
Entries
|
HealthSouth
Consolidated
|
||||||||||||||||
(In
Millions)
|
||||||||||||||||||||
Net
cash (used in) provided by
operating activities
|
$ | (477.6 | ) | $ | 111.8 | $ | 531.6 | $ | 64.8 | $ | 230.6 | |||||||||
Cash
flows from investing activities:
|
||||||||||||||||||||
Capital
expenditures
|
(5.3 | ) | (13.5 | ) | (19.8 | ) | - | (38.6 | ) | |||||||||||
Proceeds
from sale of restricted
marketable securities
|
- | - | 66.4 | - | 66.4 | |||||||||||||||
Purchase
of restricted investments
|
- | - | (23.0 | ) | - | (23.0 | ) | |||||||||||||
Net
change in restricted cash
|
0.5 | - | (3.8 | ) | - | (3.3 | ) | |||||||||||||
Proceeds
from divestiture of divisions
|
1,169.8 | - | - | (1,169.8 | ) | - | ||||||||||||||
Other
|
3.6 | 0.1 | 0.2 | - | 3.9 | |||||||||||||||
Net
cash provided by (used in) investing
activities of discontinued
operations—
|
||||||||||||||||||||
Proceeds
from divestitures of
divisions
|
- | - | - | 1,169.8 | 1,169.8 | |||||||||||||||
Other
investing activities of
discontinued operations
|
0.7 | (6.5 | ) | 15.1 | - | 9.3 | ||||||||||||||
Net
cash provided by (used in)
investing activities
|
1,169.3 | (19.9 | ) | 35.1 | - | 1,184.5 | ||||||||||||||
Cash
flows from financing activities:
|
||||||||||||||||||||
Check
in excess of bank balance
|
14.0 | - | - | (5.3 | ) | 8.7 | ||||||||||||||
Principal
borrowings on notes
|
- | 12.5 | - | - | 12.5 | |||||||||||||||
Principal
payments on debt, including
pre-payments
|
(1,235.2 | ) | (0.4 | ) | (0.2 | ) | (3.1 | ) | (1,238.9 | ) | ||||||||||
Borrowings
on revolving credit facility
|
397.0 | - | - | - | 397.0 | |||||||||||||||
Payments
on revolving credit facility
|
(492.0 | ) | - | - | - | (492.0 | ) | |||||||||||||
Principal
payments under capital lease
obligations
|
(0.2 | ) | (9.4 | ) | (1.4 | ) | - | (11.0 | ) | |||||||||||
Dividends
paid on convertible perpetual
preferred stock
|
(26.0 | ) | - | - | - | (26.0 | ) | |||||||||||||
Debt
amendment and issuance costs
|
(11.2 | ) | - | - | - | (11.2 | ) | |||||||||||||
Distributions
paid to noncontrolling interests of
consolidated
affiliates
|
- | - | (23.4 | ) | - | (23.4 | ) | |||||||||||||
Other
|
0.6 | - | - | - | 0.6 | |||||||||||||||
Change
in intercompany advances
|
655.0 | (83.5 | ) | (509.8 | ) | (61.7 | ) | - | ||||||||||||
Net
cash used in financing activities of
discontinued
operations
|
(11.9 | ) | (0.3 | ) | (40.7 | ) | - | (52.9 | ) | |||||||||||
Net
cash used in financing
activities
|
(709.9 | ) | (81.1 | ) | (575.5 | ) | (70.1 | ) | (1,436.6 | ) | ||||||||||
Effect
of exchange rate changes on
cash
and cash equivalents
|
- | - | 0.1 | - | 0.1 | |||||||||||||||
(Decrease)
increase in cash and cash
equivalents
|
(18.2 | ) | 10.8 | (8.7 | ) | (5.3 | ) | (21.4 | ) | |||||||||||
Cash
and cash equivalents at
beginning
of year
|
17.5 | 3.1 | 6.6 | - | 27.2 | |||||||||||||||
Cash
and cash equivalents of
divisions
and facilities held for sale at beginning of
year
|
2.8 | - | 11.6 | - | 14.4 | |||||||||||||||
Less:
Cash and cash equivalents of
divisions and facilities held for sale at end of
year
|
- | - | (0.4 | ) | - | (0.4 | ) | |||||||||||||
Cash
and cash equivalents at end of
year
|
$ | 2.1 | $ | 13.9 | $ | 9.1 | $ | (5.3 | ) | $ | 19.8 |
4.2.5 |
Third
Supplemental Indenture, dated as of February 15, 2006, to the Indenture,
dated as of September 28, 2001, between HealthSouth Corporation and
Wilmington Trust Company, as successor trustee to National City Bank,
relating to HealthSouth’s 8.375% Senior Notes due 2011 (incorporated by
reference to Exhibit 4.6 to HealthSouth’s Current Report on Form 8-K filed
on February 17, 2006).
|
|
4.3.1 |
Indenture,
dated as of May 22, 2002, between HealthSouth Corporation and The Bank of
Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 7.625% Senior Notes due 2012.*
|
|
4.3.2 |
Amendment
to Indenture, dated as of August 27, 2003, to the Indenture, dated as of
May 22, 2002, between HealthSouth Corporation and The Bank of Nova Scotia
Trust Company of New York, as trustee, relating to HealthSouth’s 7.625%
Senior Notes due 2012.*
|
|
4.3.3 |
First
Supplemental Indenture, dated as of June 24, 2004, to the Indenture, dated
as of May 22, 2002, between HealthSouth Corporation and The Bank of Nova
Scotia Trust Company of New York, as trustee, relating to HealthSouth’s
7.625% Senior Notes due 2012 (incorporated by reference to Exhibit 99.5 to
HealthSouth’s Current Report on Form 8-K filed on June 25,
2004).
|
|
4.3.4 |
Second
Supplemental Indenture, dated as of February 15, 2006, to the Indenture,
dated as of May 22, 2002, between HealthSouth Corporation and The Bank of
Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 7.625% Senior Notes due 2012 (incorporated by reference to
Exhibit 4.5 to HealthSouth’s Current Report on Form 8-K filed on February
17, 2006).
|
|
4.4 |
Registration
Rights Agreement, dated February 28, 2006, between HealthSouth and the
purchasers party to the Securities Purchase Agreement, dated February 28,
2006, re: HealthSouth’s sale of 400,000 shares of 6.50% Series A
Convertible Perpetual Preferred Stock.**
|
|
4.5.1 |
Warrant
Agreement, dated as of January 16, 2004, between HealthSouth Corporation
and Wells Fargo Bank Northwest, N.A., as Warrant Agent (incorporated by
reference to Exhibit 10.2 to HealthSouth’s Current Report on Form 8-K
filed on January 20, 2004).
|
|
4.5.2 |
Registration
Rights Agreement, dated as of January 16, 2004, among HealthSouth
Corporation and the entities listed on the signature pages thereto as
Holders of Warrants and Transfer Restricted Securities (incorporated by
reference to Exhibit 10.3 to HealthSouth’s Current Report on Form 8-K
filed on January 20, 2004).
|
|
4.6 |
Warrant
Agreement, dated as of September 30, 2009, among
HealthSouth
Corporation
and Computershare Inc. and Computershare Trust Company,
N.A., jointly and severally as Warrant Agent (
incorporated by
reference to Exhibit 4.1 to HealthSouth’s Registration Statement on
Form 8-A filed on October 1, 2009
).
|
|
4.7.1 |
Indenture,
dated as of December 1, 2009, between HealthSouth Corporation
and The
Bank of Nova Scotia Trust Company of New York, as trustee, relating to
HealthSouth’s 8.125% Senior Notes due 2020.
|
|
4.7.2 |
First
Supplemental Indenture, dated December 1, 2009, among HealthSouth
Corporation, the Subsidiary Guarantors (as defined therein) and The Bank
of Nova Scotia Trust Company of New York, as trustee relating to
HealthSouth’s 8.125% Senior Notes due 2020.
|
|
4.8 |
First
Supplemental Indenture, dated December 1, 2009, among HealthSouth
Corporation, the Subsidiary Guarantors (as defined therein) and The Bank
of Nova Scotia Trust Company of New York, as trustee, relating to the
Floating Rate Senior Notes due 2014 and the Indenture, dated as of June
14, 2006.
|
|
10.1 |
Stipulation
of Partial Settlement dated as of September 26, 2006, by and among
HealthSouth Corporation, the stockholder lead plaintiffs named therein,
the bondholder lead plaintiff named therein and the individual settling
defendants named therein (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on September 27,
2006).
|
10.2 |
Settlement
Agreement and Policy Release, dated as of September 25, 2006, by and among
HealthSouth Corporation, the settling individual defendants named therein
and the settling carriers named therein (incorporated by reference to
Exhibit 10.2 to HealthSouth’s Current Report on Form 8-K filed on
September 27, 2006).
|
|
10.3 |
Stipulation
of Settlement with Certain Individual Defendants dated as of September 25,
2006, by and among HealthSouth Corporation, plaintiffs named therein and
the individual settling defendants named therein (incorporated by
reference to Exhibit 10.3 to HealthSouth’s Current Report on Form 8-K
filed on September 27, 2006).
|
|
10.4.1 |
Amended
Class Action Settlement Agreement, dated March 6, 2006, with
representatives of the plaintiff class relating to the action consolidated
on July 2, 2003, captioned
In Re HealthSouth Corp. ERISA
Litigation
, No. CV-03-BE-1700 (N.D. Ala.) (incorporated by
reference to Exhibit 10.5.1 to HealthSouth’s Quarterly Report on Form 10-Q
filed on May 15, 2006).
|
|
10.4.2 |
First
Addendum to the Amended Class Action Settlement Agreement, dated April 11,
2006 (incorporated by reference to Exhibit 10.5.2 to HealthSouth’s
Quarterly Report on Form 10-Q filed on May 15, 2006).
|
|
10.4.3 |
Amended
Class Action Settlement Agreement, dated July 25, 2005, with
representatives of the plaintiff class relating to the action consolidated
on July 2, 2003, captioned
In Re HealthSouth Corp. ERISA
Litigation
, No. CV-03-BE-1700 (N.D. Ala.).*
|
|
10.5.1 |
HealthSouth
Corporation Amended and Restated 2004 Director Incentive Plan.**
+
|
|
10.5.2 |
Form
of Restricted Stock Unit Agreement (Amended and Restated 2004 Director
Incentive Plan).** +
|
|
10.6 |
HealthSouth
Corporation Amended and Restated Change in Control Benefits Plan
(incorporated by reference to Exhibit 10.11 to HealthSouth’s Annual Report
on Form 10-K filed on February 24, 2009).+
|
|
10.7.1 |
HealthSouth
Corporation 1995 Stock Option Plan, as amended.* +
|
|
10.7.2 |
Form
of Non-Qualified Stock Option Agreement (1995 Stock Option Plan).*
+
|
|
10.8.1 |
HealthSouth
Corporation 1997 Stock Option Plan.* +
|
|
10.8.2 |
Form
of Non-Qualified Stock Option Agreement (1997 Stock Option Plan).*
+
|
|
10.9.1 |
HealthSouth
Corporation 2002 Non-Executive Stock Option Plan.* +
|
|
10.9.2 |
Form
of Non-Qualified Stock Option Agreement (2002 Non-Executive Stock Option
Plan).* +
|
|
10.10 |
Description
of the HealthSouth Corporation Senior Management Compensation Recoupment
Policy (incorporated by reference to HealthSouth’s Quarterly Report on
Form 10-Q filed on November 4, 2009).+
|
|
10.11 |
Description
of the HealthSouth Corporation Senior Management Bonus and Long-Term
Incentive Plans (incorporated by reference to the section captioned
“Executive Compensation – Compensation Discussion and Analysis – Elements
of Executive Compensation” in HealthSouth’s Definitive Proxy Statement on
Schedule 14A filed on April 2, 2009).+
|
|
10.12 |
HealthSouth
Corporation Executive Deferred Compensation Plan.*+
|
|
10.13 |
HealthSouth
Corporation Second Amended and Restated Executive Severance Plan
(incorporated by reference to Exhibit 10.19 to HealthSouth’s Annual Report
on Form 10-K filed on February 24,
2009).+
|
10.14 |
Letter
of Understanding, dated as of October 31, 2007, between HealthSouth
Corporation and Jay Grinney (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on November 6,
2007).+
|
|
10.15 |
HealthSouth
Corporation 2005 Equity Incentive Plan (incorporated by reference to
Exhibit 10 to HealthSouth’s Current Report on Form 8-K, filed on November
21, 2005).+
|
|
10.16 |
Form
of Non-Qualified Stock Option Agreement (2005 Equity Incentive
Plan).**+
|
|
10.17.1 |
HealthSouth
Corporation 2008 Equity Incentive Plan (incorporated by reference to
Appendix A to HealthSouth’s Definitive Proxy Statement on Schedule 14A
filed on March 27, 2008).+
|
|
10.17.2 |
Form
of Non-Qualified Stock Option Agreement (2008 Equity Incentive
Plan)(incorporated by reference to Exhibit 10.28.2 to HealthSouth’s Annual
Report on Form 10-K filed on February 24, 2009). +
|
|
10.17.3 |
Form
of Restricted Stock Agreement (2008 Equity Incentive Plan)(incorporated by
reference to Exhibit 10.28.3 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).+
|
|
10.17.4 |
Form
of Performance Share Unit Award (2008 Equity Incentive Plan)(incorporated
by reference to Exhibit 10.28.4 to HealthSouth’s Annual Report on Form
10-K filed on February 24, 2009).+
|
|
10.18 |
HealthSouth
Corporation Nonqualified 401(k) Plan (incorporated by reference to Exhibit
99 to HealthSouth’s Current Report on Form 8-K filed on February 6,
2008).+
|
|
10.19 |
HealthSouth
Corporation Directors’ Deferred Stock Investment Plan (incorporated by
reference to Exhibit 10.30 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).+
|
|
10.20 |
Written
description of the annual compensation arrangement for non-employee
directors of HealthSouth Corporation (incorporated by reference to the
section captioned “Corporate Governance and Board Structure – Compensation
of Directors” in HealthSouth’s Definitive Proxy Statement on Schedule 14A,
filed on April 2, 2009).+
|
|
10.21 |
Form
of Indemnity Agreement entered into between HealthSouth Corporation and
the directors of HealthSouth.* +
|
|
10.22 |
Form
of letter agreement with former directors.* +
|
|
10.23 |
Settlement
Agreement, dated as of December 30, 2004, by and among HealthSouth
Corporation, the United States of America, acting through the entities
named therein and certain other parties named therein (incorporated by
reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K
filed on January 5, 2005).
|
|
10.24 |
Administrative
Settlement Agreement, dated as of December 30, 2004, by and among the
United States Department of Health and Human Services acting through the
Centers for Medicare & Medicaid Services and its officers and agents,
including, but not limited to, its fiscal intermediaries, and HealthSouth
Corporation (incorporated by reference to Exhibit 10.3 to HealthSouth’s
Current Report on Form 8-K filed on January 5, 2005).
|
|
10.25.1 |
Corporate
Integrity Agreement, dated as of December 30, 2004, by and among the
Office of Inspector General of the Department of Health and Human Services
and HealthSouth Corporation (incorporated by reference to Exhibit 10.2 to
HealthSouth’s Current Report on Form 8-K filed on January 5,
2005).
|
|
10.25.2 |
First
Addendum to the Corporate Integrity Agreement, dated as of October 27,
2006, by and among the Office of Inspector General of the Department of
Health and Human Services and HealthSouth Corporation (incorporated by
reference to Exhibit 10.33.2 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).
|
10.25.3 |
Second
Addendum to the Corporate Integrity Agreement, dated as of December 14,
2007, by and among the Office of Inspector General of the Department of
Health and Human Services and HealthSouth Corporation (incorporated by
reference to Exhibit 10.33.3 to HealthSouth’s Annual Report on Form 10-K
filed on February 24, 2009).
|
|
10.26.1 |
Amendment
No. 2, dated as of October 23, 2009, to the Credit Agreement, dated March
10, 2006, among HealthSouth Corporation, the lenders party thereto,
JPMorgan Chase Bank, N.A., as the administrative agent and the collateral
agent, and the other parties thereto,
attaching
and effecting the Amended and Restated Credit Agreement, by and among
HealthSouth, the lenders party thereto, JPMorgan Chase Bank, N.A., as the
administrative agent and the collateral agent, Citicorp North America,
Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as
co-syndication agents; and Deutsche Bank Securities Inc., Goldman Sachs
Credit Partners L.P. and Wachovia Bank, National Association, as
co-documentation agents (incorporated by reference to Exhibit 10.1 to
HealthSouth’s Current Report on Form 8-K filed on October 27,
2009).
|
|
10.26.2 |
Collateral
and Guarantee Agreement, dated as of March 10, 2006, by and among
HealthSouth, certain of the Company’s subsidiaries and JPMorgan Chase
Bank, N.A., as collateral agent (incorporated by reference to Exhibit 10.2
to HealthSouth’s Current Report on Form 8-K filed on March 16,
2006).
|
|
10.27.1 |
Partial
Final Judgment And Order of Dismissal With Prejudice of In re: HealthSouth
Corporation Securities Litigation, dated as of January 11, 2007
(incorporated by reference to Exhibit 99.2 to HealthSouth’s Current Report
on Form 8-K filed on January 12, 2007).
|
|
10.27.2 |
Order
and Final Judgment Pursuant To A.R.C.P. Rule 54(b) Approving Pro Tanto
Settlement With Certain Defendants, dated as of January 11, 2007
(incorporated by reference to Exhibit 99.3 to HealthSouth’s Current Report
on Form 8-K filed on January 12, 2007).
|
|
10.28.1 |
Purchase
and Sale Agreement, dated January 22, 2008, by and between HealthSouth
Corporation and Daniel Realty Company, LLC (incorporated by reference to
Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on May
7, 2008).
|
|
10.28.2 |
First
Amendment to Purchase and Sale Agreement, dated January 22, 2008, by and
between HealthSouth Corporation and Daniel Realty Company, LLC
(incorporated by reference to Exhibit 10.2 to HealthSouth’s Quarterly
Report on Form 10-Q filed on May 7, 2008).
|
|
10.28.3 |
Second
Amendment to Purchase and Sale Agreement, dated February 13, 2008, by and
between HealthSouth Corporation and Daniel Realty Company, LLC
(incorporated by reference to Exhibit 10.3 to HealthSouth’s Quarterly
Report on Form 10-Q filed on May 7, 2008).
|
|
10.28.4 |
Third
Amendment to Purchase and Sale Agreement, dated March 31, 2008, by and
between HealthSouth Corporation and LAKD Associates, LLC (successor by
assignment to Daniel Realty Company, LLC) (incorporated by reference to
Exhibit 10.4 to HealthSouth’s Quarterly Report on Form 10-Q filed on May
7, 2008).
|
|
10.28.5 |
Lease
between LAKD HQ, LLC and HealthSouth Corporation, dated March 31, 2008,
for corporate office space (incorporated by reference to Exhibit 10.5 to
HealthSouth’s Quarterly Report on Form 10-Q filed on May 7,
2008).
|
|
10.29.1 |
Stipulation
of Settlement with UBS Securities LLC (incorporated by reference to
Exhibit 99.2 to HealthSouth’s Current Report on Form 8-K filed on January
20, 2009).
|
|
10.29.2 |
Settlement
Agreement and Stipulation regarding Fees, dated as of January 13, 2009
(incorporated by reference to Exhibit 99.3 to HealthSouth’s Current Report
on Form 8-K filed on January 20, 2009).
|
|
10.30 |
Restrictive
Covenant Agreement, dated November 23, 2009, by and between HealthSouth
Corporation and John L. Workman (incorporated by reference to Exhibit 10.1
to HealthSouth’s Current Report on Form 8-K filed on November 23,
2009).+
|
12 |
Computation
of Ratios.
|
|
21 |
Subsidiaries
of HealthSouth Corporation.
|
|
23 |
Consent
of PricewaterhouseCoopers LLP, Independent Registered Public Accounting
Firm.
|
|
24 |
Power
of Attorney.
|
|
31.1 |
Certification
of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of
the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
|
|
31.2 |
Certification
of Principal Financial Officer required by Rule 13a-14(a) or Rule
15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1 |
Certification
of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2 |
Certification
of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
Trust Indenture | ||||||
Act Section | Indenture Section | |||||
§ | 310(a) | 11.04(a) | 16.02 | |||
(b) | 11.01(f) | 11.04(b) | 11.05(1) | 16.02 | ||
(b)(1) | 11.04(b) | 16.02 | ||||
§ | 311 | 11.01(f) | 16.02 | |||
§ | 312 | 14.02(d) | 16.02 | |||
(b) | 11.10 | 16.02 | ||||
(c) | 11.10 | 16.02 | ||||
§ | 313(a) | 10.01(a) | 16.02 | |||
§ | 314 | 16.02 | ||||
§ | 315(e) | 11.05 | 16.02 | |||
§ | 316 | 16.02 | ||||
§ | 317 | 16.02 | ||||
§ | 317 | 16.02 | ||||
Section 16.08 | Separability Clause | 73 |
Section 16.09 | Benefits of Indenture | 73 |
Section 16.10 | Counterparts Originals | 73 |
Section 16.11 | Governing Law, Waiver of Trial by Jury | 73 |
(1)
|
the
opinions and pronouncements of the Accounting Principles Board of the
American Institute of Certified Public
Accountants;
|
(2)
|
statements
and pronouncements of the Financial Accounting Standards
Board;
|
(3)
|
such
other statements by such other entity as approved by a significant segment
of the accounting profession; and
|
(4)
|
the
rules and regulations of the SEC governing the inclusion of financial
statements (including pro forma financial statements) in periodic reports
required to be filed pursuant to Section 13 of the Exchange Act, including
opinions and pronouncements in staff accounting bulletins and similar
written statements from the accounting staff of the
SEC.
|
(1)
|
such
Person;
|
(2)
|
such
Person and one or more Subsidiaries of such Person;
or
|
(3)
|
one
or more Subsidiaries of such
Person.
|
Date of authentication: | The Bank of Nova Scotia Trust Company of New York, as Trustee | ||||
By: | |||||
Authorized Signatory | |||||
Date of authentication: | The Bank of Nova Scotia Trust Company of New York, as Trustee | ||||
By: | [NAME OF AUTHENTICATING AGENT] | ||||
as Authenticating Agent | |||||
By: | |||||
Authorized Signatory | |||||
HEALTHSOUTH
CORPORATION
as Issuer
|
|||
|
By:
|
/s/ J AY G RINNEY | |
Name: Jay Grinney | |||
Title:
President and CEO
|
|||
THE BANK OF NOVA SCOTIA
TRUST
COMPANY OF NEW YORK,
as
Trustee
|
|||
|
By:
|
/s/ J OHN F. N EYLAN | |
Name | |||
Title | |||
HEALTHSOUTH CORPORATION, | ||
as Issuer | ||
By: /s/ Jay Grinney | ||
Name: | Jay Grinney | |
Title: | President and CEO | |
GUARANTORS | ||
Advantage Health Harmarville Rehabilitation Corporation | ||
Baton Rouge Rehab, Inc. | ||
CMS Jonesboro Rehabilitation, Inc. | ||
Continental Medical of Arizona, Inc. | ||
Continental Medical Systems, Inc. | ||
Continental Rehabilitation Hospital of Arizona, Inc. | ||
HEALTHSOUTH LTAC of Sarasota, Inc. | ||
HEALTHSOUTH Medical Center, Inc. | ||
HEALTHSOUTH of Altoona, Inc. | ||
HEALTHSOUTH of Austin, Inc. | ||
HEALTHSOUTH of Dothan, Inc. | ||
HEALTHSOUTH of Henderson, Inc. | ||
HEALTHSOUTH of Houston, Inc. | ||
HEALTHSOUTH of Mechanicsburg, Inc. | ||
HEALTHSOUTH of Midland, Inc. | ||
HEALTHSOUTH of Montgomery, Inc | ||
HEALTHSOUTH of New Mexico, Inc. | ||
HEALTHSOUTH of Nittany Valley, Inc. | ||
HEALTHSOUTH of San Antonio, Inc. | ||
HEALTHSOUTH of Sewickley, Inc. | ||
HEALTHSOUTH of South Carolina, Inc. | ||
HEALTHSOUTH of Spring Hill, Inc. | ||
HEALTHSOUTH of Texarkana, Inc. | ||
HEALTHSOUTH of Texas, Inc. | ||
HEALTHSOUTH of Treasure Coast, Inc. | ||
HEALTHSOUTH of Utah, Inc | ||
HEALTHSOUTH of Yuma, Inc | ||
HEALTHSOUTH Rehabilitation Center, Inc. | ||
HEALTHSOUTH Rehabilitation Hospital of Manati, Inc. | ||
HEALTHSOUTH Rehabilitation Hospital of Northern Virginia, Inc. | ||
HEALTHSOUTH Rehabilitation Hospital of Odessa, Inc. | ||
HEALTHSOUTH Specialty Hospital, Inc. | ||
HEALTHSOUTH Sub-Acute Center of Mechanicsburg, Inc. | ||
Lakeshore System Services of Florida, Inc. | ||
Rehab Concepts Corp. | ||
Rehabilitation Hospital of Colorado Springs, Inc. | ||
Rehabilitation Hospital of Fredericksburg, Inc. | ||
Rehabilitation Hospital of Nevada - Las Vegas, Inc. | ||
Rehabilitation Hospital of Petersburg, Inc. | ||
Rehabilitation Hospital of Plano, Inc. | ||
SCA-Dalton, Inc. | ||
Sherwood Rehabilitation Hospital, Inc. | ||
Southeast Texas Rehabilitation Hospital, Inc. | ||
Tarrant County Rehabilitation Hospital, Inc. | ||
Terre Haute Rehabilitation Hospital, Inc. | ||
Tyler Rehabilitation Hospital, Inc. | ||
Western Neuro Care, Inc. | ||
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Authorized Signatory | |
Beaumont Rehab Associates Limited Partnership | ||
By: | Southeast Texas Rehabilitation Hospital, Inc. | |
Its: | General Partner | |
Collin County Rehab Associates Limited Partnership | ||
By: | Rehabilitation Hospital of Plano, Inc. | |
Its: | General Partner | |
HEALTHSOUTH of Ft. Lauderdale Limited Partnership | ||
By: | HealthSouth Real Property Holding Corporation | |
Its: | General Partner | |
Lakeview Rehabilitation Group Partners | ||
By: | Continental Medical of Kentucky, Inc. | |
Its: | General Partner | |
Rehabilitation Hospital of Nevada - Las Vegas, L.P. | ||
By: | Rehabilitation Hospital of Nevada –Las Vegas, Inc. | |
Its: | General Partner | |
Southern Arizona Regional Rehabilitation Hospital, L.P. | ||
By: | Continental Rehabilitation Hospital of Arizona, Inc. | |
Its: | General Partner | |
Terre Haute Regional Rehabilitation Hospital, L.P. | ||
By: | Terre Haute Rehabilitation Hospital, Inc. | |
Its: | General Partner | |
Western Medical Rehab Associates, L.P. | ||
By: |
CMS
Development & Management and Western Neuro Care,
Inc.
|
|
Its: | General Partner | |
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Authorized Signatory | |
HEALTHSOUTH Bakersfield Rehabilitation Hospital Limited Partnership | ||
HEALTHSOUTH Meridian Point Rehabilitation Hospital Limited Partnership | ||
HEALTHSOUTH Northern Kentucky Rehabilitation Hospital Limited Partnership | ||
HEALTHSOUTH Rehabilitation Hospital of Arlington Limited Partnership | ||
HEALTHSOUTH Valley of the Sun Rehabilitation Hospital Limited Partnership | ||
By: | HealthSouth Properties, LLC, their General Partner | |
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Authorized Signatory | |
HEALTHSOUTH of Largo Limited Partnership | ||
HEALTHSOUTH of Sarasota Limited Partnership | ||
HEALTHSOUTH of Tallahassee Limited Partnership | ||
By: | HealthSouth Real Property Holding, LLC, its General Partner | |
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Authorized Signatory | |
HEALTHSOUTH Rehabilitation Center of New Hampshire, Ltd. | ||
By: | HealthSouth Corporation | |
Its: | General Partner | |
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Executive Vice President, General Counsel and Corporate Secretary | |
Advantage Health, LLC | ||
HEALTHSOUTH Aviation, LLC | ||
HEALTHSOUTH Mesa Rehabilitation Hospital, LLC | ||
HEALTHSOUTH of Charleston, LLC | ||
HEALTHSOUTH of East Tennessee, LLC | ||
HEALTHSOUTH of Erie, LLC | ||
HEALTHSOUTH of Fort Smith, LLC | ||
HEALTHSOUTH of Pittsburgh, LLC | ||
HEALTHSOUTH of Reading, LLC | ||
HEALTHSOUTH of Toms River, LLC | ||
HEALTHSOUTH of York, LLC | ||
HEALTHSOUTH Properties, LLC | ||
HEALTHSOUTH Real Property Holding, LLC | ||
HEALTHSOUTH Rehabilitation Hospital of South Jersey, LLC | ||
HEALTHSOUTH Rehabilitation Institute of Tucson, LLC | ||
HEALTHSOUTH Specialty Hospital of North Louisiana, LLC | ||
New England Rehabilitation Management Co., LLC | ||
Rebound, LLC | ||
Rehabilitation Hospital Corporation of America, LLC | ||
Rehabilitation Institute of Western Massachusetts, LLC | ||
Sarasota LTAC Properties, LLC | ||
By: /s/ J OHN P. W HITTINGTON | ||
Name: | John P. Whittington | |
Title: | Authorized Signatory | |
THE BANK OF NOVA SCOTIA TRUST COMPANY OF NEW YORK, as Trustee | ||
By: /s/ John F. Neylan | ||
Name: | John F. Neylan | |
Title: | Trust Officer | |
No.
|
$ |
HEALTHSOUTH CORPORATION | |||
|
By
|
||
Name: Jay Grinney | |||
Title: President and Chief Executive Officer | |||
|
By
|
||
Name: John P. Whittington | |||
Title: Executive Vice President, General Counsel and Secretary | |||
THE BANK OF NOVA SCOTIA TRUST COMPANY OF NEW YORK, as Trustee | ||
By | ||
Authorized Signatory |
1.
|
Interest
|
2.
|
Method of
Payment
|
3.
|
Paying Agent and
Registrar
|
4.
|
Indenture
|
5.
|
Optional
Redemption
|
Period
|
Redemption
Price
|
2015
|
104.063%
|
2016
|
102.708%
|
2017
|
101.354%
|
2018
and thereafter
|
100.000%
|
6.
|
Notice of
Redemption
|
7.
|
Put
Provisions
|
8.
|
Guarantee
|
10.
|
Persons Deemed
Owners
|
11.
|
Unclaimed
Money
|
12.
|
Discharge and
Defeasance
|
13.
|
Amendment,
Waiver
|
14.
|
Defaults and
Remedies
|
15.
|
Trustee Dealings with
the Company
|
16.
|
No Recourse Against
Others
|
17.
|
Authentication
|
18.
|
Abbreviations
|
19.
|
CUSIP
Numbers
|
20.
|
Governing
Law
|
DATE:
|
Y
YOUR SIGNATURE:
|
Date
of
Exchange
|
Amount
of decrease in Principal amount of this Global
Security
|
Amount
of increase in Principal amount of this Global Security
|
Principal
amount of this Global Security following such decrease or
increase
|
Signature
of authorized officer of Trustee or Securities
Custodian
|
Dated:
|
Your Signature: |
|
|
(Sign
exactly as your name appears on the other side of this
Security.)
|
Signature Guarantee: |
|
(Signature
must be guaranteed)
|
[NEW
GUARANTOR],
|
|
by
|
|
|
|
|
Name:
|
|
Title:
|
HEALTHSOUTH
CORPORATION,
|
|
by
|
|
|
|
|
Name:
|
|
Title:
|
[EXISTING
GUARANTORS],
|
|
by
|
|
|
|
|
Name:
|
|
Title:
|
Exhibit
21
|
||
HEALTHSOUTH CORPORATION
|
||
SUBSIDIARY LIST
|
||
Subsidiary
Name
|
State
of Incorporation
|
D/B/A
Names
|
Advantage
Health Harmarville Rehabilitation Corporation
|
PA
|
Harmarville
Home Health Agency; West Penn Hospital HealthSouth Outpatient
Rehabilitation Center; HealthSouth Washington Outpatient
Rehabilitation Center; HealthSouth Rehabilitation Center - Natrona
Heights; Harmarville Transitional Rehabilitation Unit
|
Advantage
Health, LLC
|
DE
|
HealthSouth
Sports Medicine & Rehabilitation Center of Shelton; Advantage Health
Sports Therapy North, Inc.; HealthSouth St. Joseph's Healthcare
Center
|
AnMed
Enterprises, Inc./HealthSouth, L.L.C.
|
SC
|
AnMed
Health Rehabilitation Hospital, an affiliate entity of AnMed Health and
HealthSouth Corporation
|
BJC
/ HEALTHSOUTH Rehabilitation Center, LLC
|
AL
|
The
Rehabilitation Institute of St. Louis
|
Baton
Rouge Rehab, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital of Baton Rouge; HealthSouth WorkAble; The
Rehabilitation Hospital of Baton Rouge
|
Beaumont
Rehab Associates Limited Partnership
|
DE
|
HealthSouth
Rehabilitation Center - Beaumont; HealthSouth Rehabilitation Center -
Jasper; HealthSouth Rehabilitation Center - Nederland; HealthSouth
Rehabilitation Hospital of Beaumont
|
Central
Arkansas Rehabilitation Associates, L.P.
|
DE
|
Catholic
Health Initiatives St Vincent Rehabilitation Hospital In Partnership with
HEALTHSOUTH
|
CMS
Development and Management Company, Inc.
|
DE
|
|
CMS
Elizabethtown, Inc.
|
DE
|
|
CMS
Jonesboro Rehabilitation, Inc.
|
DE
|
HealthSouth
Rehabilitation Center of Blytheville; HealthSouth Rehabilitation Hospital
of Jonesboro; HealthSouth Rehabilitation Center of Jonesboro; HealthSouth
Rehabilitation Center of Newport; HealthSouth
Rehabilitation
|
CMS
Rehab of WF, L.P.
|
DE
|
HealthSouth
Home Health Services; HealthSouth Rehabilitation Center - Burkburnett;
HealthSouth Rehabilitation Center - Vernon; HealthSouth Rehabilitation
Center - Wichita Falls; HealthSouth Rehabilitation Center -
Seymour; HealthSouth Rehabilitation Hospital of Wichita Falls; Wichita
Falls Rehabilitation Hospital; HealthSouth Home Health Agency of Wichita
Falls
|
Central
Louisiana Rehab Associates LP
|
DE
|
HealthSouth
Rehabilitation Hospital of Alexandria
|
Collin
County Rehab Associates Limited Partnership
|
DE
|
HealthSouth
Plano Rehabilitation Hospital; HealthSouth Rehabilitation
Specialists-Lewisville; HealthSouth Rehabilitation Specialists - Plano;
Healthsouth Plano Laboratory for Sleep Disorders
|
Continental
Medical of Kentucky, Inc.
|
DE
|
|
Continental
Medical Systems, Inc.
|
DE
|
HEALTHSOUTH
West Gables Rehabilitation Hospital
|
Continental
Rehabilitation Hospital of Arizona, Inc.
|
DE
|
|
DHC
Subsidiary Dissolution Corporation
|
GA
|
|
HCA
Wesley Rehabilitation Hospital, Inc.
|
DE
|
Wesley
Rehabilitation Hospital, An Affiliate of HEALTHSOUTH
|
HCS
Limited
|
||
HealthSouth
/GHS, LLC
|
PA
|
Geisinger
HEALTHSOUTH Rehabilitation Hospital; Geisinger HEALTHSOUTH Rehabilitation
Center of Danville; Geisinger HEALTHSOUTH Rehabilitation Center of
Berwick; Geisinger HEALTHSOUTH Rehabilitation Center of Mt.
Pocono
|
HealthSouth/Maine
Medical Center Limited Liability Company
|
ME
|
New
England Rehabilitation Hospital Of Portland A Joint Venture Between Maine
Medical Center And HEALTHSOUTH Llc
|
HealthSouth
Aviation, LLC
|
DE
|
|
HEALTHSOUTH
LTAC of Sarasota, Inc.
|
DE
|
HealthSouth
Ridgelake Hospital
|
HealthSouth
Mesa Rehabilitation Hospital, LLC
|
DE
|
HealthSouth
East Valley Rehabilitation Hospital
|
HEALTHSOUTH
OF HENDERSON, INC.
|
DE
|
HealthSouth
Rehabilitation Hospital of Henderson
|
HealthSouth
of Mechanicsburg, Inc.
|
DE
|
HEALTHSOUTH
Rehabilitation of Mechanicsburg - Acute Rehab Hospital; HEALTHSOUTH
Regional Work Performance and Hand Center; HEALTHSOUTH Rehab Center/New
Cumberland; HEALTHSOUTH Sports Medicine & Rehabilitation Center;
HEALTHSOUTH L.I.F.E. (Living Independently in Functional Environments);
HEALTHSOUTH Rehabilitation Center-Country Meadows West; HEALTHSOUTH
Rehabilitation Hospital of Mechanicsburg
|
HealthSouth
of Midland, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital of Midland/Odessa
|
HealthSouth
of Sarasota Limiited Partnership
|
AL
|
HEALTHSOUTH
Rehabilitation Hospital Of Sarasota; HealthSouth Rehabilitation Center -
University; Healthsouth Bee Ridge Outpatient Therapy Center; HEALTHSOUTH
Aaron Mattes Therapy Center
|
HEALTHSOUTH
OF SEA PINES LIMITED PARTNERSHIP
|
AL
|
HealthSouth
Sea Pines Rehabilitation Hospital
|
HEALTHSOUTH
OF YORK, INC.
|
DE
|
HealthSouth
Rehabilitation Hospital of York; HealthSouth Rehabilitation Center of
Industrial Highway; HealthSouth Rehabilitation Center - Shrewsbury;
HealthSouth Rehabilitation Center - Red Lion; HealthSouth Rehabilitation
Center of Queen Street; HealthSouth Rehabilitation Center - Chester
Square; HealthSouth at Country Meadows of Leader Heights; HealthSouth at
Country Meadows of York
|
HEALTHSOUTH
Rehabilitation Center, Inc.
|
SC
|
HealthSouth
Rehabilitation Hospital; HealthSouth Sports Medicine & Rehabilitation
Center
|
HealthSouth
Rehabilitation Hospital of Arlington Limited Partnership
|
AL
|
HEALTHSOUTH
Rehabilitation Hospital of Arlington
|
HealthSouth
Rehabilitation Hospital of South Jersey, LLC
|
DE
|
HealthSouth
Rehabilitation Hospital of Vineland
|
HEALTHSOUTH
Specialty Hospital, Inc.
|
TX
|
HealthSouth
Medical Center; HealthSouth Dallas Medical Center; HSMC Home Health;
HealthSouth Medical Center
|
HEALTHSOUTH
Sub-Acute Center of Mechanicsburg, Inc.
|
DE
|
HealthSouth
Rehabilitation of Mechanicsburg-Renova; HealthSouth Regional Specialty
Hospital; HealthSouth Transitional Rehabilitation Center; HealthSouth
Rehabilitation Hospital for Special Services
|
HEALTHSOUTH
of Altoona, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital of Altoona; HealthSouth Rehabilitation Center -
Regency Square; HealthSouth Bedford Rehabilitation Center; HealthSouth
Rehabilitation Center - Blair Orthopedics; HealthSouth Rehabilitation
Center - Tyrone; HealthSouth Rehabilitation and Orthopedics Center -
Altoona; HealthSouth Rehabilitation Center - Meadowbrook Plaza;
HealthSouth Rehabilitation Center - Richland; HealthSouth Rehabilitation
Center - Edensburg
|
HEALTHSOUTH
of Austin, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital of Austin
|
HEALTHSOUTH
of Dothan, Inc.
|
AL
|
HealthSouth
Rehabilitation Hospital
|
HealthSouth
of East Tennessee, LLC
|
DE
|
HEALTHSOUTH
Rehabilitation Hospital
|
HEALTHSOUTH
of Erie, Inc.
|
DE
|
HealthSouth
Rehabilitation Center of Erie; HealthSouth Lake Erie Institute of
Rehabilitation; HealthSouth Rehabilitation Center -
Sterrettania; HealthSouth Rehabilitation Hospital of Erie;
HealthSouth Occupational Health Services; HealthSouth Rehabilitation
Center - Family First Sports Park; Progressive Rehabilitation Center of
Erie
|
HEALTHSOUTH
of Fort Smith, LLC
|
DE
|
HealthSouth
Home Health Services; HealthSouth Rehabilitation Hospital
of Fort Smith
|
HEALTHSOUTH
of Houston, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital of North Houston; HealthSouth Home Health Agency
of North Houston
|
HEALTHSOUTH
of Montgomery, Inc.
|
AL
|
HealthSouth
Rehabilitation Hospital of Montgomery
|
HEALTHSOUTH
of Pittsburgh, Inc.
|
DE
|
HealthSouth
Hospital of Pittsburgh; HealthSouth Rehabilitation Center - Center Road;
HealthSouth Rehabilitation Center - Connellsville; HealthSouth
Rehabilitation Center - Hempfield; HealthSouth Rehabilitation
Center - Lebanon Church Road; HealthSouth Rehabilitation Center -
Manchester; HealthSouth Rehabilitation Center - Mcknight Road;
HealthSouth Rehabilitation Center - Monroeville; HealthSouth
Rehabilitation Center - North Versailles; HealthSouth
Rehabilitation Center - Schenley Gardens; HealthSouth Rehabilitation
Center - Allison Park
|
HEALTHSOUTH
of Reading, Inc.
|
DE
|
HealthSouth
Reading Rehabilitation Hospital - Boyertown; HealthSouth Reading
Rehabilitation Hospital - Pottstown; HealthSouth
Reading Rehabilitation Hospital - Wyomissing; HealthSouth of
Reading-Green Hills; HealthSouth Reading Rehabilitation At Outlook Pointe;
HealthSouth Reading Rehabilitation Hospital
|
HEALTHSOUTH
of San Antonio, Inc.
|
DE
|
HealthSouth
Rehabilitation Institute of San Antonio; HealthSouth Rehabilitation
Hospital of San Antonio; Rioa
|
HEALTHSOUTH
of Sewickley, Inc.
|
DE
|
HealthSouth
Bridgeville Outpatient Rehabilitation Center; HealthSouth Chippewa
Outpatient Rehabilitation Center; HealthSouth Hospitals of Pittsburgh;
HealthSouth Darlington Outpatient Rehabilitation Center; HealthSouth
Edgeworth Outpatient Rehabilitation Center; HealthSouth Rehabilitation
Hospital of Sewickley; HealthSouth Wexford Outpatient
Rehabilitation Center
|
HEALTHSOUTH
of South Carolina, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital
|
HEALTHSOUTH
of Spring Hill, Inc.
|
DE
|
HealthSouth
Rehabilitation Hospital
|
HEALTHSOUTH
of Tallahassee Limited Partnership
|
AL
|
HealthSouth
- Sterling House; HealthSouth Rehabilitation Center of Perry; HealthSouth
Rehabilitation Center of Wakulla County; HealthSouth Rehabilitation
Hospital of Tallahassee; HealthSouth Outpatient Center - Meadows;
HealthSouth Outpatient Center - Woodmount; HealthSouth Outpatient
Rehabilitation Center of Tallahassee;
HealthSouth Rehabilitation Center - Madison; HealthSouth
Rehabilitation Center - HealthSouth Rehabilitation Center
-
|
HEALTHSOUTH
of Texarkana, Inc.
|
DE
|
HealthSouth
Evaluation Center; HealthSouth Rehabilitation Hospital of Texarkana;
HealthSouth Rehabilitation Center - Texarkana; Texarkana Impairment
Center; HealthSouth Rehabilitation Hospital of
Texarkana
|
HEALTHSOUTH
of Texas, Inc.
|
TX
|
HealthSouth
Evaluation Center; HealthSouth Rehabilitation Center - Mid
Cities; HealthSouth Evaluation Center; Impairment Center of Ft. Worth;
Houston Impairment Center
|
HEALTHSOUTH
of Toms River, Inc.
|
HealthSouth
Garden State Rehabilitation Hospital; HealthSouth Neurocenter of
Plainsboro; HealthSouth Rehabilitation Hospital of New Jersey; HealthSouth
Rehabilitation Center - Toms River; HealthSouth
Rehabilitation Center - Plainsboro; HealthSouth Rehabilitation
Center - Silverton; HealthSouth Rehabilitation Center - Whiting;
HealthSouth Rehabilitation Center of Wall; HealthSouth Rehabilitation
Hospital of Toms River; HealthSouth Rehabilitation Center
of Plainsboro
|
|
HEALTHSOUTH
of Utah, Inc.
|
DE
|
HealthSouth
Home Health Services; HealthSouth Western Rehabilitation Institute;
HealthSouth Rehabilitation Hospital of Utah
|
HEALTHSOUTH/Deaconess,
L.L.C.
|
IN
|
HealthSouth
Deaconess Rehabilitation Hospital; HealthSouth
Tri-State Rehabilitation Hospital
|
HealthSouth/Maine
Medical Center Limited Liability Company
|
ME
|
|
HEALTHSOUTH/Methodist
Rehabilitation Hospital Limited Partnership
|
TN
|
HealthSouth
Rehabilitation Hospital - North
|
HealthSouth
of Ft. Lauderdale Limited Partnership
|
AL
|
HealthSouth
Comprehensive Pain Care Center; HealthSouth Occupational Rehabilitation
& Hand Therapy Center; HealthSouth Sunrise Comprehensive
Pain Care Center; HealthSouth Sunrise Outpatient Center; HealthSouth
Sunrise Outpatient Center at Forest Trace; HealthSouth Sunrise
Rehabilitation Hospital
|
HealthSouth
of Midland, Inc.
|
DE
|
HealthSouth
Home Care of Midland-Odessa; HealthSouth Rehabilitation Hospital of
Midland
|
HealthSouth
of Nittany Valley, Inc.
|
DE
|
HealthSouth
Center for Recovery At Nittany Valley; HealthSouth Rehabilitation Center
of Lewistown; HealthSouth Rehabilitation Center of State College;
HealthSouth Rehabilitation Center of Bellefonte; HealthSouth
Rehabilitation Center of Mifflintown; HealthSouth Rehabilitation Center
Mill Hall; HealthSouth Spine & Rehabilitation Center;
HealthSouth Nittany Valley Rehabilitation Hospital; HealthSouth Outlook
Pointe At Loyalsock
|
HealthSouth
of Treasure Coast, Inc.
|
DE
|
HealthSouth
Rehabilitation Center - Ft. Pierce; HealthSouth Rehabilitation Center -
Treasure Coast; HealthSouth Treasure Coast Rehabilitation Hospital;
HealthSouth Treasure Coast Rehabilitation; HealthSouth Treasure Coast
Rehabilitation - Dodgertown; HealthSouth Treasure Coast Rehabilitation
Services
|
Healthsouth
Bakersfield Rehabilitation Hospital Limited Partnership
|
AL
|
HealthSouth
Rehabilitation Center of Techachapi; HealthSouth Bakersfield
Rehabilitation Hospital
|
Healthsouth
Meridian Point Rehabilitation Hospital Limited Partnership
|
AL
|
HealthSouth
Scottsdale Rehabilitation Hospital
|
Healthsouth
Northern Kentucky Rehabilitation Hospital
Limited Partnership
|
AL
|
HealthSouth
Northern Kentucky Rehabilitation Hospital
|
HealthSouth
Rehabilitation Center of New Hampshire, Ltd.
|
AL
|
HEALTHSOUTH
Rehabilitation Hospital
|
HealthSouth
Rehabilitation Hospital of Altoona, LLC
|
DE
|
|
Healthsouth
Rehabilitation Hospital of Arlington Limited
Partnership
|
AL
|
HEALTHSOUTH
Rehabilitation Center/North Arlington; HEALTHSOUTH Rehabilitation Hospital
of Arlington
|
HealthSouth
Rehabilitation Hospital of New Mexico, Ltd.
|
AL
|
HEALTHSOUTH
Rehabilitation Hospital; HealthSouth Home Health of
Albuquerque
|
HealthSouth
Rehabilitation Hospital of Northern Virginia, Inc.
|
DE
|
|
HealthSouth
Rehabilitation Institute of Tucson, LLC
|
ME
|
HEALTHSOUTH
Rehabilitation Institute Of Tucson; Healthsouth Rehabilitation Institute
of Tucson-Country Club Clinic; HealthSouth Home Health of
Tucson
|
HealthSouth
Valley of the Sun Rehabilitation Hospital
Limited Partnership
|
AL
|
HealthSouth
Valley of The Sun Rehabilitation Hospital
|
Healthsouth
of Largo Limited Partnership
|
AL
|
HealthSouth
Rehabilitation Center of Tarpon Springs; HealthSouth
Rehabilitation Hospital; HealthSouth Town N'Country; HealthSouth
Seminole
|
HealthSouth
of New Mexico, Inc.
|
NM
|
|
Healthsouth
of Sarasota Limited
|
AL
|
HealthSouth
Bee Ridge Therapy Center; HealthSouth Fort Myers Therapy Center;
HealthSouth Gulf Gate Therapy Center; HealthSouth Northside
Therapy Center; HealthSouth Rehabilitation Center - Ft. Myers; HealthSouth
Rehabilitation Center- Northside; HealthSouth Rehabilitation
Hospital of Sarasota; HealthSouth Aaron Mattes Therapy Center;
Outpatient Rehabilitation & Sports Medicine Center
|
K.C.
Rehabilitation Hospital, Inc.
|
DE
|
Mid
America Rehabilitation Hospital
|
Kansas
Rehabilitation Hospital, Inc.
|
DE
|
Kansas
Rehabilitation Hospital, A Joint Venture of HealthSouth and
Stormont-Vail Healthcare; KRH Home Health, A Division of Kansas
Rehabilitation Hospital
|
Lakeshore
System Services of Florida, Inc.
|
FL
|
HealthSouth
Emerald Coast Outpatient Center; HealthSouth Emerald Coast Rehabilitation
Clinic; HealthSouth Emerald Coast Rehabilitation
Hospital; HealthSouth Emerald Coast Sports & Rehabilitation
Center; HealthSouth Outpatient Sleep Clinic; HealthSouth Emerald Coast
Rehabilitation Center; HealthSouth Rehabilitation Center of
Crestview
|
Lakeview
Rehabilitation Group Partners
|
KY
|
HEALTHSOUTH
Lakeview Rehabilitation Hospital of Central Kentucky; HealthSouth Lakeview
Outpatient
|
New
England Rehabilitation Management Co, Inc.
|
NH
|
Fairlawn
Rehabilitation Hospital
|
New
England Rehabilitation Services of Central Massachusetts,
Inc.
|
MA
|
Fairlawn
Rehabilitation Hospital
|
HealthSouth
Specialty Hospital of North Lousiana, LLC
|
LA
|
HealthSouth
Specialty Hospital of North Louisiana
|
Piedmont
HealthSouth Rehabilitation, LLC
|
SC
|
|
Plano
Health Associates LP
|
DE
|
|
Rebound,
LLC
|
DE
|
HEALTHSOUTH
Lakeshore Rehabilitation Hospital; HEALTHSOUTH Lakeshore Outpatient;
HEALTHSOUTH Rehabilitation Hospital Of North Alabama; HEALTHSOUTH
Rehabilitation Hospital Of North Alabama; HEALTHSOUTH Central Georgia
Rehabilitation Hospital; HEALTHSOUTH Rehabilitation Center - Central
Georgia; HEALTHSOUTH Chattanooga Rehabilitation Hospital; HEALTHSOUTH
Rehabilitation Hospital Of Huntington; HEALTHSOUTH Cane Creek
Rehabilitation Hospital; HEALTHSOUTH Lakeshore Carraway Rehabilitation
Unit
|
Rehab
Concepts Corporation
|
DE
|
Clear
Lakes Concepts Corp.
|
Rehabilitation
Hospital Corporation Of America
|
DE
|
HealthSouth
Chesapeake Rehabilitation Hospital; HealthSouth Rehabilitation Hospital of
Virginia; American Rehabilitation Hospital Corporation; HealthSouth
Rehabilitation Center - Vienna; HealthSouth Southern
Hills Rehabilitation Center; HealthSouth Rehabilitation Center
- Bluefield; HealthSouth Southern Hills Rehabilitation Hospital;
HealthSouth Western Hills Regional Rehabilitation
Hospital
|
Rehabilitation
Hospital of Colorado Springs, Inc.
|
DE
|
HealthSouth
Rehabilitation Center At The Pavilion; HealthSouth Rehabilitation Hospital
of Colorado Springs; HealthSouth Transitional Care Unit; Hand Centers of
Colorado; HealthSouth Rehabilitation Center of Skyline; HealthSouth
Rehabilitation Center - Colorado Springs; HealthSouth Rehabilitation
Center - North Pueblo; Occupational Medicine Centers of Colorado; The
Language - Learning Center, Inc.; The Womens Center For
Rehabilitation
|
Rehabilitation
Hospital of Fredericksburg, Inc.
|
DE
|
Healthsouth
Rehabilitation Hospital of Fredericksburg
|
Rehabilitation
Hospital of Nevada - Las Vegas, Inc.
|
DE
|
HEALTHSOUTH
Rehabilitation Hospital Of Las Vegas
|
Rehabilitation
Hospital of Nevada - Las Vegas, L.P.
|
DE
|
HealthSouth
Rehabilitation Hospital - Charleston Clinic;
HealthSouth Rehabilitation Hospital of Las
Vegas
|
Rehabilitation
Hospital of Petersburg, Inc.
|
DE
|
Healthsouth
Rehabilitation Hospital of Petersburg
|
Rehabilitation
Hospital of Phenix City, LLC
|
AL
|
Regional
Rehabilitation Hospital
|
Rehabilitation
Hosptal of Plano, Inc.
|
TX
|
|
Rehabilitation
Institute Of Western Massachusetts, Inc.
|
MA
|
HealthSouth
Sports Medicine and Rehabilitation Center - Belchertown;
HealthSouth Rehabilitation Hospital of Western
Massachusetts
|
Rusk
Rehabilitation Center, LLC
|
MO
|
Howard
A. Rusk Rehabilitation Center
|
Sarasota
LTAC Properties, LLC
|
FL
|
|
Saint
Barnabas / HEALTHSOUTH Rehab Center LLC
|
NJ
|
Rehabilitation
Hospital of Tinton Falls, A Joint Venture of HealthSouth And
Monmouth Medical Center
|
Sherwood
Rehabilitation Hospital, Inc.
|
DE
|
|
Southeast
Texas Rehabilitation Hospital, Inc.
|
TX
|
|
Southern
Arizona Regional Rehabilitation Hospital, L.P.
|
DE
|
HealthSouth
Rehabilitation Hospital of Southern Arizona; HealthSouth Rehabilitation
Center - Park/Ajo
|
Tarrant
County Rehabilitation Hospital, Inc.
|
TX
|
HEALTHSOUTH
City View Rehabilitation Hospital; HealthSouth Rehabilitation Center of
Burleson
|
Trident
NeuroSciences Center, LLC
|
SC
|
HEALTHSOUTH
Rehabilitation Hospital Of Charleston (no dba filing requirement in
SC)
|
Tyler
Rehab Associates LP
|
DE
|
HealthSouth
Rehabilitation Hospital of Tyler, an Affiliate of Trinity
Mother
|
University
of Virginia/HEALTHSOUTH, L.L.C.
|
VA
|
HealthSouth
Rehabilitation Center; UVA-HealthSouth
Rehabilitation Hospital
|
Van
Matre Rehabilitation Center LLC
|
IL
|
Van
Matre HealthSouth Rehabilitation Hospital
|
Vanderbilt
Stallworth Rehabilitation Hospital, L.P.
|
TN
|
Vanderbilt
Stallworth Rehabilitation Hospital
|
West
Virginia Rehabilitation Hospital, Inc.
|
WV
|
HealthSouth
Mountain View Regional Rehabilitation Hospital
|
Yuma
Rehabilitation Hospital, LLC
|
AZ
|
Yuma
Rehabilitation Hospital, A Partnership of HealthSouth & Yuma Regional
Medical Center
|
1.
|
I
have reviewed this annual report on Form 10-K of HealthSouth
Corporation;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and
have:
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
(b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant’s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the audit committee of the registrant’s
board of directors (or persons performing the equivalent
functions):
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
HealthSouth Corporation | |||
|
By:
|
/s/ J AY G RINNEY | |
Name: Jay Grinney | |||
Title: President and Chief Executive Officer | |||
1.
|
I
have reviewed this annual report on Form 10-K of HealthSouth
Corporation;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
(b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant’s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the audit committee of the registrant’s
board of directors (or persons performing the equivalent
functions):
|
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
HealthSouth Corporation | |||
|
By:
|
/s/ E DMUND F AY | |
Name: Edmund Fay | |||
Title: Senior Vice President and Treasurer | |||
(principal financial officer) |
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of HealthSouth
Corporation.
|
HealthSouth Corporation | |||
|
By:
|
/s/ J AY G RINNEY | |
Name: Jay Grinney | |||
Title: President and Chief Executive Officer | |||
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of HealthSouth
Corporation.
|
HealthSouth Corporation | |||
|
By:
|
/s/ EDMUND FAY | |
Name: Edmund Fay | |||
Title: Senior Vice President and Treasurer | |||
(principal financial officer) |